<?xml version="1.0" encoding="utf-8"?>
<add>
	<doc>
		<field name="docid">BR-TU.13441</field>
		<field name="filename">19409_Jackeline%20da%20Costa%20Maciel_TESE.pdf</field>
		<field name="filetype">PDF</field>
		<field name="text">
 

UNIVERSIDADE FEDERAL DE PERNAMBUCO 

CENTRO DE CIÊNCIAS BIOLÓGICAS 

PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS BIOLÓGICAS 

 

 

 

 

 

JACKELINE DA COSTA MACIEL 

 

 

 

COMPÓSITOS DE PARTÍCULAS MAGNÉTICAS E POLÍMEROS PARA 
IMOBILIZAÇÃO DE TRIPSINA  

 

 

 

 

 

 

 

 

 

 

 

 
 
 
 
 
 

Recife 
2012 

Tese apresentada ao Programa de Pós-Graduação em 
Ciências Biológicas para obtenção do título de Doutora em 
Ciências Biológicas pela Universidade Federal de 
Pernambuco. 

Orientador: Prof. Dr. Luiz Bezerra de Carvalho Júnior 

Co-orientadora: Profa. Dra. Maria da Paz Carvalho da Silva 

Co-orientador: Prof. Dr. David Fernando Morais Neri 



 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Elaine Barroso 
CRB 1728 

 
 
 
 

Maciel, Jackeline da Costa 
      Compósitos de partículas magnéticas e polímeros para imobilização 
de tripsina/ Jackeline da Costa Maciel. – Recife: O Autor, 2012. 
        
      104 folhas : il., fig., tab. 

 Orientador: Luiz Bezerra de Carvalho Júnior 
         Coorientadores: Maria da Paz Carvalho da Silva e David 

Fernando Morais Neri 
 Tese (doutorado) – Universidade Federal de Pernambuco, 

Centro de Ciências Biológicas. Ciências Biológicas, 2012. 
Inclui bibliografia e anexos 

 
1. Enzimas 2. Biotecnologia 3. Polímeros I.  Carvalho Júnior, 

Luiz Bezerra de (orientador) II. Silva, Maria da Paz Carvalho da 
(coorientadora) III. Neri, David Fernando Morais IV. Título 

 
                                             
572.7             CDD (22.ed.)                UFPE/CCB-2012-211                                                           
                               

 
 
 
 
 
 
 
 
 



 
 
 
 
 
 
 
 
 
 
 
 
 
 
 



JACKELINE DA COSTA MACIEL 

 

COMPÓSITOS DE PARTÍCULAS MAGNÉTICAS E POLÍMEROS PARA 
IMOBILIZAÇÃO DE TRIPSINA 

 

 

Tese apresentada ao Programa de Pós-Graduação em Ciências Biológicas para obtenção do título de 
Doutora em Ciências Biológicas (Área de concentração Biotecnologia) pela Universidade Federal 
de Pernambuco. 

 

Aprovada em 26 de julho de 2012 pela banca examinadora: 

 
 

  
Prof. Dr. Luiz Bezerra de Carvalho Júnior 

Departamento de Bioquímica/UFPE 
Orientador e Presidente da banca 

 
 
 

Profa. Dra. Adriana Fontes 
Departamento de Biofísica e Radiobiologia/UFPE 

Examinadora 
 
 

 
Profa. Dra. Maria Danielly Lima de Oliveira 

Departamento de Bioquímica/UFPE 
Examinadora 

 
 
 

Prof. Dr. José Luiz de Lima Filho 
Departamento de Bioquímica/UFPE 

Examinador 
 
 
 

Dr. Ian Porto Gurgel do Amaral 
Pesquisador do Departamento de Bioquímica/UFPE 

Examinador 
 
  

 
 
 



 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Para minha avó, Orminda (in memorian),  

pelo amor incondicional que sempre demonstrou por mim.  

 

Para minha mãe, Márcia, pelo grande exemplo de mãe e mulher. 

 

Para meu pai, Ronaldo, por tudo que me ensinou. 

 

Para o grande amor da minha vida, Humberto,  

por ser essa pessoa maravilhosa e que eu amo tanto. 

 



AGRADECIMENTOS 

Gostaria de agradecer a todos aqueles que colaboraram direta ou indiretamente para a realização 
deste trabalho. 
 
Ao meu orientador, Prof. Luiz Bezerra de Carvalho Júnior, pela paciência e confiança depositados 
ao longo desses quatro anos. 
 
À minha co-orientadora, Profa. Maria da Paz Carvalho da Silva, pela amizade, respeito e 
credibilidade desde a iniciação científica. 
 
Ao meu co-orientador, Prof. David Fernando Morais Neri, pela disponibilidade e ajuda na 
publicação do meu primeiro artigo como “primeira-autora”. 
 
Ao Prof. José Albino Aguiar (Departamento de Física, UFPE), pela colaboração valiosa e 
credibilidade. 
 
Ao Prof. Cláudio Antônio Cardoso (Departamento de Física, UFSCar), pelas análises de 
magnetometria e pelas discussões esclarecedoras. 
 
À Profa. Maristela Olzon-Dionysio (Departamento de Física, UFSCar) e a Willian Takemitsu 
Shigeyosi (Doutorando em Física, UFSCar), pelas análises de Mössbauer e por toda ajuda na 
interpretação dos resultados. 
 
À Profa. Márcia Attias, ao Prof. Kildare Miranda e ao MSc. Thiago Luiz Moreira (Laboratório de 
Ultraestrutura Celular Herta Meyer, UFRJ), pelas análises de microscopia eletrônica de transmissão 
e pelos relatórios exemplares disponibilizados. 
 
Ao CNPq e à FACEPE, pelo apoio financeiro concedido. 
 
Ao Laboratório de Imunopatologia Keizo Asami (LIKA), pela infraestrutura fornecida para 
realização dos experimentos. 
 
Aos amigos do Grupo IMOBIO, pelo clima de amizade e coleguismo sempre presentes. 
 
À minha amiga, Mariana Paola Cabrera, pela amizade, carinho e disponibilidade em todos os 
momentos e por ter-me “aguentado” tão pacientemente todas às vezes que lhe pedi “socorro” para 
compreender algo que, muitas vezes, parecia incompreensível. 
 
Às minhas amigas, Priscyla Lima de Andrade e Valdeene Albuquerque Jansen da Silva, pela 
amizade, momentos de descontração e por nossas colaborações científicas em todos esses anos. 
 
A TODOS os meus queridos amigos, pela amizade e bons momentos compartilhados. 
 
Aos meus irmãos, cunhados e cunhadas, tios e tias, avô, primos e primas e à minha exclusivíssima 
sobrinha Brenda Laryssa, pela força e pelo apoio dados desde que cada um começou a fazer parte 
da minha vida. 
 
Aos meus pais, Márcia e Ronaldo, pelo amor, confiança e apoio sempre incondicionais. 
 
Ao meu esposo, Humberto Silva, pela amizade, carinho, paciência, companheirismo e acima de 
tudo amor. Amo você! 



 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

“... Um trabalho científico não deve ser avaliado do ponto de vista de sua utilidade direta.  

Ele precisa ser feito por si só, pela beleza da ciência.” 

 

Marie Curie (1867–1934) 

  



Resumo 
 
As enzimas são muito utilizadas em processos industriais; então, a busca por novas tecnologias, que 
permitam o uso otimizado dessas biomoléculas, confere redução dos custos e permite melhor 
rendimento da enzima. Uma das alternativas para isso consiste na imobilização dessas proteínas em 
suportes insolúveis. Dentre os diferentes tipos de suportes existentes, os compósitos de 
nanopartículas magnéticas e polímeros apresentam algumas vantagens, tais como: oferecem maior 
área superficial para ligação da enzima devido ao reduzido tamanho; permitem a rápida separação 
utilizando apenas um campo magnético externo e a presença do revestimento polimérico contribui 
com grande quantidade de grupos funcionalizáveis. Embora se conheçam todas as ferramentas, é 
preciso escolher as mais adequadas para a aplicação desejada. Neste trabalho, foram produzidos 
compósitos de partículas magnéticas e polímeros. Dois tipos de polímeros foram utilizados, o 
polissacarídeo levana e o polímero sintético polianilina (PANI). Nosso objetivo foi obter derivados 
enzimáticos com boa retenção de atividade. O compósito de partículas magnéticas e levana foi 
obtido pelo método de co-precipitação na presença do polissacarídeo. Para produção do compósito 
com PANI, o polímero só foi adicionado após a síntese das partículas magnéticas por co-
precipitação. O processo de revestimento das partículas magnéticas com PANI foi otimizado por 
meio do uso de dois planejamentos fatoriais completos (23). Propriedades físicas, químicas e 
magnéticas de ambos os compósitos foram determinadas através de técnicas de microscopia 
eletrônica, FTIR, difração de raios-X, espectroscopia Mössbauer, área de superfície BET e 
porosidade e medidas de magnetização. Os resultados mostraram que as partículas magnéticas 
sintetizadas, na ausência do polímero, possuem menores tamanhos e estrutura cristalina bem 
definida. Ambos compósitos foram utilizados para imobilização de tripsina. No caso do compósito 
de partículas magnéticas e levana, após dez reutilizações, o derivado enzimático exibiu 84% de sua 
atividade inicial. Em relação, a tripsina imobilizada em compósito de partículas magnéticas e PANI, 
o derivado enzimático apresentou maior estabilidade térmica em temperaturas acima de 25C°; 
maior afinidade pelo substrato BAPNA (Kmap 1,4 vezes menor que aquele para enzima solúvel); 
pequena redução na eficiência catalítica (1,1 vezes menor que aquele para enzima solúvel); retenção 
de 89% de sua atividade inicial após 48 dias de estocagem a 4°C e retenção de 81% de sua atividade 
inicial após vinte reutilizações. Tanto o compósito magnético com PANI quanto aquele com levana 
apresentaram bom resultado quanto à retenção da atividade da enzima imobilizada, sendo o 
derivado com PANI o de menor custo. 
 
 
 
Palavras-chave: partículas magnéticas, levana, polianilina, imobilização, tripsina 

 
 

 

  



Abstract 
 

Enzymes are widely used in industrial processes, so the search for new technologies that allow the 
optimal use of these biomolecules, provides reduced costs and allow better use of the enzyme. An 
alternative to this is the immobilization of these proteins on insoluble supports. Among the different 
types of existing supports, the composite magnetic nanoparticles and polymers have certain 
advantages such as providing greater surface area for binding of the enzyme due to the reduced size; 
allow rapid separation using only an external magnetic field and the presence of the polymeric 
coating contributes large amounts of functional groups. Although you can learn all the tools you 
need to choose the most appropriate for the desired application. In this paper, were produced 
composite magnetic particles and polymers. Two types of polymers were used: the polyaniline 
(PANI) and the polysaccharide levan. Our goal was to obtain enzymatic derivatives with good 
retention of activity. The composite magnetic particles and levan was produced by co-precipitation 
in the presence of the polysaccharide. For production of the composite with PANI, the polymer was 
only added after synthesis of the magnetic particles by co-precipitation. The process of coating 
magnetic particles with PANI was optimized by using two full factorial design (23). Physical, 
chemical and magnetic properties of both composites were determined by electron microscopy, 
FTIR, X-ray diffraction, Mössbauer spectroscopy, BET surface area and porosity, and 
magnetization measurements. The results showed that the magnetic particles synthesized in the 
absence of polymer exhibit lower sizes and have well defined crystal structure. Both composites 
were used for immobilization of the trypsin. In the case of the composite of magnetic particles and 
levan, after ten reuses, the enzymatic derivative exhibited 84% of its initial activity. Regarding the 
immobilized trypsin on composite of magnetic particles and PANI, the enzymatic derivative had 
greater thermal stability at temperatures up to 25°C, greater affinity for the substrate BAPNA (Kmap 
1.4 times lower than that for the soluble enzyme), a slight decrease in catalytic efficiency (1.1 times 
lower than that for soluble enzyme), retaining 89% of its initial activity after 48 days of storage at 
4°C and retaining 81% of its initial activity after twenty reuses. The two magnetic composites 
showed good results with regard to retention of activity of the immobilized trypsin, and the PANI 
derivative with the lowest cost. 
 

Keywords: magnetic particles, levan, polyaniline, immobilization, trypsin 
 

 

  



LISTA DE ILUSTRAÇÕES 
 

Capítulo 1 
 
Figura 1. Molécula de tripsina. Em vermelho, ligações dissulfeto.......................................... 

 
03 

  
Figura 2. Métodos de imobilização de enzimas. Representação esquemática da enzima (em 
azul) e do suporte (em roxo).................................................................................................... 

05 

  
Figura 3. Interação entre suporte e enzima.............................................................................. 06 
  
Figura 4. Procedimento de extração em fase sólida magnética............................................... 
 

09 

Figura 5. Representação do octaedro de ferro (a) e sua polimerização pelo ápice (b), aresta (c) 
e face (d).............................................................................................................................. 
 

 
10 

Figura 6. Estrutura de espinélio inversa da magnetita. (a) ilustração de célula unitária cúbica; 
(b) organização ferrimagnética na magnetita; lustração do plano [1, 1, 1].................. 

 
12 

  
Figura 7. Representação esquemática da superfície de nanopartículas magnéticas (Fe3O4) 
com e sem revestimento orgânico na presença de um campo magnético aplicado. As setas 
representam o momento ferrimagnético resultante...................................................................  

 
 

14 
  
Figura 8. Estrutura química da levana..................................................................................... 15 

 
Figura 9. Desenho esquemático de um “nanobead” magnético que aprisiona moléculas de 
enzima em sua camada de sílica............................................................................................... 

 
20 

  
Figura 10. Aplicações médicas de nanopartículas magnéticas................................................  21 
  
 
Capítulo 2 

 
Figure 1. Pareto chart for the effects of variables KMnO4 concentration (a), aniline 
concentration (b) and polymerization time (c) on residual specific activity of mPANIG-
Trypsin from 1st factorial design.................................................................................................   

 
 

46 
  
Figure 2. Pareto chart for the effects of variables contact time of KmnO4 (d), polymerization 
temperature € and offered protein (f) on residual specific activity of mPANIG-Trypsin from 
2nd factorial design.......................................................................................................................   

 
 

47 
  
Figure 3. Thermal stability of the mPANIG-Trypsin (B). The obtained activities were 
referred to the highest activity (100%)……………………........................................................ 

 
49 

  
Figure 4. Shelf life of mPANIG-Trypsin at 4°C stored in Tris-HCl buffer................................ 50 
  
  



Capítulo 3 
 
Figure 1. Electron microscopic images. TEM image of (A) magnetic nanoparticles and SEM 
images of (B) magnetic nanoparticles, (C) mPANI (lower resolution), (D) mPANI (higher 
resolution)......................................................................................................................................  

 
 
 
 
62 
 

Figure 2. FTIR spectra of magnetic nanoparticles and mPANI..................................................  64 
  
Figure 3. Nitrogen adsorption/desorption isotherms of magnetic nanoparticles and mPANI..... 65 

Figure 4. XRD patterns of magnetic nanoparticles and mPANI................................................. 66 
  
Figure 5. Mössbauer spectra of (A) magnetic nanoparticles and (B) mPANI............................. 67 
  
Figure 6. Magnetization curves of magnetic nanoparticles and mPANI at 298 K and 323 K..... 69 

 
Figure 7. Specific activity of mPANIG-Trypsin. The immobilized trypsin on mPANIG was 
incubated with a 4 mM initial concentration of BAPNA and Tris-HCl buffer. After each cycle, 
the derivative were washed before new step.................................................................................  

 
 

70 
 
 

Capítulo 4 
 
Figura 1. Scanning electron microscopy images of magnetite (A) and magnetic levan (B) 
particles........................................................................................................................................  

 
80 

  
Figura 2. Magnetization curves of magnetite (A) and magnetic levan (B) particles at 293 K 
and 313 K....................................................................................................................................  

 
81 

  
Figura 3. X-ray powder diffraction patterns of magnetite and magnetic levan particles..........  81 

Figura 4. FTIR spectra of the levan polysaccharide (A), magnetic levan (B) and magnetite 
(C)............................................................................................................................................... 

 
82 

  
Figura 5. Re-utilization of immobilized trypsin (?) and magnetic levan (?) particles. The 
maximum specific activity of enzyme (100%) was 20.65±0.69 mU/mg for trypsin 
immobilized on magnetic levan and 18.59±0.08 mU/MG for trypsin immobilized on 
magnetite.....................................................................................................................................  

 
 
 

82 
 

  



LISTA DE TABELAS  
 

Capítulo 1 
 
Tabela 1. Fatores que influenciam o desempenho de um sistema de enzima imobilizada............. 07 
  
Tabela 2. Os três estados de oxidação mais importantes da polianilina: leucoesmeraldina, 
esmeraldina (isolante e condutora) e pernigranilina................................................................... 
 

 
18 

 
Capítulo 2 

 
Table 1. Matrix of experiments and results for 1st factorial design........................................... 45 

 
Table 2. Main and interaction effects for the 1st complete factorial design………..................... 
 

45 
 

Table 3. Matrix of experiments and results for 2nd factorial design........................................... 47 
  
Table 4. Main and interaction effects for the 2nd complete factorial design …........................... 
 

48 

Table 5. Identified peptide residues obtained from 15 min digestion using mPANIG-Trypsin... 51 

 
 
Capítulo 3 

 
Table 1. Analyzed results of Mössbauer spectra for magnetic nanoparticles and mPANI. Bhf: 
hyperfine field; ?: quadrupole splitting; ?: isomer shift relative to the isomer shift of ?-iron at 
room temperature............................................................................................................................ 

 
 

68 

 

  

 

 

 

  



LISTA DE ABREVIATURAS E SIGLAS  

 
 

mPANI  compósito de nanopartículas magnéticas e polianilina 
T  Temperatura 
M  Magnetização 
H  Campo magnético 
T  tesla 
nm   nanômetro 
µm   micrômetro 
°C   Grau celsius 
pH   Potencial hidrogeniônico 
Tris   Tris (hidroximetil) aminometano 
DRX   Difração de raios-X 
XDR   X-ray Diffractometry 
MEV   Microscopia Eletrônica de Varredura 
SEM   Scanning Electron Microscopy 
IV   Infravermelho 
FTIR  Fourier Transform Infrared 
Km   Constante de Michaelis-Menten 
Vmax   Velocidade máxima 
2?  Ângulo de espalhamento (graus) 
?  Comprimento de onda 
K  kelvin 
Oe  oersted 
KOe  kilooersted 
cm-1  número de ondas 
mg  miligrama 
atm  atmosfera 
emu  unidade eletromagnética 
g  grama 
min  minuto 
h  hora 
M  molar 
mM  milimolar 
mL  mililitro 
µL  microlitro 
µmol  micromol 
U  unidade 
Bhf  campo hiperfino 
?  desdobramento quadrupolar 
?  deslocamento isomérico 
  



xii 

 

SUMÁRIO 
 

1. Introdução................................................................................................................... 01 
  
Capítulo 1  
2. Revisão Bibliográfica...................................................................................................... 03 
2.1. Enzimas proteolíticas ou proteases............................................................................... 03 
2.2. Imobilização de enzimas em suportes insolúveis............................................................ 04 
   2.2.1. Classificação das enzimas imobilizadas.................................................................... 04 
   2.2.2. Métodos de imobilização de enzimas........................................................................ 05 
   2.2.3. Suportes para a imobilização de enzimas.................................................................. 06 
   2.2.4. Vantagens e limitações da imobilização de enzimas................................................. 07 
2.3. Sistemas de imobilização de biomoléculas: partículas magnéticas................................. 08 
   2.3.1. Óxidos de ferro: os principais tipos de núcleo magnético......................................... 09 
   2.3.2. Magnetita e maghemita: os óxidos de ferro mais utilizados......................................  11 
2.4.  Estabilidade de partículas magnéticas............................................................................ 14 
   2.4.1. Polissacarídeos como revestimento: levana.............................................................. 15 
   2.4.2. Polímeros orgânicos sintéticos como revestimento: polianilina................................ 16 
2.5. Aplicações de partículas magnéticas na área biomédica e biotecnológica...................... 18 
   2.5.1. Imagem por ressonância magnética (IRM)............................................................... 19 
   2.5.2. Separação magnética................................................................................................. 19 
   2.5.3. Imobilização de enzimas........................................................................................... 19 
   2.5.4. Hipertermia magnética.............................................................................................. 20 
   2.5.5. Carreador de fármacos............................................................................................... 21 
   2.5.6. Chips de células............................................................................................... 21 
  
3. Referências bibliográficas.................................................................................................. 23 
  
Capítulo 2  
4. Artigo submetido ao periódico Analytica Chimica Acta.................................................... 38 
  
Capítulo 3  
5. Artigo submetido ao periódico Composites Science and Technology............................... 55 
  
Capítulo 4  
6. Artigo publicado no periódico Journal of Magnetism and Magnetic Materials................ 78 
  
7. Conclusões.......................................................................................................................... 84 
  
8. Anexos................................................................................................................................ 85 
8.1. Instruções para autores.................................................................................................... 85 
8.2. Comprovação da submissão dos artigos.......................................................................... 100 
   8.2.1. Artigo submetido ao periódico Analytica Chimica Acta........................................... 100 
   8.2.2. Artigo submetido ao periódico Composites Science and Tecnology......................... 101 
8.3. Artigos publicados em periódicos................................................................................... 102 
8.4. Artigos a serem submetidos............................................................................................. 102 
8.5. Trabalhos apresentados em congressos........................................................................... 102 
8.6. Participação em bancas examinadoras............................................................................ 103 
8.7. Orientações e colaborações............................................................................................. 104 
 

  



1 

 

1. Introdução 

A proteólise é uma das etapas mais importantes para o sequenciamento de proteínas em 

pesquisa proteômica (PARKER e TOMER, 2000; WANG, 2002), sendo a tripsina a enzima 

proteolítica mais utilizada nessa etapa. A imobilização dessas enzimas em suportes insolúveis visa 

diminuir o longo tempo de digestão quando comparado à enzima em sua forma solúvel. As 

vantagens das enzimas imobilizadas, em relação às solúveis, surgem de sua maior estabilidade e 

facilidade de separação do meio de reação, o que acarreta economia significativa no custo global do 

processo (BON et al., 2008). 

As propriedades das preparações de enzimas imobilizadas são influenciadas pelas 

propriedades da enzima e do material do suporte (TISCHER e KASCHE, 1999). A interação entre 

esses dois componentes proporciona um derivado imobilizado com propriedades químicas, 

bioquímicas, mecânicas e cinéticas específicas. A imobilização da enzima tem um efeito benéfico 

na sua estabilidade, em função das interações físicas e químicas entre o suporte e as moléculas da 

enzima (DE CASTRO e ANDERSON, 1995; VILLENEUVE et al., 2000). Diferentes tipos de 

materiais têm sido usados como suportes para imobilização de enzimas, entre eles os suportes que 

possuem propriedade magnética. Além de serem utilizadas como adsorventes em separação 

magnética, essas partículas, dentro da escala nanométrica à micrométrica, estão sendo usadas em 

um número crescente de aplicações médicas devido a não toxicidade (ITO et al., 2005; TOKORO et 

al., 2009). 

Óxidos de ferro com estrutura “core/shell” são os mais usados como fontes de materiais 

magnéticos (DRBOHLAVOVA et al., 2009). Este tipo de estrutura consiste em partículas 

magnéticas formadas por um núcleo magnético (“core”) e um revestimento (“shell”). No entanto, 

somente maghemita e magnetita encontraram maior interesse em bioaplicações (TUCEK et al., 

2006). Vários procedimentos sintéticos foram desenvolvidos para sintetizar nanopartículas de óxido 

de ferro (AH et al., 2007), sendo o método de co-precipitação o procedimento mais simples, barato 

e ecologicamente correto, que envolve a precipitação simultânea de íons Fe2+ e Fe3+ em meio 

aquoso básico (KANG et al., 1996; QU et al., 1999).  

As nanopartículas de óxido de ferro apresentam alta sensibilidade magnética e baixa 

toxicidade, porém pequena estabilidade coloidal na fase aquosa. Modificações da superfície dessas 

partículas representam um ponto-chave para impedir a agregação e para torná-las altamente 

monodispersas (SAWANT et al., 2009). Para melhorar a estabilidade e biocompatibilidade, 

nanopartículas de óxido de ferro são frequentemente modificadas com alguns surfactantes ou 

polímeros (BERRY et al., 2003). O uso de um revestimento de superfície adequado permite que 

essas nanopartículas sejam dispersas dentro de fluidos homogêneos e melhorem sua estabilidade. 

Vários grupos de materiais de revestimento são usados para modificar a superfície química de 



2 

 

nanopartículas magnéticas (SHUBAYEV et al., 2009) tais como polímeros orgânicos, surfactantes 

orgânicos, metais inorgânicos, óxidos inorgânicos, moléculas e estruturas bioativas. 

O objetivo deste trabalho foi produzir derivados enzimáticos magnéticos para serem 

utilizados em digestão de proteínas. Sabe-se que a presença do revestimento polimérico confere 

estabilidade às partículas magnéticas, diminuindo sua agregação e melhorando a 

biocompatibilidade; além de estabilizar a enzima imobilizada. A escolha dos polímeros foi baseada 

em alguns critérios. No caso da polianilina, o fato de ser um polímero de fácil síntese e de baixo 

custo foram fatores importantes; além de ser promissor para uso em biossensores. Já o 

polissacarídeo levana, foi escolhido por ser biocompatível, não tóxico e possuir propriedades 

biológicas interessantes para aplicações em sistemas de liberação de drogas e hipertermia 

magnética. 

Uma vez que a presença do revestimento forneceria uma superfície quimicamente 

controlada, esses compósitos magnéticos poderiam ser usados como suportes para imobilizar 

tripsina. Com o objetivo inicial de aplicar estes derivados enzimáticos na etapa de proteólise, que 

antecede a identificação e o sequenciamento de uma proteína e, assim diminuindo custos, reduzindo 

o tempo de digestão e tornando o procedimento o mais simples possível. No entanto, outras 

possíveis aplicações para estes materiais também são visadas, como a montagem de reatores para 

produção de hidrolisados protéicos.  

 



 

2. Revisão da literatura 

2.1. Enzimas proteolíticas ou proteases

 As proteases são amplamente utilizadas em aplicações industriais e biomédicas, entre as 

quais a tripsina (Figura 1) foi mais extensivamente empregada. 

atrai considerável interesse devido a

de detergentes, no amaciamento do couro, 

nutricional (ROCHA et al., 2011), 

BANUMATHI et al., 2009; YANG 

de sequenciamento (SCHUCHERT

fibrose cística (TZETIS et al., 2007) e pancreatite crônica (CHEN 

aplicações são limitadas no que diz respeito 

durante os períodos operacionais e de estocagem resultantes da autólise, desnaturação e agregação 

dessas enzimas (VILLALONGA et al., 2000). A imobilização de enzimas pode superar essas 

limitações; a imobilização estabiliza a estrutura e, por conseguinte, 

pontos-chave são o suporte e o método de imobilização adequados (NIKOLIC et al., 2010).

 

Figura 1. Molécula de tripsina. Em vermelho, ligações dissulfeto. 

 Dependendo das propriedades do suporte, a simples sedimentação, filtração ou centrifução 

podem ser suficientes. Se propriedades magnéticas podem ser adicionadas

removido com maior facilidade e rapidez 

2011). Por essa vantagem, a imobilização de tripsina em suporte magnético tem sido considerada 

como um procedimento potencialmente poderoso nos últimos anos (AMARAL et al., 

al., 2007; BAYRAMO?LU et al., 2008

crescente na área de proteômica induz esforços intensivos para desenvolver metodologias analíticas 

automatizadas, sensíveis e com alto rendimento. 

2.1. Enzimas proteolíticas ou proteases 

As proteases são amplamente utilizadas em aplicações industriais e biomédicas, entre as 

foi mais extensivamente empregada. A tripsina, uma serino protease,

atrai considerável interesse devido a sua ampla variedade de aplicações, tais como

de detergentes, no amaciamento do couro, na produção de hidrolisados protéicos com valor 

nutricional (ROCHA et al., 2011), em cultura de células e tecidos (SOLEIMANI 

2009; YANG et al., 2009), na identificação de proteínas por meio de técnicas 

(SCHUCHERT-SHI e HAUSER, 2009), em doenças pancreáticas, incluindo 

2007) e pancreatite crônica (CHEN et al., 

aplicações são limitadas no que diz respeito a sua instabilidade e rápida perda de atividade catalítica 

durante os períodos operacionais e de estocagem resultantes da autólise, desnaturação e agregação 

dessas enzimas (VILLALONGA et al., 2000). A imobilização de enzimas pode superar essas 

imobilização estabiliza a estrutura e, por conseguinte, a atividad

método de imobilização adequados (NIKOLIC et al., 2010).

 
. Em vermelho, ligações dissulfeto. Fonte: http://prince.openwetware.org/FASP.html

 

Dependendo das propriedades do suporte, a simples sedimentação, filtração ou centrifução 

podem ser suficientes. Se propriedades magnéticas podem ser adicionadas ao suporte, ele pode ser 

com maior facilidade e rapidez pela aplicação de um campo magnético

imobilização de tripsina em suporte magnético tem sido considerada 

como um procedimento potencialmente poderoso nos últimos anos (AMARAL et al., 

LU et al., 2008; SUN et al., 2011; MACIEL et al., 2012)

crescente na área de proteômica induz esforços intensivos para desenvolver metodologias analíticas 

automatizadas, sensíveis e com alto rendimento. Por exemplo, Krogh et al. (1999) demonstraram a 

3 

Capítulo 1 

As proteases são amplamente utilizadas em aplicações industriais e biomédicas, entre as 

, uma serino protease, 

tais como na composição 

na produção de hidrolisados protéicos com valor 

SOLEIMANI et al., 2009; 

na identificação de proteínas por meio de técnicas 

em doenças pancreáticas, incluindo 

 2009). Contudo, suas 

sua instabilidade e rápida perda de atividade catalítica 

durante os períodos operacionais e de estocagem resultantes da autólise, desnaturação e agregação 

dessas enzimas (VILLALONGA et al., 2000). A imobilização de enzimas pode superar essas 

a atividade da enzima. Os 

método de imobilização adequados (NIKOLIC et al., 2010). 

nce.openwetware.org/FASP.html 

Dependendo das propriedades do suporte, a simples sedimentação, filtração ou centrifução 

ao suporte, ele pode ser 

pela aplicação de um campo magnético (ROCHA et al., 

imobilização de tripsina em suporte magnético tem sido considerada 

como um procedimento potencialmente poderoso nos últimos anos (AMARAL et al., 2006; LIU et 

; MACIEL et al., 2012). O interesse 

crescente na área de proteômica induz esforços intensivos para desenvolver metodologias analíticas 

plo, Krogh et al. (1999) demonstraram a 



4 

 

rápida digestão de proteínas usando enzimas imobilizadas em “beads” de vidro paramagnético. 

Wang et al. (2008) também ligaram tripsina a nanocómposito magnético para digestão de proteínas, 

resultando em boa sequência de conversão.  

 

2.2. Imobilização de enzimas em suportes insolúveis  

 As vantagens das enzimas imobilizadas, em relação às solúveis, surgem de sua maior 

estabilidade e facilidade de separação do meio de reação, o que acarreta economia significativa no 

custo global do processo, desde que o procedimento de imobilização não seja muito dispendioso, 

haja boa recuperação da atividade enzimática e que a meia-vida operacional da enzima imobilizada 

seja suficientemente longa (BON et al., 2008). 

 De particular interesse é o aumento do uso de enzimas imobilizadas, fisicamente confinadas 

ou localizadas numa certa região do espaço com retenção de sua atividade catalítica, podendo ser 

usada repetida e continuadamente (WINGARD JR., 1972). Nesta técnica, a enzima fica retida no 

interior (poros) ou na superfície de um material que é utilizado como suporte. O complexo enzima-

suporte mantém as características físicas do suporte e, ao mesmo tempo, retém a atividade biológica 

da enzima na forma solúvel (BON et al., 2008).  

 

2.2.1. Classificação das enzimas imobilizadas 

 Zaborsky (1973, 1976) propôs uma classificação que leva em consideração – o tipo de 

interação responsável pela imobilização –, que pode ser conseguida por meios químicos (formação 

de ligação covalente) ou por meios físicos (envolvem somente forças físicas: adsorção, interações 

eletrostáticas e outras); – a natureza dos suportes –, que podem ser porosos ou não-porosos, 

orgânicos ou inorgânicos (VIETH, 1994; ZANIN e MORAES, 2004).   

Do ponto de vista prático, o método de classificação não altera o sistema obtido, uma vez 

que as técnicas mais utilizadas para a preparação dos biocatalisadores de aplicação comercial 

envolvem uma combinação de métodos básicos (BON et al., 2008). 

 A classificação dos métodos de imobilização de enzimas, mais aceita na literatura, foi 

proposta por Kennedy e Roig (1995), que considera a combinação da natureza da interação 

responsável pela imobilização e o tipo de suporte utilizado. Assim: 

 

1) Ligação em suportes – modificação da enzima, por meio de técnicas apropriadas, para 

torná-las imóveis no meio de reação e “cross-linking” – ligação cruzada intermolecular. 

2) Enzimas solúveis sem derivatização – enzimas solúveis, utilizadas em reatores 

equipados com membranas semipermeáveis de ultrafiltração e fibras ocas que retêm a 

enzima no interior do reator. 



 

3) Enzimas solúveis com derivatização 

ligação com outra macromolécula, porém permanecendo o complexo solúvel em água.

 

2.2.2. Métodos de imobilização de enzimas

É muito importante escolher um método de imobilização que conserve 

atividade catalítica da enzima. Dentre as técnicas de 

citar-se: adsorção, onde há uma interação física não

matriz; oclusão ou enclausuramento em uma matriz semi

reações cruzadas ou cross-linking, consiste na ligação da enzima a uma outra proteína ou a grupos 

funcionais existentes na matriz; e 

entre a enzima e a matriz (POWELL, 1990). 

O método de ligação covalente é o mais estudado entre os métodos já citados. Este método 

pode ser classificado de acordo com o tipo de ligação (diaz

condições para imobilização por este método são mais 

ligação covalente, pode ainda, alterar a estrutura conformacional e o sítio ativo da enzima, 

resultando em maior perda da atividade e/ou mudanças do substrato. Contudo, a força de ligação 

entre a enzima e a matriz é tão forte que mesmo na presença do substrato ou de soluções de alta 

força iônica a ligação não é desfeita e a enzima continua imobilizada (HERMANSON 

HERMANSON, 1996).  

A imobilização covalente de biomoléculas em superfícies é de substancial interesse em 

aplicações biomédicas, tais como biosensores, cromatografia de afinidade, bioprocessamento, 

diagnósticos de fase sólida, terapia extracorpórea e libe

al., 1999). 

 

Figura 2. Métodos de imobilização de enzimas.
roxo). Reproduzido de http://www.turqase.com/research/5/ 

com derivatização – enzimas cuja mobilidade foi restringida pela 

ligação com outra macromolécula, porém permanecendo o complexo solúvel em água.

.2. Métodos de imobilização de enzimas 

É muito importante escolher um método de imobilização que conserve 

atividade catalítica da enzima. Dentre as técnicas de imobilização (Figura 

nde há uma interação física não-específica entre a enzima e a superfície da 

matriz; oclusão ou enclausuramento em uma matriz semi-permeável ou no interior de polímeros; 

linking, consiste na ligação da enzima a uma outra proteína ou a grupos 

; e ligação covalente, onde há a formação de ligações covalentes 

entre a enzima e a matriz (POWELL, 1990).  

O método de ligação covalente é o mais estudado entre os métodos já citados. Este método 

pode ser classificado de acordo com o tipo de ligação (diazotização, amida, base de Schiff, etc). As 

condições para imobilização por este método são mais elaboradas que a técnica de

pode ainda, alterar a estrutura conformacional e o sítio ativo da enzima, 

atividade e/ou mudanças do substrato. Contudo, a força de ligação 

entre a enzima e a matriz é tão forte que mesmo na presença do substrato ou de soluções de alta 

força iônica a ligação não é desfeita e a enzima continua imobilizada (HERMANSON 

A imobilização covalente de biomoléculas em superfícies é de substancial interesse em 

aplicações biomédicas, tais como biosensores, cromatografia de afinidade, bioprocessamento, 

diagnósticos de fase sólida, terapia extracorpórea e liberação controlada de drogas 

Métodos de imobilização de enzimas. Representação esquemática da enzima (em azul) e do suporte (em 
http://www.turqase.com/research/5/  

5 

enzimas cuja mobilidade foi restringida pela 

ligação com outra macromolécula, porém permanecendo o complexo solúvel em água. 

É muito importante escolher um método de imobilização que conserve grande parte da 

Figura 2) conhecidas podem 

entre a enzima e a superfície da 

permeável ou no interior de polímeros; 

linking, consiste na ligação da enzima a uma outra proteína ou a grupos 

ligação covalente, onde há a formação de ligações covalentes 

O método de ligação covalente é o mais estudado entre os métodos já citados. Este método 

otização, amida, base de Schiff, etc). As 

que a técnica de adsorção. A 

pode ainda, alterar a estrutura conformacional e o sítio ativo da enzima, 

atividade e/ou mudanças do substrato. Contudo, a força de ligação 

entre a enzima e a matriz é tão forte que mesmo na presença do substrato ou de soluções de alta 

força iônica a ligação não é desfeita e a enzima continua imobilizada (HERMANSON et al., 1992; 

A imobilização covalente de biomoléculas em superfícies é de substancial interesse em 

aplicações biomédicas, tais como biosensores, cromatografia de afinidade, bioprocessamento, 

ração controlada de drogas (MALMSTEN et 

 

Representação esquemática da enzima (em azul) e do suporte (em 



 

2.2.3. Suportes para a imobilização de enzimas

 As propriedades das preparações de enzimas imobilizadas são influenciadas pelas 

propriedades da enzima e do material do suporte (TISCHER e KASCHE, 1999). A interação entre 

esses dois componentes proporciona um derivado imobilizado 

bioquímicas, mecânicas e cinéticas 

 

Figura 3. Interação entre suporte e enzima. 

 

Dentre os vários parâmetros que devem ser considerados

enzimas, os mais importantes são apresentados na 

força iônica, pressão, agitação, liberação de co

Estes fatores influem no desempenho do suporte, na conformação 

transferência de massa e de reação intrínseca, e, portanto, afetam o comportamento da enzima 

imobilizada. De todos os fatores anteriormente citados, com exceção da enzima, a maior 

contribuição para o bom desempenho da enzima imo

suporte para uma determinada aplicação, devem ser analisadas suas propriedades físicas e químicas, 

bem como as relativas à possibilidade de regeneração do material.

resistente nas condições de ativação, durante o processo de imobilização e nas condições em que se 

processa a reação. Em geral, os supores inorgânicos são mais apropriados para uso industrial por 

apresentarem elevada resistência mecânica, boa estabilidade térmica, res

orgânicos e ao ataque por microrganismos 

imobilização de enzimas 

As propriedades das preparações de enzimas imobilizadas são influenciadas pelas 

propriedades da enzima e do material do suporte (TISCHER e KASCHE, 1999). A interação entre 

esses dois componentes proporciona um derivado imobilizado com propriedades químicas, 

bioquímicas, mecânicas e cinéticas específicas (Figura 3). 

Interação entre suporte e enzima. Reproduzido de BON et al., 2008. 

Dentre os vários parâmetros que devem ser considerados, no processo de imobilização de 

os mais importantes são apresentados na Tabela 1, os quais incluem pH, temperatura, 

força iônica, pressão, agitação, liberação de co-fatores e do substrato com a remoção dos produtos. 

Estes fatores influem no desempenho do suporte, na conformação da enzima, na velocidade de 

transferência de massa e de reação intrínseca, e, portanto, afetam o comportamento da enzima 

De todos os fatores anteriormente citados, com exceção da enzima, a maior 

contribuição para o bom desempenho da enzima imobilizada é dada pelo suporte. Na escolha de um 

suporte para uma determinada aplicação, devem ser analisadas suas propriedades físicas e químicas, 

bem como as relativas à possibilidade de regeneração do material. O suporte deve ser quimicamente 

as condições de ativação, durante o processo de imobilização e nas condições em que se 

processa a reação. Em geral, os supores inorgânicos são mais apropriados para uso industrial por 

apresentarem elevada resistência mecânica, boa estabilidade térmica, res

orgânicos e ao ataque por microrganismos (BON et al., 2008). 

6 

As propriedades das preparações de enzimas imobilizadas são influenciadas pelas 

propriedades da enzima e do material do suporte (TISCHER e KASCHE, 1999). A interação entre 

com propriedades químicas, 

 

, no processo de imobilização de 

, os quais incluem pH, temperatura, 

fatores e do substrato com a remoção dos produtos. 

da enzima, na velocidade de 

transferência de massa e de reação intrínseca, e, portanto, afetam o comportamento da enzima 

De todos os fatores anteriormente citados, com exceção da enzima, a maior 

bilizada é dada pelo suporte. Na escolha de um 

suporte para uma determinada aplicação, devem ser analisadas suas propriedades físicas e químicas, 

O suporte deve ser quimicamente 

as condições de ativação, durante o processo de imobilização e nas condições em que se 

processa a reação. Em geral, os supores inorgânicos são mais apropriados para uso industrial por 

apresentarem elevada resistência mecânica, boa estabilidade térmica, resistência a solventes 



7 

 

Tabela 1. Fatores que influenciam o desempenho de um sistema de enzima imobilizada. Reproduzido de TISCHER e 
KASCHE, 1999. 

 

Enzima Propriedades Bioquímicas: massa molar, grupos funcionais da 
superfície proteica, pureza (funções de inativação ou proteção das 
impurezas).  
 
Parâmetros Cinéticos: atividade específica, perfil de pH e 
temperatura, parâmetros cinéticos para ativação e inibição, estabilidade 
térmica, pH, solventes, contaminantes e impurezas.  
 

Suporte Características Químicas: composição e base química, grupos 
funcionais, estabilidade química, contribuições da superfície do 
suporte, tais como os microefeitos (pH, carga da superfície, natureza 
hidrofóbica e hidrofílica, efeito redutor e a presença de íons metálicos). 
 
Características Mecânicas: diâmetro do poro, comportamento de 
compressão, tamanho da partícula; área superficial; volume acessível 
da matriz, resistência à compactação em operações em altas vazões 
para reatores de leito fixo; abrasão para reatores agitados e velocidade 
de sedimentação para leitos fluidizados.  
 
Características Morfológicas: suportes não-porosos (baixa área 
superficial), porosos (grande área superficial), estrutura de gel. 
 

Enzima imobilizada Método de Imobilização: fixação de proteína, eficiência da enzima 
ativa, parâmetros cinéticos intrínsecos.  
 
Efeitos de Transferência de Massa: partição (diferente concentração 
do soluto dentro e fora das partículas do catalisador), difusão interna 
(poros) e externa.  
 
Estabilidade: operacional (expressa em tempo de meia-vida sob 
condições operacionais), estabilidade em estocagem.  
 
Desempenho: produtividade (produto formado por unidade de 
atividade ou massa de enzima), consumo de enzima (por exemplo, 
unidades por kg de produto).  

 

2.2.4. Vantagens e limitações da imobilização de enzimas 

 A enzima imobilizada tem muitas vantagens sobre a enzima solúvel, tais como capacidade 

de reutilização, estabilidade melhorada, término da reação rápido, fácil separação entre 

biocatalisador e produto, redução dos custos operacionais, etc. (ELIF BOYUKBAYRAM et al., 

2006). A imobilização também auxilia a dispersão homogênea da enzima no meio, essencial, para a 

condução de reações enzimáticas (DE CASTRO e ANDERSON, 1995; VILLENEUVE et al., 

2000). Do ponto de vista comercial, as principais vantagens da utilização de enzimas imobilizadas, 

em relação às enzimas solúveis são, praticamente, as relativas à catálise.  

 O sucesso da tecnologia de imobilização mostra que, de modo geral, as vantagens superam 

as limitações. Porém, alguns fatores devem ser apontados, não como desvantagens do processo, mas 



8 

 

sim como pontos a serem evitados. Dentre estes fatores podem ser citados (ROSEVEAR et al., 

1987): perda da atividade durante o processo de imobilização, os efeitos difusionais (transferência 

de massa), as características físicas do biocatalisador e do fluido e a estabilidade do biocatalisador. 

Como os métodos de imobilização, de modo geral, envolvem interações fracas, ou fortes, 

entre a frágil estrutura da enzima e o suporte, ocorre invariavelmente alteração da estrutura 

tridimensional da proteína, resultando em menor atividade. Para se superar esse problema, busca-se 

a proteção do sítio ativo da enzima durante o processo de imobilização, o que pode ser conseguido 

empregando-se altas concentrações de substrato ou um inibidor de sítio ativo (BON et al., 2008). 

 A mobilidade restringida da enzima imobilizada consiste em outra desvantagem e provoca 

uma diminuição na acessibilidade ao substrato, o que leva à aparente redução da atividade, neste 

caso provocada por restrições difusionais (limitações do acesso do substrato ao sítio ativo devido à 

presença da matriz sólida). Este efeito deve ser evitado ou diminuído pela escolha criteriosa do 

suporte, ou pelas condições de operação. Normalmente, as enzimas imobilizadas devem ser 

utilizadas quando o substrato é solúvel. Quando as enzimas estão retidas no interior de matrizes 

porosas, os poros devem facilitar o livre acesso do substrato e reter ao mesmo tempo a molécula de 

enzima no seu interior. O custo da imobilização deve ser compensado pela longa vida do 

biocatalisador. O suporte deve manter suas propriedades físicas (resistência mecânica e ao ataque 

por reagentes químicos) durante o tempo de meia-vida estimado (BON et al., 2008). 

 

2.3. Sistemas de imobilização de biomoléculas: partículas magnéticas 

O emprego de partículas magnéticas ocorreu pela primeira vez na década de 1940 como uma 

nova tecnologia no tratamento de água poluída (ARIAS et al., 2001). Hoje em dia, a síntese e a 

aplicação de partículas magnéticas funcionalizadas tem despertado grande interesse em diferentes 

áreas (WU et al., 2008; HAO et al., 2010), sendo as técnicas de separação magnética as mais 

estudadas, uma vez que elas apresentam benefícios sobre a centrifugação, filtração e extração em 

fase sólida. No caso da extração em fase sólida usando materiais magnéticos, o adsorvente 

magnético é adicionado à solução ou à suspensão contendo o analito alvo. Esse analito é, então, 

adsorvido sobre o adsorvente magnético; capturado e recuperado da suspensão usando um 

separador magnético apropriado, sendo, em seguida, eluido do adsorvente e analisado (CHEN et al., 

2011) como pode ser visto no esquema da Figura 4.  

Esses sólidos magnéticos são amplamente usados em sistemas de detecção e analítico, pois 

oferecem algumas vantagens quando comparados aos sólidos similares que não possuem 

propriedades magnéticas. Tais sólidos podem ser usados na pré-concentração de analitos, na 

separação magnética, na identificação molecular de biomoléculas, de compostos orgânicos e 

inorgânicos (AGUILAR-ARTEAGA et al., 2010).  



 

Figura 4. Procedimento de extração em fase sólida magnética. 

Além de serem utilizadas como adsorventes em separação magnética, essas partículas, 

dentro da escala nanométrica à micrométrica, estão sendo usadas em um número crescente de 

aplicações médicas (hipertermia magnética, agentes de contraste para imagem por re

magnética e liberação de drogas, por exemplo), em especial, devido a suas importantes propriedades 

tais como não toxicidade, biocompatibilidade, injetabilidade e alto nível de acumulação no tecido 

ou órgão (ITO et al., 2005; TOKORO et al., 2009).

propriedades mencionadas acima, a mais importante é a não toxicidade.  De acordo com Kreuter 

(1983), em nanopartículas com um diâmetro geralmente menor que cerca de 100 nm, o 

revestimento é provavelmente o fator

caso de grandes microesferas magnéticas de diâmetros acima de 10 µ m, o revestimento da 

microesfera tem maior influencia na reação tecidual (

Em geral, um único tipo de partí

tamanho e o processo de produção das micropartículas ou nanopartículas magnéticas são 

determinados pelo tipo de aplicação. Partículas superparamagnéticas, ferromagnéticas e 

ferrimagnéticas podem ser usadas como carreadores magnéticos de drogas; enquanto que partículas 

superparamegnéticas são utilizadas para uso biomédico por que elas não exibem magnetismo 

quando não estão sob influencia de um campo magnético externo, prevenindo a aglomeração 

magnética indesejada (BRANDL et al., 2010).

2.3.1. Óxidos de ferro: os principais tipos de núcleo magnético
 Os óxidos de ferro com estrutura “core/shell” são os mais usados como fontes de materiais 

magnéticos (DRBOHLAVOVA et al., 2009).

magnéticas formadas por um núcleo magnético (“core”) e um revestimento (“shell”).

formas cristalinas conhecidas como 

Procedimento de extração em fase sólida magnética. Reproduzido de CHEN et al., 2011

 

Além de serem utilizadas como adsorventes em separação magnética, essas partículas, 

dentro da escala nanométrica à micrométrica, estão sendo usadas em um número crescente de 

aplicações médicas (hipertermia magnética, agentes de contraste para imagem por re

magnética e liberação de drogas, por exemplo), em especial, devido a suas importantes propriedades 

tais como não toxicidade, biocompatibilidade, injetabilidade e alto nível de acumulação no tecido 

ou órgão (ITO et al., 2005; TOKORO et al., 2009). Segundo Ito et al. (2005),  dentre todas as 

propriedades mencionadas acima, a mais importante é a não toxicidade.  De acordo com Kreuter 

(1983), em nanopartículas com um diâmetro geralmente menor que cerca de 100 nm, o 

revestimento é provavelmente o fator mais importante e determina muitas de suas propriedades. No 

caso de grandes microesferas magnéticas de diâmetros acima de 10 µ m, o revestimento da 

microesfera tem maior influencia na reação tecidual (HÄFELI e PAUER, 1999).

Em geral, um único tipo de partículas não pode ser usado para todas as aplicações. O 

tamanho e o processo de produção das micropartículas ou nanopartículas magnéticas são 

determinados pelo tipo de aplicação. Partículas superparamagnéticas, ferromagnéticas e 

as como carreadores magnéticos de drogas; enquanto que partículas 

superparamegnéticas são utilizadas para uso biomédico por que elas não exibem magnetismo 

quando não estão sob influencia de um campo magnético externo, prevenindo a aglomeração 

esejada (BRANDL et al., 2010). 

principais tipos de núcleo magnético 
xidos de ferro com estrutura “core/shell” são os mais usados como fontes de materiais 

magnéticos (DRBOHLAVOVA et al., 2009). Este tipo de estrutura consiste em partículas 

magnéticas formadas por um núcleo magnético (“core”) e um revestimento (“shell”).

formas cristalinas conhecidas como ?-Fe2O3 (hematita), ?-Fe2O3, ?-Fe2O3 (maghemita), 

9 

 

Reproduzido de CHEN et al., 2011. 

Além de serem utilizadas como adsorventes em separação magnética, essas partículas, 

dentro da escala nanométrica à micrométrica, estão sendo usadas em um número crescente de 

aplicações médicas (hipertermia magnética, agentes de contraste para imagem por ressonância 

magnética e liberação de drogas, por exemplo), em especial, devido a suas importantes propriedades 

tais como não toxicidade, biocompatibilidade, injetabilidade e alto nível de acumulação no tecido 

Segundo Ito et al. (2005),  dentre todas as 

propriedades mencionadas acima, a mais importante é a não toxicidade.  De acordo com Kreuter 

(1983), em nanopartículas com um diâmetro geralmente menor que cerca de 100 nm, o 

mais importante e determina muitas de suas propriedades. No 

caso de grandes microesferas magnéticas de diâmetros acima de 10 µ m, o revestimento da 

, 1999). 

culas não pode ser usado para todas as aplicações. O 

tamanho e o processo de produção das micropartículas ou nanopartículas magnéticas são 

determinados pelo tipo de aplicação. Partículas superparamagnéticas, ferromagnéticas e 

as como carreadores magnéticos de drogas; enquanto que partículas 

superparamegnéticas são utilizadas para uso biomédico por que elas não exibem magnetismo 

quando não estão sob influencia de um campo magnético externo, prevenindo a aglomeração 

xidos de ferro com estrutura “core/shell” são os mais usados como fontes de materiais 

Este tipo de estrutura consiste em partículas 

magnéticas formadas por um núcleo magnético (“core”) e um revestimento (“shell”). Há várias 

(maghemita), ?-Fe2O3, 



 

Fe3O4 (magnetita) (ZBORIL et al., 2002)

magnético. No entanto, somente maghemita e magnetita encontraram maior interesse em 

bioaplicações (TUCEK et al., 2006).

 Em alguns trabalhos, metais puros, tais como Fe e Co foram utilizad

magnético por que eles têm várias vantagens sobre os óxidos de ferro, por ex., melhores 

propriedades magnéticas e alta magnetização de saturação (ARIAS et al., 2009). Contudo, Fe e Co 

apresentam menor estabilidade oxidativa, baixa compatibil

toxicidade que os óxidos de ferro (CHOMOUKA et al., 2010).

 A estrutura básica de um óxido de ferro é de um octaedro, no qual cada átomo ferro (Fe

Fe3+) é rodeado por seis O2- ou por seis OH

compactos, em que essas unidades podem interagir por meio de seus ápices, arestas ou faces, forma 

a estrutura cristalina de todos os minerais deste grupo. A característica comum entre todos os óxidos 

de ferro é a presença de um

compartilhados, que varia de 0,288 a 0,289 nm para ligações com ápices comuns (

(PEREIRA, 2010).  

Figura 5. Representação do octaedro de ferro (a) e sua polimerização pelo ápice (b), a
PEREIRA, 2010. 

Vários procedimentos sintéticos foram desenvolvidos para sintetizar nanopartículas de ó

de ferro (AH et al., 2007), sendo a

decomposição térmica e/ou redução (PARK et al., 2004) e síntese hidrotermal (WANG et al., 2005) 

os métodos mais usados e com altos r

O procedimento mais simples, barato e ecologicamente correto é o método de co

precipitação, que envolve a precipitação simultânea de íons

IL et al., 2002) que podem ser utilizadas para composição do núcleo 

. No entanto, somente maghemita e magnetita encontraram maior interesse em 

bioaplicações (TUCEK et al., 2006). 

Em alguns trabalhos, metais puros, tais como Fe e Co foram utilizad

magnético por que eles têm várias vantagens sobre os óxidos de ferro, por ex., melhores 

propriedades magnéticas e alta magnetização de saturação (ARIAS et al., 2009). Contudo, Fe e Co 

apresentam menor estabilidade oxidativa, baixa compatibilidade em sistemas não aquosos e maior 

toxicidade que os óxidos de ferro (CHOMOUKA et al., 2010). 

A estrutura básica de um óxido de ferro é de um octaedro, no qual cada átomo ferro (Fe

ou por seis OH-. A polimerização destes octaedros em arranjos 

compactos, em que essas unidades podem interagir por meio de seus ápices, arestas ou faces, forma 

a estrutura cristalina de todos os minerais deste grupo. A característica comum entre todos os óxidos 

de ferro é a presença de uma distância interatômica Fe-Fe, comuns entre dois octaedros 

compartilhados, que varia de 0,288 a 0,289 nm para ligações com ápices comuns (

 

 

Representação do octaedro de ferro (a) e sua polimerização pelo ápice (b), aresta (c) e face (d). 

 

Vários procedimentos sintéticos foram desenvolvidos para sintetizar nanopartículas de ó

de ferro (AH et al., 2007), sendo as técnicas de co-precipitação (WILLIS et al., 2005), 

redução (PARK et al., 2004) e síntese hidrotermal (WANG et al., 2005) 

os métodos mais usados e com altos rendimentos.  

O procedimento mais simples, barato e ecologicamente correto é o método de co

precipitação, que envolve a precipitação simultânea de íons Fe2+ e Fe3+ em meio aquoso básico 

10 

que podem ser utilizadas para composição do núcleo 

. No entanto, somente maghemita e magnetita encontraram maior interesse em 

Em alguns trabalhos, metais puros, tais como Fe e Co foram utilizados como núcleo 

magnético por que eles têm várias vantagens sobre os óxidos de ferro, por ex., melhores 

propriedades magnéticas e alta magnetização de saturação (ARIAS et al., 2009). Contudo, Fe e Co 

idade em sistemas não aquosos e maior 

A estrutura básica de um óxido de ferro é de um octaedro, no qual cada átomo ferro (Fe2+ ou 

destes octaedros em arranjos 

compactos, em que essas unidades podem interagir por meio de seus ápices, arestas ou faces, forma 

a estrutura cristalina de todos os minerais deste grupo. A característica comum entre todos os óxidos 

Fe, comuns entre dois octaedros 

compartilhados, que varia de 0,288 a 0,289 nm para ligações com ápices comuns (Figura 5) 

resta (c) e face (d). Fonte: 

Vários procedimentos sintéticos foram desenvolvidos para sintetizar nanopartículas de óxido 

precipitação (WILLIS et al., 2005), 

redução (PARK et al., 2004) e síntese hidrotermal (WANG et al., 2005) 

O procedimento mais simples, barato e ecologicamente correto é o método de co-

em meio aquoso básico 



11 

 

(KANG et al., 1996; QU et al., 1999). Durante ou após a sua preparação, as nanopartículas são 

usualmente revestidas com polímeros tais como dextrana, por exemplo, para garantir sua 

estabilidade sob condições fisiológicas (FIGUEROLA et al., 2010).  

No método de co-precipitação, a temperatura de reação é limitada pelo ponto de ebulição da 

água, e nanopartículas de óxido de ferro sintetizadas, sob essas condições, exibem usualmente um 

baixo grau de cristalinidade e grande polidispersão. Uma melhoria neste sentido foi representada 

pelas rotas de síntese empregando microemulsões água em óleo (MUNSHI et al., 1997). Nesses 

tipos de sínteses, uma melhoria na dispersão das partículas foi relatada devido ao confinamento de 

tamanho oferecido pela água dentro de cada micela. Mesmo nesses casos, a limitada temperatura de 

reação leva a baixa cristalinidade do material e adicionalmente os produtos são obtidos com baixo 

rendimento (FIGUEROLA et al., 2010). 

 As técnicas de síntese hidrotérmicas são um método alternativo para a preparação de 

nanopartículas de óxido de ferro altamente cristalinas (WANG et al., 2005). Neste caso, uma 

mistura de sais de ferro dissolvidos em meio aquoso é introduzida em um recipiente de teflon selado 

e aquecida acima da temperatura de ebulição da água, e consequentemente, a pressão da reação é 

aumentada muito acima da pressão atmosférica. O efeito sinérgico de altas temperaturas e pressões 

melhora a qualidade dos nanocristais e por isso suas características magnéticas. Infelizmente, e em 

contraste à técnica de microemulsão, não há um caminho simples para controlar o tamanho e a 

forma das partículas resultantes e usualmente amostras polidispersas são obtidas (FIGUEROLA et 

al., 2010). 

O tamanho e a forma das nanopartículas de óxido de ferro depende do tipo de sal usado (tais 

como cloretos, sulfatos, nitratos, percloratos, etc), da proporção entre os íons férrico e ferroso, da 

temperatura de reação, do valor do pH, da força iônica do meio e de outros parâmetros da reação 

(por ex., velocidade de agitação, velocidade de gotejamento da solução básica) (WU et al., 2008). 

2.3.2. Magnetita e maghemita: os óxidos de ferro mais utilizados  
A magnetita (Fe3O4) pertence à família dos óxidos de ferro, sendo um mineral magnético de 

cor preta encontrado em rochas. Já a maghemita (?-Fe2O3) é um mineral magnético castanho 

avermelhado, estruturalmente similar à magnetita, mas com vacâncias (CORNELL e 

SCHWERTMANN, 2003). Suas propriedades globais são muito semelhantes, o que torna muito 

difícil distinguir entre elas.  

A magnetita tem a particularidade de conter tanto o íon Fe2+ quanto Fe3+, dentro de uma 

estrutura de espinélio inversa. Trinta e dois ânions oxigênio formam uma face centrada cúbica com 

um comprimento da aresta de 0.839 nm. Nesta célula unitária, os íons de ferro estão localizados em 

8 sítios tetraédricos (cercado por 4 íons oxigênio) e 16 sítios octaédricos (cercado por 8 íons 

oxigênio). Os sítios tetraédricos são ocupados exclusivamente por íons Fe3+, enquanto que os íons 



 

Fe2+ e Fe3+ ocupam alternadamente sítios octaédricos (

de íons Fe3+ tetraédricos e octaédricos, o momento resultante em um cristal de magnetita surge 

apenas dos íons Fe2+ octaédricos não compensados (

maghemita são devidas aos íons Fe

SCHWERTMANN, 2003). 

 

Figura 6. Estrutura de espinélio inversa da magnetita.
ferrimagnética na magnetita. Reproduzido de 

 

Suspensões aquosas estáveis de nanopartículas de magnetita (ou maghemita) são ditas ser 

superparamagnéticas por que elas não mostram

ao campo magnético, seu momento magnético global alinha na direção do campo, mas quando o 

campo é zero, o momento magnético da amostra também retorna a zero. Este comportamento é o 

mesmo do paramagnético, mas com um mome

aquele de um íon paramagnético, por exemplo): este fenômeno é chamado de superparamagnetismo 

(CORNELL e SCHWERTMANN, 2003).

Por sua biocompatibilidade, a magnetita, incluindo outras formas de nanopartículas de ó

de ferro, tem sido ressaltada p

partículas usualmente se refere ao diâmetro total destas incluindo o núcle

revestimento. Partículas com tamanhos maiores e/ou agregados de partícula

aprisionadas, causando embolia dent

nanopartículas com diâmetro menor que 100 nm, o revestimento é provavelmente o fator mais 

importante e determina muita das

ocupam alternadamente sítios octaédricos (Figura 6a). Como existe o mesmo número 

tetraédricos e octaédricos, o momento resultante em um cristal de magnetita surge 

octaédricos não compensados (Figura 6b). As propriedades magnéticas da 

maghemita são devidas aos íons Fe3+ octaédricos não compensados (CORNELL e 

inversa da magnetita. (a) ilustração de célula unitária cúbica; (b) organização 
Reproduzido de CORNELL e SCHWERTMANN, 2003. 

Suspensões aquosas estáveis de nanopartículas de magnetita (ou maghemita) são ditas ser 

superparamagnéticas por que elas não mostram remanescência, ou seja, quando elas

ao campo magnético, seu momento magnético global alinha na direção do campo, mas quando o 

campo é zero, o momento magnético da amostra também retorna a zero. Este comportamento é o 

mesmo do paramagnético, mas com um momento magnético de partícula imenso (comparado 

aquele de um íon paramagnético, por exemplo): este fenômeno é chamado de superparamagnetismo 

(CORNELL e SCHWERTMANN, 2003). 

Por sua biocompatibilidade, a magnetita, incluindo outras formas de nanopartículas de ó

de ferro, tem sido ressaltada para aplicações biomédicas (HUBER, 2005)

partículas usualmente se refere ao diâmetro total destas incluindo o núcle

. Partículas com tamanhos maiores e/ou agregados de partículas pequenas podem ser 

aprisionadas, causando embolia dentro dos capilares pulmonares (KREUTER

nanopartículas com diâmetro menor que 100 nm, o revestimento é provavelmente o fator mais 

importante e determina muita das propriedades das partículas (KONCRACKÁ

12 

). Como existe o mesmo número 

tetraédricos e octaédricos, o momento resultante em um cristal de magnetita surge 

As propriedades magnéticas da 

octaédricos não compensados (CORNELL e 

 

unitária cúbica; (b) organização 

Suspensões aquosas estáveis de nanopartículas de magnetita (ou maghemita) são ditas ser 

ou seja, quando elas são submetidas 

ao campo magnético, seu momento magnético global alinha na direção do campo, mas quando o 

campo é zero, o momento magnético da amostra também retorna a zero. Este comportamento é o 

nto magnético de partícula imenso (comparado 

aquele de um íon paramagnético, por exemplo): este fenômeno é chamado de superparamagnetismo 

Por sua biocompatibilidade, a magnetita, incluindo outras formas de nanopartículas de óxido 

2005). O tamanho dessas 

partículas usualmente se refere ao diâmetro total destas incluindo o núcleo de ferro e o 

s pequenas podem ser 

KREUTER, 1983). Em 

nanopartículas com diâmetro menor que 100 nm, o revestimento é provavelmente o fator mais 

KONCRACKÁ et al., 2002). O 



13 

 

tamanho da partícula é um fator importante no desempenho destas e uma redução neste tamanho 

assegura uma maior magnetização quando aplicado um campo magnético externo (O’HANDLEY, 

2000). 

 

2.4.  Estabilidade de partículas magnéticas 

 As nanopartículas de óxido de ferro apresentam alta sensibilidade magnética e baixa 

toxicidade. No entanto, devido à sua baixa estabilidade coloidal na fase aquosa (tendência de se 

agregar), a modificação apropriada da superfície dessas partículas representa um ponto-chave para 

impedir a agregação e para torná-las altamente monodispersas (SAWANT et al., 2009).  

Em geral, um revestimento polimérico pode reduzir a agregação e melhorar a estabilidade 

coloidal das nanopartículas magnéticas. Contudo, em alguns casos, a camada de polímero pode 

aumentar significativamente o tamanho total das nanopartículas, levando a limitadas distribuição 

tecidual, penetração e depuração metabólica das partículas. O desenvolvimento de nanopartículas 

magnéticas revestidas com pequenas moléculas pode ser promissor para obter nanopartículas 

revestidas de pequeno tamanho (CHENG et al., 2005; YANG et al., 2010). 

Para melhorar a estabilidade e biocompatibilidade, nanopartículas de óxido de ferro 

superparamagnéticas são frequentemente modificadas com alguns surfactantes ou polímeros 

(BERRY et al., 2003). As nanopartículas de magnetita superparamagnéticas revestidas com 

polímeros são usualmente formadas por núcleos magnéticos responsáveis por uma resposta 

magnética forte e uma camada polimérica para fornecer grupos funcionalizáveis e característicos 

(WUNDERBALDINGER et al., 2002). 

Alguns autores sugerem a substituição do ácido oléico por um polímero solúvel em água, 

revestimento individual das nanopartículas com polímeros anfifílicos e incorporação dessas 

nanopartículas em micelas lipídicas para obter nanopartículas solúveis em água monodispersas 

(TROMSDORF et al., 2007).   

 Revestimento de materiais poliméricos pode ser classificado em sintético e natural. 

Polímeros baseados em poli(etileno-co-vinil acetato), poli(vinilpirrolidona) (PVP), poli(ácido 

lático-co-glicólico) (PLGA), poli(etilenoglicol) (PEG), poli(álcool vinílico) (PVA), etc. São 

exemplos típicos de sistemas poliméricos sintéticos (NUNES et al., 2006). Sistemas de polímero 

natural incluem o uso de gelatina, dextrana, quitosana, pululana. A modificação de polímeros 

naturais oferece vantagens significativas em aplicações biomédicas devido a sua boa 

biocompatibilidade e degradabilidade (MASSIA et al., 2000). 

 Em muitos estudos, conduzidos principalmente sobre nanopartículas de maghemita, uma 

diminuição no valor da magnetização de saturação tem sido observado e atribuído ao efeito do 

tamanho finito, à desordem estrutural em toda a partícula e aos efeitos de superfície (DAOU et al., 



 

2008). É bem estabelecido que as propriedades das nanopartículas são fortemente dependentes do 

seu tamanho, mas diferentes rotas sintéticas podem fornecer nanopartícul

com diferentes propriedades magnéticas. De fato, a distinção entre o tamanho finito e as 

contribuições do efeito de superfície não é fácil. Além disso, pode

específica da ligação orgânica sobre as propried

aplicações tecnológicas de nanopartículas magnéticas requerem a compreensão da infuencia de 

modificações químicas de superfície sobre as propriedades magnéticas (DAOU et al., 2008).

DAOU et al. (2008) observaram 

nanopartículas de magnetita, na qual moléculas funcionais foram ligadas, depende da natureza do 

agente de ligação através do qual as moléculas são ligadas à superfície. O agente de ligação 

carboxilato induz um spin inclinado na camada oxidada, reduzindo a magnetização de saturação. 

Pelo contrário, não existe estrutura de superfície inclinada quando moléculas fosfonatadas são 

ligadas covalentemente às nanopartículas de óxido de ferro. Isto é de especial i

manter as propriedades magnéticas inalteradas quando nanopartículas forem revestidas com uma 

camada orgânica (Figura 7). 

 

Figura 7. Representação esquemática da superfície de nanopartículas magnéticas (Fe
orgânico na presença de um campo magnético aplicado. As setas representam o momento ferrimagnético resultante. 
Fonte: DAOU et al., 2008. 
 
 
 A área de superfície, o tamanho e a forma das nanopartículas são responsáveis pelas 

propriedades físicas e químicas dessas partículas em grande extensão, que por sua vez são 

responáveis pelo desempenho em várias aplicações (TARTAJ et al., 2003). O tamanho das 

partículas, e sua distribuição, as propriedades magnéticas e de fluxo do fluido influen

aplicação dos parâmetros especialmente em biomedicina. A forma esférica e monodispersibilidade 

de nanopartículas de óxido de ferro são frequentemente requeridas para aplicação em tecidos vivos 

2008). É bem estabelecido que as propriedades das nanopartículas são fortemente dependentes do 

seu tamanho, mas diferentes rotas sintéticas podem fornecer nanopartículas de tamanhos similares 

com diferentes propriedades magnéticas. De fato, a distinção entre o tamanho finito e as 

contribuições do efeito de superfície não é fácil. Além disso, pode-se notar que a influencia 

específica da ligação orgânica sobre as propriedades magnéticas tem sido pouco estudada. As 

aplicações tecnológicas de nanopartículas magnéticas requerem a compreensão da infuencia de 

modificações químicas de superfície sobre as propriedades magnéticas (DAOU et al., 2008).

DAOU et al. (2008) observaram que a estrutura magnética da camada  de superfície de 

nanopartículas de magnetita, na qual moléculas funcionais foram ligadas, depende da natureza do 

agente de ligação através do qual as moléculas são ligadas à superfície. O agente de ligação 

nduz um spin inclinado na camada oxidada, reduzindo a magnetização de saturação. 

Pelo contrário, não existe estrutura de superfície inclinada quando moléculas fosfonatadas são 

ligadas covalentemente às nanopartículas de óxido de ferro. Isto é de especial i

manter as propriedades magnéticas inalteradas quando nanopartículas forem revestidas com uma 

Representação esquemática da superfície de nanopartículas magnéticas (Fe3O4) com e sem revestimento 
orgânico na presença de um campo magnético aplicado. As setas representam o momento ferrimagnético resultante. 

A área de superfície, o tamanho e a forma das nanopartículas são responsáveis pelas 

dades físicas e químicas dessas partículas em grande extensão, que por sua vez são 

responáveis pelo desempenho em várias aplicações (TARTAJ et al., 2003). O tamanho das 

partículas, e sua distribuição, as propriedades magnéticas e de fluxo do fluido influen

aplicação dos parâmetros especialmente em biomedicina. A forma esférica e monodispersibilidade 

de nanopartículas de óxido de ferro são frequentemente requeridas para aplicação em tecidos vivos 

14 

2008). É bem estabelecido que as propriedades das nanopartículas são fortemente dependentes do 

as de tamanhos similares 

com diferentes propriedades magnéticas. De fato, a distinção entre o tamanho finito e as 

se notar que a influencia 

ades magnéticas tem sido pouco estudada. As 

aplicações tecnológicas de nanopartículas magnéticas requerem a compreensão da infuencia de 

modificações químicas de superfície sobre as propriedades magnéticas (DAOU et al., 2008). 

que a estrutura magnética da camada  de superfície de 

nanopartículas de magnetita, na qual moléculas funcionais foram ligadas, depende da natureza do 

agente de ligação através do qual as moléculas são ligadas à superfície. O agente de ligação 

nduz um spin inclinado na camada oxidada, reduzindo a magnetização de saturação. 

Pelo contrário, não existe estrutura de superfície inclinada quando moléculas fosfonatadas são 

ligadas covalentemente às nanopartículas de óxido de ferro. Isto é de especial importância para 

manter as propriedades magnéticas inalteradas quando nanopartículas forem revestidas com uma 

 

) com e sem revestimento 
orgânico na presença de um campo magnético aplicado. As setas representam o momento ferrimagnético resultante. 

A área de superfície, o tamanho e a forma das nanopartículas são responsáveis pelas 

dades físicas e químicas dessas partículas em grande extensão, que por sua vez são 

responáveis pelo desempenho em várias aplicações (TARTAJ et al., 2003). O tamanho das 

partículas, e sua distribuição, as propriedades magnéticas e de fluxo do fluido influenciam a 

aplicação dos parâmetros especialmente em biomedicina. A forma esférica e monodispersibilidade 

de nanopartículas de óxido de ferro são frequentemente requeridas para aplicação em tecidos vivos 



 

(PETRI-FINK e HOFMANN, 2007). Então, a otimização da sín

conjugação com moléculas orgânicas sobre a superfície torna

 Nanopartículas magnéticas sem revestimento tem superfícies hidrofóbicas com uma grande 

área de superfície em relação ao volume e uma tendência a aglomerar (LU et al., 2007). O uso de 

um revestimento de superfície adequado permite que nanopartículas de óxid

dispersas dentro de fluidos homogêneos e melhorem sua estabilidade. Vários grupos de materiais de 

revestimento são usados para modificar a superfície química de nanopartículas magnéticas 

(SHUBAYEV et al., 2009): 

a. Polímeros orgânicos, tais c

b. Surfactantes orgânicos, tais como oleato de sódio e dodecilamina

c. Metais inorgânicos, tais como ouro

d. Óxidos inorgânicos, tais como sílica e carbono

e. Moléculas e estruturas bioativas, tais como lipossomas, peptídeos e 

 

2.4.1. Polissacarídeos como revestimento: levana

 A levana (Figura 8) é um polissacarídeo constituído por resíduos de D

ligações ?(2?6), podendo apresentar pontos de ramifica

espécies de plantas e bactérias (KANG et al., 1998). Segundo alguns autores (

DERYCKE, 1983; FUCHS et al., 1985; FUCHS, 1991

glicose terminal, enquanto que as de origem bacteriana só possuem unidades de f

(CALAZANS, 1997).  

 

Figura 8. Estrutura química de uma 
 
 

As levanas podem ser produzidas por diversas espécies de plantas e de bactérias, onde a 

distribuição do peso molecular e 

biopolímero. Aquelas produzidas por vegetais apresentam baixo peso molecular e poucas 

ramificações; enquanto as produzidas por síntese microbiana ou enzimática exibem peso molecular 

elevado, da ordem de 2,5 x 106 daltons, e podem conter numerosas ramificações

BEKERS et al., 2005). A hidrólise ácida parcial de levana produz uma série de oligossacarídeos e 

FINK e HOFMANN, 2007). Então, a otimização da síntese de nanopartículas e sua 

conjugação com moléculas orgânicas sobre a superfície torna-se muito mais essencial.

Nanopartículas magnéticas sem revestimento tem superfícies hidrofóbicas com uma grande 

área de superfície em relação ao volume e uma tendência a aglomerar (LU et al., 2007). O uso de 

um revestimento de superfície adequado permite que nanopartículas de óxid

dispersas dentro de fluidos homogêneos e melhorem sua estabilidade. Vários grupos de materiais de 

revestimento são usados para modificar a superfície química de nanopartículas magnéticas 

Polímeros orgânicos, tais como dextrana, quitosana, polianilina 

Surfactantes orgânicos, tais como oleato de sódio e dodecilamina 

Metais inorgânicos, tais como ouro 

Óxidos inorgânicos, tais como sílica e carbono 

Moléculas e estruturas bioativas, tais como lipossomas, peptídeos e ligantes/receptores.

Polissacarídeos como revestimento: levana 

) é um polissacarídeo constituído por resíduos de D

6), podendo apresentar pontos de ramificação ?(2?1) e ser produzida por diversas 

spécies de plantas e bactérias (KANG et al., 1998). Segundo alguns autores (

et al., 1985; FUCHS, 1991), as levanas de origem vegetal possuem uma 

glicose terminal, enquanto que as de origem bacteriana só possuem unidades de f

 

Estrutura química de uma levana de origem vegetal, mostrando a molécula de glicose terminal

As levanas podem ser produzidas por diversas espécies de plantas e de bactérias, onde a 

distribuição do peso molecular e do grau de ramificação depende da fonte produtora deste 

biopolímero. Aquelas produzidas por vegetais apresentam baixo peso molecular e poucas 

ramificações; enquanto as produzidas por síntese microbiana ou enzimática exibem peso molecular 

daltons, e podem conter numerosas ramificações

A hidrólise ácida parcial de levana produz uma série de oligossacarídeos e 

15 

tese de nanopartículas e sua 

se muito mais essencial. 

Nanopartículas magnéticas sem revestimento tem superfícies hidrofóbicas com uma grande 

área de superfície em relação ao volume e uma tendência a aglomerar (LU et al., 2007). O uso de 

um revestimento de superfície adequado permite que nanopartículas de óxido de ferro sejam 

dispersas dentro de fluidos homogêneos e melhorem sua estabilidade. Vários grupos de materiais de 

revestimento são usados para modificar a superfície química de nanopartículas magnéticas 

ligantes/receptores. 

) é um polissacarídeo constituído por resíduos de D-frutose unidos por 

1) e ser produzida por diversas 

spécies de plantas e bactérias (KANG et al., 1998). Segundo alguns autores (VANDAMME e 

), as levanas de origem vegetal possuem uma 

glicose terminal, enquanto que as de origem bacteriana só possuem unidades de frutose 

de origem vegetal, mostrando a molécula de glicose terminal. 

As levanas podem ser produzidas por diversas espécies de plantas e de bactérias, onde a 

do grau de ramificação depende da fonte produtora deste 

biopolímero. Aquelas produzidas por vegetais apresentam baixo peso molecular e poucas 

ramificações; enquanto as produzidas por síntese microbiana ou enzimática exibem peso molecular 

daltons, e podem conter numerosas ramificações (BARROS, 2002; 

A hidrólise ácida parcial de levana produz uma série de oligossacarídeos e 



16 

 

levulanas (levanas degradadas) (FEINGOLD e GEHATIA, 1957). Levanas de pesos moleculares 

elevados são sorologicamente ativas e estimulam a formação de anticorpos; aquelas hidrolisadas ou 

purificadas não são antigênicas. A levana é eliminada do corpo lentamente e não é tóxica (HAN, 

1990). 

As levanas são um dos poucos polímeros naturais em que o carboidrato existe na forma de 

furanose. Esta característica estrutural tem um importante papel na conformação final das moléculas 

em solução (MARCHESSAULT et al., 1980). Além disso, a maior flexibilidade do anel de 

furanose, em comparação com o relativamente rígido anel de piranose da maioria dos 

polissacarídeos de reserva, confere uma flexibilidade adicional à molécula de frutana inteira.  

As propriedades gerais das levanas assemelham-se aquelas das dextranas. As levanas são 

levorotatórias, amorfas ou microcristalinas, de solubilidade variada em água fria, muito solúvel em 

água quente e insolúvel em álcool etílico absoluto. As levanas são geralmente mais solúveis do que 

a inulina, a qual é quase insolúvel (&amp;lt;0,5%) em água à temperatura ambiente (HAN, 1990). A 

elevada solubilidade das levanas pode ser uma característica da ligação ?(2? 6) comparada à 

ligação ?(2? 1). A ramificação deve ser apenas um fator secundário. As levanas são não-redutoras, 

não-hidrolisadas por invertase de levedura e amilase, mas são muito susceptíveis à hidrólise por 

ácidos. Elas não são coradas por iodo, mas cloreto de hidrogênio confere uma cor púrpura que 

distingue a levana de outros polissacarídeos que não contém frutose. O peso molecular e a 

viscosidade das levanas variam de acordo com a fonte produtora (HAN, 1990). 

Certas propriedades da levana, tais como efeito antineoplásico (CALAZANS et al., 1997), 

aumento da permeabilidade celular para um agente citotóxico (LEIBOVICI e STARK, 1986), 

purificação de glicoproteínas (ANGELI et al., 2009) e imobilização de enzimas (VINA et al., 2001; 

MACIEL et al., 2012) têm atraído atenção. Maciel et al. (2012) estabilizaram partículas magnéticas 

produzidas por co-precipitação utilizando levana de Zymomonas mobilis, apresentando bons 

resultados ao imobilizarem a enzima tripsina. 

 

2.4.2. Polímeros orgânicos sintéticos como revestimento: polianilina 

 Os polímeros que apresentam propriedade elétrica são chamados de “polímeros condutores” 

ou “metais sintéticos”, pois possuem propriedades elétricas, magnéticas e ópticas de metais e 

semicondutores. Entre os principais polímeros condutores, estão o poliacetileno, polianilina e 

polipirrol. A oxidação/redução da cadeia polimérica pode ser efetuada por agentes de transferência 

de carga (aceptores/doadores de elétrons), convertendo o polímero de isolante em condutor ou 

semicondutor. Esses agentes são chamados de dopantes. Na maioria dos polímeros condutores, 

como o polipirrol, o processo de dopagem ocorre simultaneamente com a oxidação da cadeia. Já a 

polianilina e seus derivados formam outra classe de polímeros condutores, pois ela pode ser dopada 



17 

 

por protonação, isto é, sem que ocorra alteração do número de elétrons associados à cadeia 

polimérica (FAEZ et al., 2000).  

Os polímeros condutores são materiais extremamente versáteis e estão sendo amplamente 

utilizados em diversas aplicações, tais como tintas anticorrosivas, dispositivos eletrocrômicos e 

dispositivos emissores de luz (LEDs) (HEEGER, 2002). Como citado em Gizdavic-Nikolaidis et al. 

(2004), estes polímeros são utilizados no desenvolvimento de músculos artificiais, na liberação 

controlada de drogas e como estímulo para a regeneração de nervos. Considerando-se as aplicações 

na área biomédica, a eficiência dos dispositivos construídos a partir dos polímeros condutores é 

determinada através de duas características: a habilidade de o material desempenhar uma função 

específica e apropriada dentro do organismo e, a compatibilidade do material dentro do corpo.  

Como a polianilina (PANI) pode ser utilizada em biomateriais, é necessário um melhor 

entendimento a respeito da toxicidade deste material. O monômero (anilina) e os subprodutos da 

síntese (compostos aromáticos, a maioria aminas) são altamente tóxicos (SOUZA et al., 2003).  No 

entanto, estudos in vivo mostraram que ambas as formas de polianilina, condutora (sal de 

esmeraldina) e não-condutora (base esmeraldina), não provocaram respostas inflamatórias em 

modelos animais (roedores), sugerindo uma boa tolerância e bio/histocompatibilidade (WANG et 

al., 1999; KAMALESH et al., 2000). Yslas et al. (2012) verificaram que nanofibras de polianilina 

não exibiram qualquer efeito tóxico (morte ou teratogênese) em embriões de anfíbios. Resultados 

semelhantes foram observados por Villalba et al. (2012) ao realizarem estudos utilizando células 

embrionárias humanas (rim). Por outro lado, Oh et al. (2011) reportaram o efeito tóxico de 

nanomaterias de polianilina em células humanas (fibroblastos) e que essa toxicidade foi dependente 

da forma. 

 A polianilina (PANI) é um dos polímeros condutores mais estudados devido a suas 

propriedades eletrônica e óptica, excelente estabilidade ambiental (JARAMILLO-TABARES et al., 

2012), fácil polimerização por síntese química (NERI et al., 2011), eletroquímica (TAKASHIMA et 

al., 1995), fotoquímica (ARAÚJO et al., 2010) e mais recentemente através de condições extremas 

ou não clássicas (AZEVEDO et al., 2008; BARROS e AZEVEDO, 2008) e baixo custo do 

monômero (UMARE et al., 2010). A PANI pode ocorrer em diferentes estados de oxidação 

(Tabela 2), dos quais a forma sal de esmeraldina, 50% oxidada, é a mais estável. A forma base 

esmeraldina (isolante) do polímero pode reagir com ácidos (ex: HCl) resultando na forma sal de 

esmeraldina (condutora). A reação de protonação ocorre principalmente nos nitrogênios imínicos da 

polianilina (–N=). Além da elevada condutividade elétrica, outra propriedade interessante da 

polianilina é exibir diferentes colorações quando se variam as condições de pH ou o potencial 

elétrico (FAEZ et al., 2000). 



18 

 

Devido as suas diferentes propriedades físico-químicas e a presença de grupos químicos 

funcionalizáveis, a PANI é utilizada como revestimento de partículas magnéticas. Um dos objetivos 

é unir as propriedades elétricas do polímero e a propriedade magnética da partícula magnética. A 

maioria dos trabalhos consiste no revestimento de nanopartículas de magnetita (APHESTEGUY e 

JACOBO, 2007; XIAO et al., 2007; ZHANG et al., 2010; GANDHI et al., 2011; SUN et al., 2011; 

BELAABED et al., 2012). 

 
Tabela 2. Os três estados de oxidação mais importantes da polianilina: leucoesmeraldina, esmeraldina (isolante e 
condutora) e pernigranilina. Fonte: FAEZ et al., 2000 
 

Estado de 
oxidação 

Estrutura Cor* Característica 

Leucoesmeraldina 

 
 

Amarela 
310 

Isolante completamente 
reduzida 

 

Sal de 
esmeraldina  

Verde 
320, 420, 

800 

Condutora parcialmente 
oxidada 

 
Base esmeraldina 

 

Azul 
320, 620 

Isolante parcialmente 
oxidada 

 
Pernigranilina 

 

Púrpura 
320, 530 

Isolante completamente 
oxidada 

*Os valores numéricos referem-se ao comprimento de onda (em nanometros) onde a absorção é máxima 
 

 

2.5. Aplicações de partículas magnéticas na área biomédica e biotecnológica  

 Em biomedicina, o revestimento polimérico garante a estabilidade das partículas 

magnéticas, em meio fisiológico, fornecendo não-toxicidade por evitar a ligação do ferro e permite 

a modificação química para ligar componentes biologicamente ativos. Não somente as 

características da superfície, mas primariamente o tamanho das partículas, são fatores cruciais que 

determinam o sucesso das partículas in vivo (HORÁK et al., 2007). 

Em biotecnologia, essas partículas magnéticas têm encontrado aplicações em diagnósticos 

médicos como pesquisa genética (SCHERER et al., 2002) e tecnologias baseadas em separação 

magnética imune de células, proteínas, DNA/RNA, bactérias, vírus e outras biomoléculas, como 

adsorventes de bioafinidade, tratamento de água poluída via adsorção eletrostática, suportes para 

imobilização ou adsorção de enzimas e proteínas (HALLING e DUNNILL, 1980; MOFFAT et al., 

1994; ANSELL e MOSBACH, 1998; DUNNILL e LILLY, 2000).  

 

 

 



19 

 

2.5.1. Imagem por ressonância magnética (IRM) 

 A imagem por ressonância magnética é baseada em sinal de ressonância magnética nuclear 

de prótons através do efeito combinado de um forte campo magnético e um campo de 

radiofreqüência (PANKHURST et al., 2003). As partículas magnéticas melhoram o contraste das 

imagens obtidas por ressonância magnética (WEISSLEDER et al., 1991; WEISSLEDER et al., 

1992; KRESSE et al., 1998; BACHGANSMO, 1993).  

Os agentes de contraste, constituídos por nanopartículas magnéticas, podem ser administrados 

por diferentes vias (aérea, oral, intersticial ou intravenosa) (SAIYED et al., 2003). Em comparação 

aos íons paramagnéticos, partículas de óxido de ferro superparamagnéticas têm relaxitividades 

maiores (SAINI et al., 1987; STARK et al., 1988).  

Os ferrofluidos, usados como contraste para IRM, são formados por magnetita e estabilizados 

mais comumente por um polissacarídeo (ex: dextrana). O diâmetro médio desses agentes varia de 

10 nm a 1 µ m (WEISSLEDER et al., 1991; KRESSE et al., 1998; WEISSLEDE et al., 1992). 

 

2.5.2. Separação magnética 

 As técnicas de separação magnética possibilitam a separação de compostos alvo 

biologicamente ativos e células de uma variedade de materiais (extratos brutos, meios de cultivo, 

sangue, fluidos corporais, amostras ambientais, etc.) (ŠAFA??K, e ŠAFA??KOVÁ, 1999; 

ŠAFA??K e ŠAFA??KOVÁ, 2000). Várias partículas magnéticas têm sido desenvolvidas como 

carreadores magnéticos em processos de separação incluindo purificação e imunoensaios (HUBER, 

2005). Adsorventes de afinidade têm sido usados para a separação de proteínas (enzimas, 

anticorpos, antígenos, receptores, etc.), ácidos nucléicos (DNA, RNA, etc.), compostos 

biologicamente ativos de baixo peso molecular (drogas) e xenobióticos (corantes solúveis em água, 

metais pesados, radionuclídeos, etc.) (ŠAFA??K e ŠAFA??KOVÁ, 2000). O uso de colunas 

cromatográficas convencionais pode consumir muito tempo e é neste campo que o uso de 

adsorventes magnéticos ou magnetizáveis ganha importância.  

 

2.5.3. Imobilização de enzimas 

A suscetibilidade das enzimas à ação de fatores externos e às dificuldades de regeneração 

catalítica limita a aplicação das mesmas em larga escala. Alguns métodos de estabilização são 

comumente empregados para preservar a atividade da enzima, incluindo técnicas de imobilização 

física e/ou química, que abrem possibilidades para aplicações industriais. Entre estes, a ligação 

covalente de enzimas em matrizes insolúveis em água é o método mais atrativo para estabilização, 

reutilização e recuperação de enzimas (ENGASSER e COULET, 1977; MARTINEK et al., 1977; 

BRYJAK e KOLARZ, 1998; XI et al., 2005). As enzimas imobilizadas podem substituir as enzimas 



 

nativas em vários processos, resultando em reações mais rápidas, menor contaminação da amostra e 

melhorando o interfaciamento para procedimentos modernos, como espectrometria de ma

(KROGH et al., 1999). 

A escolha da matriz (propriedades químicas e magnéticas, tamanho da partícula e 

distribuição, porosidade) é um fator chave que influencia na qualidade da imobilização e na 

conquista das aplicações finais (BÍLKOVÁ et al., 2002

ser magnetizadas pelo tratamento com materiais magnéticos sem qualquer perda de atividade da 

ligação subsequente. Uma variedade de materiais magnéticos 

produzir partículas magnéticas (AMARAL et al., 2006; ANGELI et al., 2009; NERI et al., 2009; 

NERI et al, 2011; MACIEL et al., 2012). 

 

Figura 9. Desenho esquemático de um “nanobead” magnético que aprisiona moléculas de enzima em sua camada de 
sílica. Reproduzido de http://seeds.kyushu
 

2.5.4. Hipertermia magnética 

A técnica de hipertermia magnética se baseia na teoria que qualquer objeto metálico, quando 

colocado em um campo magnético alternado, tem induzida uma corrente elétrica. A quantidade de 

corrente é proporcional à intensidade do campo magnético e ao tamanho do objeto. Como essas 

correntes fluem dentro do metal, o metal resiste ao fluxo da corrente e assim se aquece um processo 

denominado de aquecimento indutivo, se o metal é magnético, como o ferro, o

ampliado. Portanto, quando um fluido magnético é exposto a um campo magnético alternado, as 

partículas tornam-se poderosas fontes de calor

(BABINCOVA et al., 2000).  

Essa técnica destrói especificamente tumores sem danificar tecidos normais pelo 

aquecimento seletivo das células tumorais. Portanto, a hipertermia magnética é uma terapia 

promissora contra o câncer (HAYASHI et al., 2009).

clínica da hipertermia magnética é que as nanopartículas devem apresentar baixos níveis de 

toxicidade, assim como um elevado momento de saturação magnética que permita minimizar as 

doses eletromagnéticas requeridas quando a radioterapia é utili

 

nativas em vários processos, resultando em reações mais rápidas, menor contaminação da amostra e 

melhorando o interfaciamento para procedimentos modernos, como espectrometria de ma

A escolha da matriz (propriedades químicas e magnéticas, tamanho da partícula e 

distribuição, porosidade) é um fator chave que influencia na qualidade da imobilização e na 

BÍLKOVÁ et al., 2002). Matrizes (suportes) convencionais podem 

ser magnetizadas pelo tratamento com materiais magnéticos sem qualquer perda de atividade da 

ligação subsequente. Uma variedade de materiais magnéticos (Figura 9) 

(AMARAL et al., 2006; ANGELI et al., 2009; NERI et al., 2009; 

NERI et al, 2011; MACIEL et al., 2012).  

 
Desenho esquemático de um “nanobead” magnético que aprisiona moléculas de enzima em sua camada de 

Reproduzido de http://seeds.kyushu-u.ac.jp/en/seed/d382.html 

A técnica de hipertermia magnética se baseia na teoria que qualquer objeto metálico, quando 

colocado em um campo magnético alternado, tem induzida uma corrente elétrica. A quantidade de 

proporcional à intensidade do campo magnético e ao tamanho do objeto. Como essas 

correntes fluem dentro do metal, o metal resiste ao fluxo da corrente e assim se aquece um processo 

denominado de aquecimento indutivo, se o metal é magnético, como o ferro, o

ampliado. Portanto, quando um fluido magnético é exposto a um campo magnético alternado, as 

se poderosas fontes de calor (Figura 10), destruindo as células tumorais 

Essa técnica destrói especificamente tumores sem danificar tecidos normais pelo 

aquecimento seletivo das células tumorais. Portanto, a hipertermia magnética é uma terapia 

promissora contra o câncer (HAYASHI et al., 2009). Um pré-requisito importante para a

clínica da hipertermia magnética é que as nanopartículas devem apresentar baixos níveis de 

toxicidade, assim como um elevado momento de saturação magnética que permita minimizar as 

doses eletromagnéticas requeridas quando a radioterapia é utilizada (CASTRO et al., 2010).

20 

nativas em vários processos, resultando em reações mais rápidas, menor contaminação da amostra e 

melhorando o interfaciamento para procedimentos modernos, como espectrometria de massa 

A escolha da matriz (propriedades químicas e magnéticas, tamanho da partícula e 

distribuição, porosidade) é um fator chave que influencia na qualidade da imobilização e na 

. Matrizes (suportes) convencionais podem 

ser magnetizadas pelo tratamento com materiais magnéticos sem qualquer perda de atividade da 

) tem sido usada para 

(AMARAL et al., 2006; ANGELI et al., 2009; NERI et al., 2009; 

 
Desenho esquemático de um “nanobead” magnético que aprisiona moléculas de enzima em sua camada de 

A técnica de hipertermia magnética se baseia na teoria que qualquer objeto metálico, quando 

colocado em um campo magnético alternado, tem induzida uma corrente elétrica. A quantidade de 

proporcional à intensidade do campo magnético e ao tamanho do objeto. Como essas 

correntes fluem dentro do metal, o metal resiste ao fluxo da corrente e assim se aquece um processo 

denominado de aquecimento indutivo, se o metal é magnético, como o ferro, o fenômeno é muito 

ampliado. Portanto, quando um fluido magnético é exposto a um campo magnético alternado, as 

destruindo as células tumorais 

Essa técnica destrói especificamente tumores sem danificar tecidos normais pelo 

aquecimento seletivo das células tumorais. Portanto, a hipertermia magnética é uma terapia 

requisito importante para a utilização 

clínica da hipertermia magnética é que as nanopartículas devem apresentar baixos níveis de 

toxicidade, assim como um elevado momento de saturação magnética que permita minimizar as 

zada (CASTRO et al., 2010). 



 

2.5.5. Carreador de fármacos 

A tecnologia de liberação controlada caracteriza o sistema capaz de prover algum controle 

terapêutico, seja de natureza temporal, espacial ou ambos. Os sistemas de liberação de drogas 

(“drug delivery systems”) oferecem inúmeras vantagens quando comparados a outros de dosagem 

convencional, tais como: maior eficácia terapêutica, liberação progressiva e controlada do fármaco, 

diminuição significativa da toxicidade e maior tempo de permanência na circula

número de doses devido à liberação progressiva e possibilidade de direcionamento a alvos 

específicos são alguns exemplos (DURÁN e AZEVEDO, 2003). 

Muitos sistemas nanoparticulados estão sendo usados atualmente e, entre eles, os baseados 

nas nanopartículas magnéticas assumem um papel importante devido à propriedade de serem 

conduzidas e retidas em uma região específica do corpo por meio de gradiente de campo magnético 

externo. Com o objetivo de aumentar a especificidade, o conjugado nanopa

pode ser associado à outra molécula capaz de reconhecer e se ligar especificamente ao sítio alvo. 

Tais moléculas podem ser anticorpos, proteínas, lectinas, hormônios, entre outros

 

Figura 10. Aplicações médicas de nanopartículas magnéticas. 
 

 

2.5.6. Chips de células 

 Os sensores de células são úteis para estudar os efeitos de drogas e

estímulos externos e as células (CHOI et

importante processo na fabricação de “chips de células”

dessas células à superfície do chip constitui uma carcaterística importante para a imobilização 

A tecnologia de liberação controlada caracteriza o sistema capaz de prover algum controle 

terapêutico, seja de natureza temporal, espacial ou ambos. Os sistemas de liberação de drogas 

y systems”) oferecem inúmeras vantagens quando comparados a outros de dosagem 

convencional, tais como: maior eficácia terapêutica, liberação progressiva e controlada do fármaco, 

diminuição significativa da toxicidade e maior tempo de permanência na circula

número de doses devido à liberação progressiva e possibilidade de direcionamento a alvos 

específicos são alguns exemplos (DURÁN e AZEVEDO, 2003).  

Muitos sistemas nanoparticulados estão sendo usados atualmente e, entre eles, os baseados 

nas nanopartículas magnéticas assumem um papel importante devido à propriedade de serem 

conduzidas e retidas em uma região específica do corpo por meio de gradiente de campo magnético 

externo. Com o objetivo de aumentar a especificidade, o conjugado nanopartícula magnética

pode ser associado à outra molécula capaz de reconhecer e se ligar especificamente ao sítio alvo. 

Tais moléculas podem ser anticorpos, proteínas, lectinas, hormônios, entre outros

Aplicações médicas de nanopartículas magnéticas. Reproduzido de http://www.madrimasd.org/ 

ensores de células são úteis para estudar os efeitos de drogas e 

s externos e as células (CHOI et al., 2005). A imobilização de células 

bricação de “chips de células”, e a interação entre as células e a adesão 

dessas células à superfície do chip constitui uma carcaterística importante para a imobilização 

21 

A tecnologia de liberação controlada caracteriza o sistema capaz de prover algum controle 

terapêutico, seja de natureza temporal, espacial ou ambos. Os sistemas de liberação de drogas 

y systems”) oferecem inúmeras vantagens quando comparados a outros de dosagem 

convencional, tais como: maior eficácia terapêutica, liberação progressiva e controlada do fármaco, 

diminuição significativa da toxicidade e maior tempo de permanência na circulação, diminuição do 

número de doses devido à liberação progressiva e possibilidade de direcionamento a alvos 

Muitos sistemas nanoparticulados estão sendo usados atualmente e, entre eles, os baseados 

nas nanopartículas magnéticas assumem um papel importante devido à propriedade de serem 

conduzidas e retidas em uma região específica do corpo por meio de gradiente de campo magnético 

rtícula magnética-droga 

pode ser associado à outra molécula capaz de reconhecer e se ligar especificamente ao sítio alvo. 

Tais moléculas podem ser anticorpos, proteínas, lectinas, hormônios, entre outros (Figura 10).  

 
Reproduzido de http://www.madrimasd.org/  

 de interações entre os 

al., 2005). A imobilização de células in vitro constitui um 

, e a interação entre as células e a adesão 

dessas células à superfície do chip constitui uma carcaterística importante para a imobilização 



22 

 

celular sem perda de viabilidade. Os fatores que têm um papel essencial nos mecanismos de adesão 

celular são: a composição química da superfície e a morfologia do suporte e as interações deste com 

proteínas (LAKARD et al., 2004). Os polímeros condutores são amplamente utilizados no 

desenvolvimento de tecnologias de biosensores, sendo as enzimas, os anticorpos e as células os 

principais elementos de bioreconhecimento dentro desses polímeros condutores (MORRIN et al., 

2005). Entre os polímeros condutores, a PANI é um dos mais empregados, em especial devido ao 

fácil processo de síntese, ao baixo custo e à estabilidade ambiental (CAMALET et al., 1998). El-

Said et al. (2009) imobilizaram células HeLa em filme de PANI depositado em eletrodo de índio-

estanho. Esses autores verificaram a viabilidade dessas células para diferentes concentrações de 

drogas anticâncer. 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



23 

 

3. Referências bibliográficas 

 

AGUILAR-ARTEAGA, K., RODRIGUEZ, J.A., BARRADO, E. Magnetic solids in analytical 

chemistry: a review. Analytica Chimica Acta, 674, 157–165, 2010. 

 

AH, L., SALABAS, E.L., SCHUTH, F. Magnetic nanoparticles: synthesis, protection, 

functionalization, and application. Angewandte Chemie International  Edition, 46, 1222–1244, 

2007. 

 

AMARAL, I.P.G., CARNEIRO-DA-CUNHA, M.G., CARVALHO JR., L.B., BEZERRA, R.S. 

Fish trypsin immobilized on ferromagnetic Dacron.  Process Biochemistry, 41, 1213–1216, 2006. 

 

ANGELI, R., DA PAZ, N.V. N., MACIEL, J.C., ARAÚJO, F.F.B., PAIVA, P.M.G., CALAZANS, 

G.M.T., VALENTE, A.P., ALMEIDA, F.C.L., COELHO, L.C.B.B., CARVALHO JR., L.B., 

SILVA, M.P.C., CORREIA, M.T.S. Ferromagnetic Levan Composite: An Affinity Matrix to Purify 

Lectin. Journal of Biomedicine and Biotechnology, 200, 1-7, 2009. 

 

ANSELL, R.J., MOSBACH, K. Magnetic molecularly imprinted polymer beads for drug 

radioligand binding assay.  Analyst, 123, 1611–1616, 1998. 

 

APHESTEGUY, J.C., JACOBO, S.E. Synthesis of a soluble polyaniline-ferrite composite: 

magnetic and electric properties. Journal of Materials Science, 42, 7062–7068, 2007. 

 

ARAÚJO, A.C.V., OLIVEIRA, R.J., ALVES JÚNIOR, S., RODRIGUES, A.R., MACHADO, 

F.L.A., CABRAL, F.A.O., AZEVEDO, W.M. Synthesis, characterization and magnetic properties 

of polyaniline-magnetite nanocomposites. Synthetic Metals, 160, 685–690, 2010. 

 

ARIAS, J.L., GALLARDO, V., GÓMEZ-LOPERA, S.A., PLAZA, R.D., DELGADO, A.V. 

Synthesis and characterization of poly(ethyl-2-cyanoacrylate) nanoparticles with a magnetic core. 

Journal of Controlled Release, 77, 309 – 321, 2001. 

 

ARIAS, J.L., LÓPEZ-VIOTA, M., LÓPEZ-VIOTA, J. DELGADO, Á.I.V. Development of 

iron/ethylcellulose (core/shell) nanoparticles loaded with diclofenac sodium for arthritis treatment. 

International Journal of Pharmaceutics, 382, 270–276, 2009. 

 



24 

 

ARIAS, J.L., LÓPEZ-VIOTA, M., LÓPEZ-VIOTA, J. DELGADO, Á.I.V. Development of 

iron/ethylcellulose (core/shell) nanoparticles loaded with diclofenac sodium for arthritis treatment. 

International Journal of Pharmaceutics, 382, 270–276, 2009. 

 

AZEVEDO, W.M., BARROS, R.A., DA SILVA JR., E.F. Conductive polymer preparation under 

extreme or non-classical conditions. Journal of Materials Science, 43, 1400–1405, 2008. 

 

BABINCOVA, M., LESZCZYNSKA, D., SOURIVONG, P., BABINEC, P. Selective treatment of 

neoplastic cells using ferritin-mediated electromagnetic hyperthermia. Medical Hypotheses, 54, 

177–179, 2000. 

 

BACHGANSMO, T. Ferrimagnetic Susceptibility Contrast Agents. Acta Radiologica, 34, 1–13, 

1993.   

 

BANUMATHI, E., HARIBALAGANESH, R., BABU, S., KUMAR, N., SANGILIYANDI, G.: 

High-yielding Enzymatic Method for Isolation and Culture of Microvascular Endothelial Cells from 

Bovine Retinal Blood Vessels. Microvascular Research, 77, 377–381, 2009. 

 

BARROS, V.V.R. Utilização de levana como suporte para imobilização de gentamicina. 2002. 

Dissertação (Mestrado em Bioquímica), Universidade Federal de Pernambuco, Recife.  

 

BARROS, R.A., AZEVEDO, W.M. Polyaniline/silver nanocomposite preparation under extreme or 

non-classical conditions. Synthetic Metals, 158, 922–926, 2008. 

 

BAYRAMO?LU, G., YILMAZ, M., ?ENEL, A.Ü., ARICA, M.Y. Preparation of nanofibrous 

polymer grafted magnetic poly(GMA-MMA)-g-MAA beads for immobilization of trypsin via 

adsorption. Biochemical Engineering Journal, 40, 262–274, 2008. 

 

BEKERS, M., UPITE, D., KAMINSKA, E., LAUKEVICS, J., GRUBE, M., VIGANTS, A., 

LINDE, R. Stability of levan produced by Zymomonas mobilis. Process Biochemistry, 40, 1535–

1539, 2005. 

 

BELAABED, B., WOJKIEWICZ, J.L., LAMOURI, S., KAMCHI, N.E., LASRI, T. Synthesis and 

characterization of hybrid conducting composites based on polyaniline/magnetite fillers with 



25 

 

improved microwave absorption properties. Journal of Alloys and Compounds, 527, 137–144, 

2012. 

 

BERRY, C.C., WELLS, S., CHARLES, S., CURTIS, A.S.G. Dextran and albumin derivatised iron 

oxide nanoparticle: influence on fibroblasts in vitro. Biomaterials, 24, 4551–4557, 2003. 

 

B?LKOVÁ, Z., SLOVÁKOVÁ, M., LY?KA, A., HORAK, D., LENFELD, J., TURKOVA, J., 

CHURACEK, J. Oriented immobilization of galactose oxidase to bead and magnetic bead cellulose 

and poly(HEMA-co-EDMA) and magnetic poly(HEMA-co-EDMA) microspheres. Journal of 

Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 770, 25–34, 

2002.  

 

BON, E.P.S., FERRARA, M.A., CORVO, M.L. Enzimas em biotecnologia: produção, aplicações 

e mercado. Rio de Janeiro, Editora Interciência, 2008. 

 

BRANDL, M., MAYER, M., HARTMANN, J., POSNICEK, T., FABIAN, C., FALKENHAGEN, 

D. Theoretical analysis of ferromagnetic microparticles in streaming liquid under the influence of 

external magnetic forces. Journal of Magnetism and Magnetic Materials, 322, 2454–2464, 2010. 

 

BRYJAK, J., KOLARZ, B.N. Immobilisation of trypsin on acrylic copolymers. Process 

Biochemistry, 33, 4, 409–417, 1998.  

 

CALAZANS, G.M.T. Produção de levana para uso clínico. 1997. Tese (Doutorado em Tecnologia 

de processos químicos e bioquímicos), Escola de Química, Universidade Federal do Rio de 

Janeiro, Rio de Janeiro. 

 

CAMALET, J.L., LACROIX, J.C., AEIYACH, S., CHANE-CHING, K., LACAZE, P.C. 

Electrosynthesis of adherent polyaniline films on iron and mild steel in aqueous oxalic acid 

médium. Synthetic Metals, 93, 133–142, 1998. 

 

CASTRO, V.F., CELESTINO, J., DE QUEIROZ, A.A.A., GARCIA, F.G. Propriedades magnéticas 

e biocompatíveis de nanocompósitos para utilização em magneto-hipertermia. Revista Brasileira de 

Física Médica, 4, 79–82, 2010. 

 



26 

 

CHENG, F.Y., SU, C.H., YANG, Y.S., YEH, C.S., TSAI, C.Y., WU, C.L. Characterization of 

aqueous dispersions of Fe3O4 nanoparticles and their biomedical applications. Biomaterials, 26, 

729–738, 2005. 

 

CHEN, L., WANG, T., TONG, J. Application of derivatized magnetic materials to the separation 

and the preconcentration of pollutants in water samples. Trends in Analytical Chemistry, 30, 1095–

1108, 2011. 

 

CHEN, N., ZOU, J., WANG, S., YE, Y., HUANG, Y., GADDA, G., YANG, J. Designing Protease 

Sensors for Real-time Imaging of Trypsin Activation in Pancreatic Cancer Cells. Biochemistry, 48, 

3519–3526, 2009. 

 

CHOI, W., PARK, K.W., LEE, D.B., LEE, W., LEE, W.H. Cell immobilization using self-

assembled synthetic oligopeptide and its application to biological toxicity detection using surface 

Plasmon resonance. Biosensors and Bioelectronics, 20, 2300–2305, 2005. 

 

CHOMOUCKA, J., DRBOHLAVOVA, J., HUSKA, D., ADAM, V., KIZEK, R., HUBALEK, J. 

Magnetic nanoparticles and targeted drug delivering. Pharmacological Research, 62, 144–149, 

2010. 

 

CORNELL, R.M., SCHWERTMANN, U. The iron oxides: structure, properties, reactions, 

occurrences and uses. Weinheim: Wiley-VCH, 2003. 

 

DAOU, T.J., GRENÈCHE, J.M., POURROY, G., BUATHONG, S., DERORY, A., ULHAQ-

BOUILLET, C., DONNIO, B., GUILLON, D., BEGIN-COLIN, S. Coupling agent effect on 

magnetic properties of functionalized magnetite-based nanoparticles. Chemistry of Materials, 20, 

5869–5875, 2008. 

 

DE CASTRO, H.F., ANDERSON, W.A. Fine chemicals by biotransformation using lipases. 

Química Nova, 18, 544–554, 1995. 

 

DRBOHLAVOVA, J., HRDY, R., ADAM, V., KIZEK, R., SCHNEEWEISS, O., HUBALEK, J. 

Preparation and properties of various magnetic nanoparticles. Sensors, 9, 2352–2362, 2009. 

 



27 

 

DUNNILL, P., LILLY, M.D. Purification of enzymes using. magnetic bioaffinity materials.  

Biotechnology and Bioengineering, 16, 987–990, 1974. 

 

DURÁN, N., AZEVEDO, M.M.M. O que é nanotecnologia? Atualidades e perspectivas. Instituto 

de Química, UNICAMP, 2003 em: RUTH LUQUEZE CAMILO, Síntese e caracterização de 

nanopartículas magnéticas de ferrita de cobalto recobertas por 3-aminopropiltrietoxissilano para uso 

como material híbrido em nanotecnologia. Tese (Doutorado em Ciências na Área de Tecnologia 

Nuclear – Materiais), Instituto de Pesquisas Energéticas e Nucleares/ Universidade de São Paulo, 

SP, 2006. 

  

EL-SAID, W.A., YEA, C.-H., CHOI, J.-W., KWON, I.-K. Ultrathin polyaniline film coated on an 

indium–tin oxide cell-based chip for study of anticancer effect. Thin Solid Films, 518, 661–667, 

2009. 

 

ELIF BOYUKBAYRAM, A., KIRALP, S., TOPPARE, L., YAGCI, Y. Preparation of biosensors 

by immobilization of polyphenol oxidase in conducting co-polymers and their use in determination 

of phenolic compounds in red wine. Bioelectrochemistry, 69, 164–71, 2006. 

 

ENGASSER, J.M., COULET, P.R. Comparison of intrinsic stabilities of free and bound enzyme by 

graphical removal of diffusional effects. Biochimica et Biophysica Acta, 485, 29–36, 1977.  

 

FAEZ, R., REIS, C., FREITAS, P.S. DE, KOSIMA, O.K., RUGGERI, G., DE PAOLI, M.-A. 

Polímeros condutores. Química Nova na Escola, 11, 13–18, 2000. 

 

FEINGOLD, D.S., GEHATIA, M. The structure and properties of levan, a polymer of D- fructose 

produced by cultures and cell-free extracts of Aerobacter levanicum. Journal of Polymer Science, 

23, 783–790, 1957.  

 

FIGUEROLA, A., DI CORATO, R., MANNA, L., PELLEGRINO, T. From iron oxide 

nanoparticles towards advanced iron-based inorganic materials designed for biomedical 

applications. Pharmacological Research, 62, 126–143, 2010. 

 

FUCHS, A. Current and potencial food and non-food application of fructans. In: 686th Meeting 

Reading of Biochemical Society Transactions, 19, 555–560, 1991.  

 



28 

 

FUCHS, A., BRUIJN, J.M., NIEDEVELD, C.J. Bacteria and yeasts as possible candidates for the 

production of inulinases and levanases. Antonie van Leeuwenhoek, Delft, 5, 333–351, 1985. 

 

GANDHI, N., SINGH, K., OHLAN, A., SINGH, D.P., DHAWAN, S.K. Thermal, dielectric and 

microwave absorption properties of polyaniline–CoFe2O4 nanocomposites. Composites Science 

and Technology, 71, 1754–1760, 2011. 

 

GIZDAVIC-NIKOLAIDIS, M., TRAVAS-SEJDIC, J., BOWMAKER, G.A., COONEY, R.P., 

THOMPSON, C., KILMARTIN, P.A. The antioxidant activity of conducting polymers in 

biomedical applications. Current Applied Physics, 4, 347–350, 2004. 

 

HÄFELI, U.O., PAUER, G.J. In vitro and in vivo toxicity of magnetic microspheres. Journal of 

Magnetism and Magnetic Materials, 194, 76–82, 1999. 

 

HALLING, P.J., DUNNILL, P. Magnetic supports for immobilized enzymes and bioaffinity 

adsorbents. Enzyme and Microbial Technology, 2, 2–10, 1980.  

 

HAN, Y.W. Microbial levan. Advances in Applied Microbiology, 35, 171–194, 1990.  

 

HAO, R., XING, R.J., XU, Z.C., HOU, Y.L., GAO, S., SUN, S.H. Synthesis, functionalization, and 

biomedical applications of multifunctional magnetic nanoparticles. Advanced Materials, 25, 2729–

2742, 2010. 

 

HAYASHI, K., MORIYA, M., SAKAMOTO, W., YOGO, T. Chemoselective synthesis of folic 

acid functionalized magnetite nanoparticles via click chemistry for magnetic hyperthermia. 

Chemistry of Materials, 21, 1318–1325, 2009. 

 

HEEGER, A.J. Semiconducting and metallic polymers: the fourth generation of polymeric 

materials. Synthetic Metals, 125, 23–42, 2002. 

 

HERMANSON, G.T., MALLIA, A. K., SMITH, P. K. The matrix. In: Immobilized Affinity Ligand 

Techniques. New York: Academic Press, 1992. 

 

HERMANSON, G.T. In: Bioconjugate techniques. New York:  Academic Press, 134-185, 1996. 

 



29 

 

HORÁK, D., PETROVSKÝ, E., KAPI?KA, A., FREDERICHS, T. Synthesis and characterization 

of magnetic poly(glycidyl methacrylate) microspheres. Journal of Magnetism and Magnetic 

Materials, 311, 500–506, 2007.  

 

HUBER, D.L. Synthesis, properties, and applications of iron nanoparticles. Small, 1, 482–501, 

2005.  

 

ITO, A., SHINKAI, M., HONDA, H., KOBAYASHI, T. Medical application of functionalized 

magnetic nanoparticles. Journal of Bioscience and Bioengineering, 100, 1–11, 2005. 

 

JARAMILLO-TABARES, B.E., JARAMILO, F.I, TORRESI, S.I.C. Stabilization of polyaniline by 

the incorporation of magnetite nanoparticles. Materials Chemistry and Physics, 132, 529–533, 

2012.  

 

KAMALESH, S., TAN, P., WANG, J., LEE, T., KANG, E., WANG, C. Biocompatibility of 

electroactive polymers in tissues. Journal of Biomedical Materials Research, 52, 467–478, 2000. 

 

KANG, S.K., LEE, S.O., LIM, Y.S., JANG, K.L., LEE, T.H. Purification and characterization of 

novel levanoctaose-producing levanase from Pseudomonas strain K-52. Biotechnology Applied 

Biochemistry, 27, 159–166, 1998. 

 

KANG, Y.S., RISBUD, S., RABOLT, J.F., STROEVE, P. Synthesis and characterization of 

nanometer-size Fe3O4 and gamma-Fe2O3 particles. Chemistry of Materials, 8, 2209–2211, 1996. 

 

KENNEDY, J.F., ROIG, M.G. Principles of immobilization of enzymes. In: Handbook of enzyme 

biotechnology. London: T.P. Press, 1995. 

 

KONCRACKÁ, M., KOP?ANSKÝ, P., TIMKO, M., RAMCHAND, C.N. Direct binding 

procedure of proteins and enzymes to fine magnetic particles. Journal of Magnetism and Magnetic 

Materials, 252, 409–411, 2002. 

 

KRESSE, M., WAGNER, S., PFEFFERER, D., LAWACZECK, R., ELSTE, V., SEMMLER, D.W. 

Targeting of ultrasmall superparamagnetic iron oxide (uspio) particles to tumor cells in vivo by 

using transferrin receptor pathways. Magnetic Resonance in Medicine, 40, 236–242, 1998. 

 



30 

 

KREUTER, J. Evaluation of nanoparticles as drug-delivery systems. III: materials, stability, 

toxicity, possibilities of targeting, and use. Pharmaceutica Acta Helvetiae, 58, 242–250, 1983. 

 

KROGH, T.N., BERG, T., HØJRUP, P. Protein analysis using enzymes immobilized to 

paramagnetic beads. Analytical Biochemistry, 274, 153–162, 1999. 

 

LAKARD, S., HERLEM, G., PROPPER, A., KASTNER, A., MICHEL, G., VALLÈS-

VILLARREAL, N., GHARBI, T., FAHYS, B. Adhesion and proliferation of cells on new polymers 

modified biomaterials. Bioelectrochemistry, 62, 19–27, 2004. 

 

LEIBOVICI, J., STARK, Y. Slow citotoxicity of the polysaccharide levan on tumor cells in vitro. 

Chemico-Biological Interactions, 60, 191–200, 1986. 

 

LIU, J., LIN, S., QI, D., DENG, C., YANG, P., ZHANG, X. On-chip enzymatic microreactor using 

trypsin-immobilized superparamagnetic nanoparticles for highly efficient proteolysis. Journal of 

Chromatography A, 1176, 169–177, 2007. 

 

LU, A.H., SALABAS, E.L., SCHUTH, F. Magnetic nanoparticles: synthesis, protection, 

functionalization, and application. Angewandte Chemie International Edition in English, 46, 

1222–1244, 2007. 

 

MACIEL, J.C.,  ANDRADE, P.L., NERI, D.F.M., CARVALHO JR., L.B., CARDOSO, C.A., 

CALAZANS, G.M.T.,  AGUIAR, J. ALBINO,  SILVA, M.P.C. Preparation and characterization of 

magnetic levan particles as matrix for trypsin immobilization.  Journal of Magnetism and 

Magnetic Materials, 324, 1312–1316, 2012. 

 

MALMSTEN, M., XING, K., LJUNGLÖF, A. Confocal microscopy studies of trypsin 

immobilization on porous glycidyl methacrylate beads. Journal of Colloid and Interface Science, 

220, 436-442, 1999. 

 

MARCHESSAULT, R.H., BLEHA, T., DESLENDES, Y., REVOL, J.T. Canadian Journal of 

Chemistry, 58, 2415–2417, 1980. 

 

MARTINEK, K., KLIBANOV, A.M., GOLDMACHER, V.S., BEREZIN, I.V. The principles of 

enzyme stabilization. Biochimica et Biophysica Acta, 485, 1–12, 1977.  



31 

 

MASSIA, S.P., STARK, J., LETBETTER, D.S. Surface immobilized dextran limits cell adhesion 

and spreading. Biomaterials, 21, 2253–2261, 2000. 

 

MOFFAT, G., WILLIAMS, R.A., WEBB, C., STIRLING, R. Selective separations in 

environmental and industrial processes using magnetic carrier technology.  Minerals Engineering, 

7, 1039–1056, 1994. 

 

MORRIN, A., NGAMNA, O., KILLARD, A.J., MOULTON, S.E., SMYTH, M.R., WALLACE, 

G.G. An amperometric polyaniline enzyme biosensor fabricated from nanoparticles. 

Electroanalysis, 17, 423–430, 2005. 

 

MUNSHI, N., DE, T.K., MAITRA, A. Size modulation of polymeric nanoparticles under controlles 

dynamics of microemulsion droplets. Journal of Colloid and Interface Science, 190, 387–391, 

1997. 

 

NERI, D.F.M., BALCÃO, V.M., DOURADO, F.O.Q., OLIVEIRA, J.M.B., CARVALHO JR., 

L.B., TEIXEIRA, J.A. Galactooligosaccharides production by ?-galactosidase immobilized onto 

magnetic polysiloxane-polyaniline particles. Reactive &amp;amp; Functional Polymers, 69, 246–251, 2009.  

 

NERI, D.F.M., BALCÃO, V.M., DOURADO, F.O.Q., OLIVEIRA, J.M.B., CARVALHO JR., 

L.B., TEIXEIRA, J.A. Immobilized ?-galactosidase onto magnetic particles coated with 

polyaniline: support characterization and galactooligosaccharides production. Journal of Molecular 

Catalysis B: Enzymatic, 70, 74–80, 2011.  

 

NIKOLIC, T., KOSTIC, M., PRASKALO, J., PEJIC, B., PETRONIJEVIC, Z., SKUNDRIC, P. 

Sodium periodate oxidized cotton yarn as carrier for immobilization of trypsin. Carbohydrate 

Polymers, 82, 976 – 981, 2010.  
NUNES, J.S., VASCONCELOS, C.L., CABRAL, F.A.O., ARAÚJO, J.H., PEREIRA, M.R., 

FONSECA, J.L.C. Synthesis and characterization of poly(ethyl methacrylate-co-methacrylic acid) 

magnetic particles via miniemulsion polymerization. Polymer, 47, 7646–7652, 2006. 

 

OH, W.K., KIM, S., KWON, O., JANG, J. Shape-dependent cytotoxicity of polyaniline 

nanomaterials in human fibroblast cells. Journal of Nanoscience and Nanotechnology, 11, 4254–

4260, 2011. 



32 

 

O’HANDLEY, R.C. Modern Magnetic Materials: Principles and Applications. New York: John 

Wiley, 2000. 

 

PANKHURST, Q.A., CONNOLLY, J., JONES, S.K., DOBSON, J. The underlying physics of 

biomedical applications of magnetic nanoparticles.  Journal of Physics D: Applied Physics, 36, 

167–181, 2003.  

 

PARK, A.K., HWANG, Y., PARK, J.G., NOH, H.J., KIM, J.Y., PARK, J.H., HWANG, N.M., 

HYEON, T. Ultra-large-scale syntheses of monodisperse nanocrystals. Nature Materials, 3, 891–

895, 2004.  

 

PEREIRA, A.R.P. Formação e transformação químico-mineralógica de hematita em um 

geodomínio do quadrilátero ferrífero, Minas Gerais. 2010. Tese (Doutorado em Ciências – 

Química), Universidade Federal de Minas Gerais, Belo Horizonte. 

 

PETRI-FINK, A., HOFMANN, H. Superparamagnetic iron oxide nanoparticles (SPIONs): from 

synthesis to in vivo studies – A summary of the synthesis, characterization, in vitro, and in vivo 

investigations of SPIONs with particular focus on surface and colloidal properties. IEEE 

Transactions on Nanobioscience, 6, 289–297, 2007. 

 

POWELL, L.W. Immobilized biocatalyst technology. In: Forgat W.M. &amp;amp; Kelly C.T., eds. 

Microbial Enzyme and Biotechnology. London: Elsevier Science Publishers, 1990. 

 

QU, S.C., YANG, H.B., REN, D.W., KAN, S.H., ZOU, G.T., LI, D.M. Magnetite nanoparticles 

prepared by precipitation from partially reduced ferric chloride aqueous solutions. Journal of 

Colloid and Interface Science, 215, 190–192, 1999. 

 

ROCHA, C., GONÇALVES, M.P., TEIXEIRA, J.A. Immobilization of trypsin on spent grains for 

whey protein hydrolysis. Process Biochemistry, 46, 505–511, 2011. 

 

ROSEVEAR, A., KENNEDY, J.F., CABRAL, J.M.S. Immobilized enzymes and cells. Bristol: 

Adam Hilger, 1987.  

 

ŠAFA??K, I., ŠAFA??KOVÁ, M. Use of magnetic techniques for the isolation of cells. Journal of 

Chromatography B, 722, 33–53, 1999.  



33 

 

ŠAFA??K, I., ŠAFA??KOVÁ, M. One-step partial purification of Solanum tuberosum tuber lectin 

using magnetic chitosan particles. Biotechnology Letters, 22, 941–945, 2000. 

 

SAINI, S., STARK, D.D., HAHN, P.F., WITTENBERG, J., BRADY, T.J., FERRUCCI, J.T. Ferrite 

particles: a superparamagnetic MR contrast agent for the reticuloendothelial system. Radiology, 

162, 211–216, 1987. 

 

SAIYED, Z.M., TELANG, S.D., RACNCHAND, C.N. Application of magnetic techniques in the 

field of drug discovery and biomedicine. BioMagnetic Research and Technology, 1, 23–33, 2003. 

 

SAWANT, R.M., SAWANT, R.R., GULTEPE, E., NAGESHA, D., BRIGITTE, P.S., SRIDHAR, 

S., TORCHILIN, V.P. Nanosized cancer cell-targeted polymeric immunomicelles loaded with 

superparamagnetic iron oxide nanoparticles. Journal of Nanoparticle Research, 11, 1777–1785, 

2009. 

 

SCHERER, F., ANTON, M., SCHILLINGER, U., HENKE J., BERGEMANN C., KRÜGER A., 

GÄNSBACHER B., PLANK C. Magnetofection: enhancing and targeting gene delivery by 

magnetic force in vitro and in vivo. Gene Therapy, 9, 102–109, 2002.  

 

SCHUCHERT-SHI, A., HAUSER, P.C. Peptic and tryptic digestion of peptides and proteins 

monitored by capillary electrophoresis with contactless conductivity detection.  Analytical 

Biochemistry: Methods in the Biological Sciences, 387, 202–207, 2009.  

 

SHUBAYEV, V.I., PISANIC II, T.R., JIN, S. Magnetic nanoparticles for theragnostics. Advanced 

Drug Delivery Reviews, 61, 467–477, 2009. 

 

SOLEIMANI, M., NADRI, S. A protocol for isolation and culture of mesenchymal stem cells from 

mouse bone marrow. Nature Protocols, 4, 102–106, 2009. 

 

SOUZA, R.A., ARAÚJO, O.A., FREITAS, P.S., DEPAOLI, M.A. Tratamento de resíduos gerados 

na síntese de polianilina em escala pré-piloto. Química Nova, 26, 938–942, 2003. 

 

STARK, D.D., WEISSLEDER, R., ELIZONDO, G., HAHN, P.F., SAINI, S., TODD, L.E., 

WITTENBERG, J., FERRUCCI, J.T. Superparamagnetic iron oxide: clinical application as a 

contrast agent for MR imaging of the liver. Radiology, 168, 297–301, 1988.  



34 

 

SUN, L., LI, Q., WANG, W., PANG, J., ZHAI, J. Synthesis of magnetic and lightweight hollow 

microspheres/polyaniline/Fe3O4 composite in one-step method. Applied Surface Science, 257, 

10218–10223, 2011. 

 

TAKASHIMA, W., KANEKO, M., KANETO, K., MACDIARMID, A.G. The electrochemical 

actuator using electrochemically-deposited polyaniline film. Synthetic Metals, 71, 2265–2266, 

1995. 

 

TARTAJ, P., MORALES, M.P., VEINTEMILLAS-VERDAGUER, S., GONZÁLEZ-CARREÑO, 

T., SERNA, C.J. Preparation of magnetic nanoparticles for applications in biomedicine. Journal of 

Physics D: Applied Physics, 36, 182–197, 2003. 

 

TISCHER, W., KASCHE, V. Immobilized enzymes: crystals or carriers. Trends in Biotechnology, 

17, 326–335, 1999.  

 

TOKORO, H., NAKABAYASHI, T., FUJII, S., ZHAO, H., HÄFELI, U.O. Magnetic iron particles 

with high magnetization useful for immunoassay. Journal of Magnetism and Magnetic Materials, 

321, 1676–1678, 2009. 

 

TROMSDORF, U.I., BIGALL, N.C., KAUL, M.G., BRUNS, O.T., NIKOLIC, M.S., MOLLWITZ, 

B. Size and surface effects on the MRI relaxivity of manganese ferrite nanoparticle contrast agents. 

Nano Letters, 7, 2422–2427, 2007. 

 

TZETIS, M., KALIAKATSOS, M., FOTOULAKI, M., PAPATHEODOROU, A., 

DOUDOUNAKIS, S., TSEZOU, A., MAKRYTHANASIS, P., KANAVAKIS, E., NOUSIA-

ARVANITAKIS, S. Contribution of the CFTR gene, the pancreatic secretory trypsin inhibitor gene 

(SPINK1) and the cationic trypsinogen gene (PRSS1) to the etiology of recurrent pancreatitis. 

Clinical Genetics, 71, 451–457, 2007. 

 

TUCEK, J., ZBORIL, R., PETRIDIS, D. Maghemite nanoparticles by view of Mossbauer 

spectroscopy. Journal of Nanoscience Nanotechnol, 6, 926–947, 2006. 

 

UMARE, S.S., SHAMBHARKAR, B.H., NINGTHOUJAM, R.S. Synthesis and characterization of 

polyaniline-Fe3O4 nanocomposite: electrical conductivity, magnetic, electrochemical studies. 

Synthetic Metals, 160, 1815–1821, 2010. 



35 

 

VANDAMME, E.J., DERYCKE, D.G. Microbial inulinases: fermentation process, properties and 

applications. Advances in Applied Microbiology, 29, 139–176, 1983. 

 

VIETH, W.R. Bioprocess engineering – kinetic, mass transport, reactors and gene expression. 

New York: John Wiley &amp;amp; Sons, 1994. 

 

VILLALBA, P., RAM, M.K., GOMEZ, H., BHETHANABOTLA, V., HELMS, M.N., KUMAR, 

A., KUMAR, A. Cellular and in vitro toxicity of nanodiamond-polyaniline composites in 

mammalian and bacterial cell. Materials Science and Engineering: C, 32, 594–598, 2012. 

 

VILLALONGA, R., VILLALONGA, M.L., GÓMEZ, L. Preparation and functional properties of 

trypsin modified by carboxymethylcelulose. Journal of Molecular Catalysis B: Enzymatic, 10, 

483–490, 2000. 

 

VILLENEUVE, P., MUDERHWA, J.M., GRAILLE, J., HAAS, M.J. Customizing lipases for 

biocatalysis: a survey of chemical, physical and molecular biological approaches. Journal of 

Molecular Catalysis B: Enzymatic, 9, 113–148, 2000. 

 

VINA, I., KARSAKEVICH, A., BEKERS, M. Stabilization of anti-leukemic enzyme L-

asparaginase by immobilization on polysaccharide levan. Journal of Molecular Catalysis B: 

Enzymatic, 11, 551–558, 2001.  

 

WANG, X., ZHUANG, J., PENG, Q., LI, Y.D. A general strategy for nanocrystal synthesis. 

Nature, 437, 121–124, 2005.  

 

WANG, C.H., DONG, Y.Q., SENGOTHI, K., TAN, K.L., KANG, E.T. In vivo tissue response to 

polyaniline. Synthetic Metals, 102, 1313–1314, 1999. 

 

WANG, S., BAO, H., YANG, P., CHEN, G. Immobilization of trypsin in polyaniline-coated nano-

Fe3O4/carbon nanotube composite for protein digestion. Analytica Chimica Acta, 612, 182–189, 

2008. 

 

WEISSLEDER, R., BOGDANOV, A., NEUWELT, E.A., PAPISOV, M. Long-circulating iron 

oxides for MR imaging. Advanced Drug Delivery Reviews, 16, 321–334, 1995. 



36 

 

WEISSLEDER, R., LEE, A.S., FISCHMAN, A.J., REIMER, P., SHEN, T., WILKINSON, R., 

CALLAHAN, R.J., BRADY, T.J. Polyclonal human immunoglobulin-G labeled with polymeric 

iron oxide antibody MR imaging. Radiology, 181, 245–249, 1991. 

 

WEISSLEDER, R., LEE, A.S., KHAW, B.A., SHEN, T., BRADY, T.J. Antimyosin-labeled 

monocrystalline iron-oxide allows detection of myocardial infarct – MR antibody imaging. 

Radiology, 182, 381-385, 1992.  

 

WILLIS, A.L., TURRO, N.J., O’BRIEN, S. Spectroscopic characterization of surface of iron oxide 

nanocrystals. Chemistry of Materials, 17, 5970–5975, 2005. 

 

WINGARD JR., L.B. Enzyme Engineering. New York: Interscience Publishers, 1972. 

 

WU, W., HE, Q.G., JIANG, C.Z. Magnetic iron oxide nanoparticles: synthesis and surface 

functionalization strategies. Nanoscale Research Letters, 3, 397–415, 2008.  

 

WUNDERBALDINGER, P., JOSEPHSON, L., WEISSLEDER, R. Tat peptide directs enhanced 

clearance and hepatic permeability of magnetic nanoparticles. Bioconjugate Chemistry, 13, 264–

268, 2002. 

 

XI, F., WU, J., JIA, Z., LIN, X. Preparation and characterization of trypsin immobilized on silica 

gel supported macroporous chitosan bead. Process Biochemistry, 40, 2833–2840, 2005.  

 

XIAO, Q., TAN, X., JI, L., XUE, J. Preparation and characterization of polyaniline/nano-Fe3O4 

composites via a novel Pickering emulsion route. Synthetic Metals, 157, 784–791, 2007. 

 

YANG, H., ZHANG, C.X., SHI, X.Y., HU, H., DU, X.X., FANG, Y., MA, Y.B., WU, H.X., 

YANG, S.P. Water-soluble superparamagnetic manganese ferrite nanoparticles for magnetic 

resonance imaging. Biomaterials, 31, 3667–3673, 2010.  

 

YANG, M., CHEN, C., WANG, X., ZHU, Y., GU, Y. Favorable Effects of the Detergent and 

Enzyme Extraction Method for Preparing Decellularized Bovine Pericardium Scaffold for Tissue 

Engineered Heart Valves. Journal of Biomedical Materials Research Part A, 91, 354–361, 2009. 

 



37 

 

YSLAS, E.I., IBARRA, L.E., PERALTA, D.O., BARBERO, C.A., RIVAROLA, V.A., 

BERTUZZI, M.L. Polyaniline nanofibers: acute toxicity and teratogenic effect on Rhinella 

arenarum embryos. Chemosphere, 87, 1374–1380, 2012. 

 

ZABORSKY, O.R. Immobilized enzymes. Cleveland: CRC Press, 1973. 

 

ZABORSKY, O.R. Immobilized enzymes – Miscellaneous methods and general classification. In: 

Immobilized enzymes – Methods in Enzymology. New York: Academic Press, 1976. 

 

ZANIN, G.M., MORAES, F.F. Enzimas como agentes biotecnológicos.  Ribeirão Preto: Legis 

Summa, 2004. 

 

ZBORIL, R., MASHLAN, M., PETRIDIS, D. Iron(iii) oxides from thermal processes-synthesis, 

structural and magnetic properties, Mossbauer spectroscopy characterization, and applications. 

Chemistry of Materials, 14, 969–982, 2002. 

 

ZHANG, Y.-J., LIN, Y.-W., CHANG, C.-C., WU, T.-M. Magnetic properties of hydrophilic iron 

oxide/polyaniline nanocomposites synthetisized by in situ chemical oxidative polymerization. 

Synthetic Metals, 160, 1086–1091, 2010. 

 

ZHU, L., MA, J., JIA, N., ZHAO, Y., SHEN, H. Chitosan-coated magnetic nanoparticles as carriers 

of 5-fluorouracil: preparation, characterization and cytotoxicity studies. Colloids and Surfaces B-

Biointerfaces, 68, 1–6, 2009. 

 

 

  



38 

 

Capítulo 2 

 

4. Artigo submetido ao periódico Analytica Chimica Acta 

 

Título: Magnetic particles coated with polyaniline: effect of the polymerization conditions on the 
activity of immobilized trypsin for protein digestion 
 

Autores: Jackeline C. Maciel, Mariana Cabrera, David F.M. Neri, Maria da Paz C. Silva, Luiz B. 
Carvalho Jr. 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



39 

 

Magnetic particles coated wtih polyaniline: effect of the polymerization conditions on the 

activity of immobilized trypsin for protein digestion 

 

Jackeline C. Maciela, Mariana Cabreraa, David F.M. Nerib, Maria da Paz C. Silvaa, Luiz B. 

Carvalho Jr.a 
 

aDepartamento de Bioquímica and Laboratório de Imunopatologia Keizo Asami, Universidade 

Federal de Pernambuco, Cidade Universitária, Recife-PE CEP 50670-901, Brazil 
bUniversidade Federal do Vale do São Francisco, Centro, Petrolina-PE CEP 56304-205, Brazil 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

*Corresponding author: 

Luiz Bezerra de Carvalho Júnior 

Laboratório de Imunopatologia Keizo Asami (LIKA) 

Universidade Federal de Pernambuco 

Cidade Universitária, Recife – PE CEP 50670–901, Brazil 

Telephone number: + 55-81-21268485/ Fax: +55-81-21268485 

E-mail address: lbcj@hotlink.com.br  



40 

 

Abstract 

The main objective of this work was to produce an enzymatic derivative with higher retention 

activity to be used the protein digestion. The proteolytic enzyme trypsin was immobilized on 

composite of magnetic nanoparticles-polyaniline and the influence of coating on residual specific 

activity of the enzyme was studied using two 23 complete factorial designs. The 1st factorial design 

results showed that the best conditions for the KMnO4 concentration, aniline concentration and 

polymerization time were 0.1 M; 0.5 M and 1 h, respectively, with a maximum residual specific 

activity of 70% of the initial activity of the free enzyme solution. In the sequence, the best result in 

the 2nd factorial design for the contact time of KMnO4, polymerization temperature and offered 

protein were 1 h; 4°C and 50 µ g mL-1, respectively, with a maximum residual specific activity of 

79%. Under the optimized conditions, the immobilized trypsin exhibited higher thermal stability 

(35°C–65°C); higher apparent affinity for the substrate (Kmapp was 1.4-fold lower than that of the 

soluble enzyme) and after 48 days of storage at 4°C retained 89% of its initial activity. The 

feasibility and performance of this enzymatic derivative offers a wide range of applications in the 

biomedical sciences including proteome research due the simple method and low cost of production 

of the enzymatic derivative. 

 

Keywords: magnetic composite, magnetic nanoparticles, PANI, enzyme 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



41 

 

1. Introduction 

Immobilization of biomolecules onto insoluble supports is an important tool for the fabrication of a 

diverse range of functional materials or devices [1]. It provides many distinct advantages including 

enhanced stability, easy separation from reaction mixture, possible modulation of the catalytic 

properties, and easier prevention of microbial growth [2]. Numerous approaches had been taken to 

immobilize bioactive molecules onto solid substrates including adsorption, covalent coupling and 

tethering via an intermediate linker molecule [3].  

The typical protocol for protein digestion is accomplished by enzymatic hydrolysis [4]. However, 

the traditional digestion (in solution) has drawbacks, because often produces autoproteolysis of the 

enzyme, leading to non-substrate related background peaks [5]. Different types of enzymes can be 

used in this step, depending of the purpose of the analysis [6]. Trypsin is by far the most common 

enzyme used, this enzyme cleaves peptide bonds predominantly at the carboxyl side of amino acids 

lysine and arginine [7].  

Magnetite (Fe3O4) or maghemite (?- Fe2O3) are usually used as magnetic materials [8], especially as 

supports for immobilization. The magnetite particles are preferred because of their greater 

saturation magnetization [9].  These magnetite beads are generally of core-shell type: the biological 

species cells, nucleic acids, and proteins are connected to the magnetite core through an organic or 

polymeric shell [10].  

In our lab a composite has been proposed including polyaniline (PANI) to the magnetite [11,12]. 

PANI is one of the most investigated conducting polymers. It has been studied frequently because 

of its low cost, its ease in preparation, good thermal and environmental stabilities, its versatile 

applications [13–16], its diverse structures, good solution processability and high conductivity [17]. 

For the optimization of process, factorial designs are widely used to investigate the effects of 

experimental factors and the interactions between those factors, that is, how the effect of one factor 

varies with the level of the other factors in a response [18]. The advantages of factorial experiments 

include the relatively low cost, a reduced number of experiments, and increased possibilities to 

evaluate interactions among the variables [19]. 

In this work, were optimized the aniline polymerization conditions. Two factorial designs were used 

to investigate the effects of experimental factors and the interactions between those factors. The 

properties of immobilized trypsin were characterized and compared with those of the soluble 

trypsin. Finally, the applicability of this enzymatic derivative shows advantages due to its low cost 

and simple method, specially. 

 

 

 



42 

 

2. Materials and methods 

 

2.1. Materials 

Trypsin (E.C.3.4.21.4) from porcine pancreas, N-benzoyl-D-L-arginine-p-nitroanilide (BAPNA), 

aniline (ACS reagent), potassium permanganate (ACS reagent) and glutaraldehyde were all 

products from Sigma-Aldrich (USA). Dimethylsulfoxide (DMSO) and sodium hydroxide were from 

Vetec Chemical (Brazil). Ferric chloride hexahydrate and ferrous chloride tetrahydrate were from 

Merck (Germany). All other reagents were of analytical grade. 

 

2.2. Magnetic particles preparation 

Solutions of 1.1 M FeCl3 .6H2O (5 mL) and of 0.6 M FeCl2 .4H2O (5 mL) were added to 50 mL of 

distilled water, under magnetic agitation, then 5.0 M NaOH was added dropwise up to pH 10 when 

black particles precipitate were being produced. The mixture was heated at 50°C for 30 min with 

vigorous stirring. The magnetic particles were thoroughly washed with distilled water until pH was 

neutral. The material was dried up and kept at room temperature.  

 

2.3. Polymerization of aniline 

The oxidative polymerization of aniline was carried out in the presence of magnetic particles (0.01 

g) by treating them with KMnO4 solution at 25°C and washing with distilled water (in the 1st 

design, contact time of KMnO4 with magnetic particles was overnight; whereas in the 2nd design it 

was in agreement with the Table 3). Then magnetic-KMnO4 particles were immersed into aniline 

solution in 1.0 M HNO3. After polymerization, the magnetic nanoparticles-polyaniline (mPANI) 

were successively washed with distilled water, 0.1 M citric acid and rewashed with distilled water, 

and finally the material was dried up and kept at 25°C. 

 

2.4. Immobilization of trypsin 

mPANI (0.01g) was incubated with 2.0% w/v glutaraldehyde (1.0 mL) at 25°C for 2 h under mild 

stirring, washed with distilled water and Tris-HCl buffer to remove the excess of glutaraldehyde. 

mPANI activated with glutaraldehyde (mPANIG) was kept in buffer at 4°C until use. mPANIG was 

incubated with trypsin solution ranging from 50–200 µ g mL-1 (Table 3) for 16 h at 4°C under mild 

stirring. The enzymatic derivative (mPANIG-Trypsin) was collected by a magnetic field (Ciba 

Corning; 0.6 T) and the supernatant and washings were used for protein determination.  

 

 

 



43 

 

2.5. Activity assay  

Amidase activity of the trypsin was measured by using the artificial substrate BAPNA (4.0 mM 

BAPNA in DMSO). The mixture of reaction was incubated at 25°C for 15 min. The hydrolyzed p-

nitroanilide was monitored in spectrophotometer at 440 nm and the activity of enzyme was 

calculated. All assays were carried out in replicates and the results are expressed as mean ± standard 

deviation. One unit of proteolytic activity of trypsin was defined as 1µmol of BAPNA hydrolyzed 

per minute using an absorption coefficient of 9.100 M-1 cm-1. The specific activity was calculated by 

dividing the enzymatic activity (U) by the amount of protein (mg). For the residual specific activity 

was considered  the specific activity of the free enzyme as 100%.  

 

2.6. Protein determination 

The retained protein was estimated by the difference between the offered protein and that found in 

the supernatant and washing solutions measured according to the method of Lowry et al. [20] using 

bovine serum albumin (BSA) as a standard. 

 

2.7. Experimental design 

According to literature data, the synthesis of PANI is influenced for experimental factors, such as 

aniline concentration and polymerization temperature for example. Therefore based in an 

experimental protocol routinely in our laboratory [11,12] were carried out two 23 complete factorial 

designs in this study, requiring 10 experiments for  1st factorial design and 20 experiments for 2nd 

factorial design. The central point was run in replicates to provide an estimate of the pure error 

variance in the experimental responses. Experimental errors of the effects were estimated and used 

to assess the significance of the effects and interactions of the independent variables. The variables 

and their levels selected for study were: KMnO4 concentration (0.1–0.3 M), aniline concentration 

(0.5–1.0 M), polymerization time (1–3 h), contact time of KMnO4 (1–5 h), polymerization 

temperature (4–50ºC), and offered protein amount (50–200 µ g mL-1). Table 1 and 3 show the 

independent factors, levels and experimental design. The results were statistically analyzed by 

variance analysis (ANOVA) at a significance level of p ? 0.05. All statistical and graphical analyses 

were carried out with the “Statistical 8.0” software (StatSoft, Inc., 2004, USA).  

 

2.8. Characterization of mPANIG-Trypsin 

2.8.1. Thermal stability  

The thermal stability was evaluated by incubating samples of soluble trypsin and mPANIG-Trypsin 

in Tris-HCl buffer for 30 min at temperatures ranging from 25oC to 65oC. The heated samples were 



44 

 

kept at 25oC for temperature equilibration and their activities measured. All activity assays were 

carried out as described in the item 2.5.  

 

2.8.2. Kinetic constants  

The Km for soluble trypsin and mPANIG-Trypsin was calculated from initial rate data using 

BAPNA as substrate (0.15–3.75 mM). The Michaelis constant (Km) and the maximum reaction 

velocity (Vmax) of the soluble trypsin and mPANIG-Trypsin were determined mathematically using 

the Michaelis-Menten equation. 

 

2.8.3. Stability during storage  

The mPANIG-Trypsin was stored in Tris-HCl buffer at 4°C. The remaining activity of immobilized 

trypsin was evaluated during 48 days, by measurements of its activity, followed by washing with 

Tris-HCl buffer and storage again in the buffer at 4°C.  

 

2.9. Protein digestion  

mPANIG-Trypsin was used for digestion of bovine serum albumin (BSA). The stock solution of 

BSA (2.0 µ g mL-1) was prepared in Tris-HCl buffer. Before tryptic digestion, it was denatured in a 

95°C water bath for 5 min. Then, 100 µ L of stock solution and 800 µ L of Tris-HCl buffer were 

transferred into an tube containig mPANIG-Trypsin (10 µ g of protein/mg of mPANI). After the 

mixture solution was incubated in 37°C water bath for 15 min, mPANIG-Trypsin was separated by 

an external field. The supernatant was transferred to an Eppendorf tube and lyophilized. For 

comparison, 0.2 mg mL-1 BSA was digested by conventional in-solution proteolysis in Tris-HCl 

buffer for 12 h at 37°C (trypsin/substrate ratio, 1:40 w/w). 

 

2.10. MALDI-TOF MS procedure 

Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) 

measurements were performed in positive ion mode using an Autoflex III proteomics analyzer 

(Bruker Daltonics Inc., Billerica, MA, USA). The samples were prepared using the dried-droplet 

method [21]. They were dissolved in 100 µ L of 0.1% TFA. A volume of 1.0 µ L of matrix solution 

(10 µ g mL-1 CHCA dissolved in 50% aqueous ACN containing 0.3% TFA) was mixed to 1.0 µ L of 

the sample and 0.5 µ L of mixture was deposited on a MALDI plate. The MS instrument was 

operated at an accelerating voltage of 19 kV. A 100 Hz pulsed Nd:YAG laser at 355 nm was used. 

“FlexAnalysis” software obtained from Bruker Daltonics was used to identify proteins using the 

peptide fingerprint mass spectra (PMF). For PMF data, 1000 laser shots were accumulated for each 



45 

 

spectrum. Data obtained were searched using MASCOT (Matrix Sciences, London, UK) as the 

search engine.  

 

3. Results and discussion 

3.1. KMnO4 concentration, aniline concentration and polymerization time effect in the mPANIG-

Trypsin activity (1st factorial design) 

The main effects represent deviations of the average between the high and low levels for each 

factor. When the effect of a factor is positive, the response increase as the factor changes from low 

to high levels, for example [22]. The results of the 1st complete factorial design are presented in the 

Table 1.  

Table 1. Matrix of experiments and results for 1st factorial design 
 

Run    Response 
 KMnO4 

concentration 
(M) 

Aniline 
concentration 

(M) 

Polymerization 
time 
(h) 

Residual 
specific activity  

(%) 
1 0.1 0.5 1 70.05 
2 0.3 0.5 1 47.09 
3 0.1 1.0 1 26.37 
4 0.3 1.0 1 32.86 
5 0.1 0.5 3 69.49 
6 0.3 0.5 3 53.46 
7 0.1 1.0 3 33.04 
8 0.3 1.0 3 39.98 
9 0.2 0.75 2 37.09 

10 0.2 0.75 2 36.75 
 

 

The KMnO4 concentration and aniline concentration showed significant negative effect, suggesting 

that the decrease of the parameter values increase the residual specific activity of mPANIG-Trypsin 

(Table 2). Moreover, the polymerization time factor showed significant positive effect, suggesting 

that the increase of the parameter values increase the residual specific activity of enzyme. Alone the 

aniline and KMnO4 concentrations interaction between was statistically significant have positive 

effect (Table 2).  

Table 2. Main and interaction effects for the 1st complete factorial design 
 

Factors Effects on residual 
specific activity 

(a) KMnO4 concentration    –6.39 
(b) Aniline concentration   –26.96 
(c) Polymerization time      4.90 
a*b  13.10 
a*c     1.84* 
b*c    1.99* 
a*b*c  –1.61* 

                                        *Not significant (p&lt;0.05) 



 

According to the results shown in Table 

corresponded to lowest levels (0.5 M aniline, 0.1 M KMnO

results are similar to the conditions used in our research group [11,12], except by reduction in the 

polymerization time of 2 h to 1 h, thus an advantage in this study. 

As shown in Pareto chart (Figure 

and polymerization time) and their interactions that extend beyond the reference line were 

significant at the level of the 0.05. These results can be corroborated by data showed in the Table 

The aniline concentration represented the main effect most significant on residual specific activity 

of mPANIG-Trypsin, ie, it was what exerted a greater influence in the response.  This 1st design 

allowed obtaining an enzymatic derivative with 70.05% residual spec

 

Figure 1. Pareto chart for the effects of 
polymerization time (c) on residual specific activity of mPANIG
 

 

3.2. Contact time of KMnO4, polymerization temperature and offered protein effects in the 

mPANIG-Trypsin activity (2nd factorial design) 

A 2nd complete factorial design was carried out to produce an enzymatic derivative with greater 

activity than that observed in the 1st design done in this work. The results of this 2nd design can be 

seen in the Table 3.  

It is possible to see that the leve

(76.01%). According to data from Table 3

5 h, maintaining the polymerization temperature at 4°C and 50 µ g mL

decreased about 15%. This result shows the advantage of the optimization of original protocol, that 

uses a contact time of KMnO4 overnight [11,12].

 

According to the results shown in Table 1, the highest residual specific activity (70.05%) 

corresponded to lowest levels (0.5 M aniline, 0.1 M KMnO4 and polymerization time of 1 h). These 

results are similar to the conditions used in our research group [11,12], except by reduction in the 

polymerization time of 2 h to 1 h, thus an advantage in this study.  

As shown in Pareto chart (Figure 1), the main factors (KMnO4 concentration, aniline concentration 

and polymerization time) and their interactions that extend beyond the reference line were 

significant at the level of the 0.05. These results can be corroborated by data showed in the Table 

ne concentration represented the main effect most significant on residual specific activity 

Trypsin, ie, it was what exerted a greater influence in the response.  This 1st design 

allowed obtaining an enzymatic derivative with 70.05% residual specific activity.

Pareto chart for the effects of the variables KMnO4 concentration (a), aniline concentration (
) on residual specific activity of mPANIG-Trypsin from the 1st factorial design.

, polymerization temperature and offered protein effects in the 

Trypsin activity (2nd factorial design)  

A 2nd complete factorial design was carried out to produce an enzymatic derivative with greater 

activity than that observed in the 1st design done in this work. The results of this 2nd design can be 

It is possible to see that the levels inferiors are the best conditions observed in this design also 

According to data from Table 3, when the contact time of KMnO4 was elevated from 1 to 

5 h, maintaining the polymerization temperature at 4°C and 50 µ g mL-1 offered protein, the act

decreased about 15%. This result shows the advantage of the optimization of original protocol, that 

overnight [11,12]. 

46 

, the highest residual specific activity (70.05%) 

and polymerization time of 1 h). These 

results are similar to the conditions used in our research group [11,12], except by reduction in the 

concentration, aniline concentration 

and polymerization time) and their interactions that extend beyond the reference line were 

significant at the level of the 0.05. These results can be corroborated by data showed in the Table 2.  

ne concentration represented the main effect most significant on residual specific activity 

Trypsin, ie, it was what exerted a greater influence in the response.  This 1st design 

ific activity. 

 

), aniline concentration (b) and 
1st factorial design. 

, polymerization temperature and offered protein effects in the 

A 2nd complete factorial design was carried out to produce an enzymatic derivative with greater 

activity than that observed in the 1st design done in this work. The results of this 2nd design can be 

ls inferiors are the best conditions observed in this design also 

was elevated from 1 to 

offered protein, the activity 

decreased about 15%. This result shows the advantage of the optimization of original protocol, that 



 

Table 3. Matrix of experiments and results for 2nd factorial design
 

Run  
 Time of

KMnO
(h) 

1 (1) 1 
2 (1) 5 
3 (1) 1 
4 (1) 5 
5 (1) 1 
6 (1) 5 
7 (1) 1 
8 (1) 5 
9 (1) 3 
10 (1) 3 
11 (2) 1 
12 (2) 5 
13 (2) 1 
14 (2) 5 
15 (2) 1 
16 (2) 5 
17 (2) 1 
18 (2) 5 
19 (2) 3 
20 (2) 3 

       
 

 

The Pareto chart represents the estimated effects of the variables, and their interactions on residual 

specific activity in decreasing order of magnitude. It can be seen in Figure 

(polymerization temperature, contact time of KMnO

confidence level of 95%. Thus the values of the effects indicate that, on average, higher activities 

were obtained when factors contact time of

protein were at their lowest levels. 

 

Figure 2. Pareto chart for the effects of 
offered protein (f) on residual specific activity 
 

Matrix of experiments and results for 2nd factorial design

  Response
of 

KMnO4 
 

Polymerization 
temperature 

(°C) 

Offered protein 
amount 

(µg mL-1) 

Residual 
specifica 

(%)
4 50 72.70
4 50 60.45

50 50 34.85
50 50 32.38
4 200 37.01
4 200 41.61

50 200 31.51
50 200 30.74
27 125 44.41
27 125 43.80
4 50 79.05
4 50 60.87

50 50 30.07
50 50 30.63
4 200 38.32
4 200 36.70

50 200 33.35
50 200 31.93
27 125 45.33
27 125 39.69

The Pareto chart represents the estimated effects of the variables, and their interactions on residual 

specific activity in decreasing order of magnitude. It can be seen in Figure 2

(polymerization temperature, contact time of KMnO4, offered protein) are significant at a 

confidence level of 95%. Thus the values of the effects indicate that, on average, higher activities 

were obtained when factors contact time of KMnO4, polymerization temperature a

at their lowest levels.  

Pareto chart for the effects of the variables contact time of KMnO4 (d), polymerization temperature (
) on residual specific activity of mPANIG-Trypsin from the 2nd factorial design.

47 

Matrix of experiments and results for 2nd factorial design 

Response 
Residual 

specifica ctivity 
(%) 

72.70 
60.45 
34.85 
32.38 
37.01 
41.61 
31.51 
30.74 
44.41 
43.80 
79.05 
60.87 
30.07 
30.63 
38.32 
36.70 
33.35 
31.93 
45.33 
39.69 

The Pareto chart represents the estimated effects of the variables, and their interactions on residual 

2 that all main effects 

, offered protein) are significant at a 

confidence level of 95%. Thus the values of the effects indicate that, on average, higher activities 

, polymerization temperature and offered 

 

), polymerization temperature (e) and 
2nd factorial design. 



48 

 

Raising the polymerization temperature from 4 to 50°C with contact time of KMnO4 of 1 h and 50 

µ g mL-1 offered protein, the activity was reduced about 44%. The polymerization of aniline showed 

best results when carried out at 4°C than at higher temperatures as in the original protocol [11,12].   

Increasing offered protein from 50 to 200 µ g mL-1 with contact time of KMnO4 of 1 h and 

polymerization temperature of 4°C, the activity decreased about 38%. Among these, the 

polymerization temperature represented the main effect most significant on residual specific activity 

of mPANIG-Trypsin, it is corroborated by data showed in the Table 4. The results observed in these 

experiments show the influence of the conditions of coating on the catalytic performance of the 

mPANIG-Trypsin. In addition, the advantages of using a factorial design to obtain an enzymatic 

derivative with good retention of the activity when compared to the enzyme in its soluble form.  

 

Table 4. Main and interaction effects for the 2nd complete factorial design 
 

Factors Effects on residual 
specific activity 

(d) Contact time of KMnO4   –3.94 
(e) Polymerization temperature  –21.41 
(f) Offered protein amount  –14.98 
d*e    2.92 
d*f   4.14 
e*f  14.88 
d*e*f  –4.21 

                                         *Not significant (p&lt;0.05) 

 

3.3. mPANIG-Trypsin characterization 

 

3.3.1. Thermal stability 

The second goal this study was the mPANIG-Trypsin characterization with respect to temperature, 

substrate concentration and stored stability. The presence of the coating has an important role in the 

properties of the immobilized enzyme, in particular their catalytic performance as observed by 

Maciel et al. [23]. Activity of retention on the support is one of the most important aspects in the 

enzyme immobilization process. 

Fig. 3 shows the higher thermal stability of the immobilized trypsin at temperatures higher than 

35oC. This results were similar to those obtained by Bryjak and Kolarz [24], using trypsin 

immobilized on acrylic carrier.  

The link of a molecule of an enzyme to rigid support by several strong chemical bonds makes the 

structure of the protein molecule much more rigid, and hence unfolding and inactivation (for 

example, on heating) of such immobilized enzyme will be much more difficult occur than that of 

the starting, native enzyme [24]. At 45°C, the activity of mPANIG-Trypsin was 77%, compared to 



 

soluble trypsin which was 44%. An increase in thermal stability was observed when trypsin was 

immobilized on vermiculite [26], on  carboxymethylcellulose [27] and ferromagnetic Dacron [28]. 

These results suggest that the immobilized enzyme was more stable compared to 

enzyme.  

Thermal deactivation of soluble enzyme is caused by disruption of weak intra

subsequent unfolding of the protein chain. Immobilization of trypsin on composite of magnetic 

nanoparticles-polyaniline increased the the

hydrogen bonds, there by increasing the range of operating temperatures. Increase in thermal 

stability of the mPANIG-Trypsin was also due to multipoint attachment of the enzyme to PANI via 

glutaraldehyde  and prevention of autolysis.

 

Figure 3. Thermal stability of the mPANIG
(100%). 
 

3.3.2. Kinetic constants 

The affinity of the enzyme for substrate is characterized by the 

Km for soluble trypsin and mPANIG

Km of soluble trypsin (2.96 ± 0.23 mM) 

± 0.19 mM. In this amidolytic reacti

constant Km was 1.4-fold lower than that of the soluble enzyme, a clear sign of higher “apparent” 

affinity of BAPNA to the bound enzyme. This indicates an alteration in the affinity of the enzyme

towards to the substrate upon covalent

Gupta [29] and, Korecká et al. [30] reported 

the catalytic efficiency of an enzyme

of the soluble trypsin and mPANIG

sin which was 44%. An increase in thermal stability was observed when trypsin was 

immobilized on vermiculite [26], on  carboxymethylcellulose [27] and ferromagnetic Dacron [28]. 

These results suggest that the immobilized enzyme was more stable compared to 

Thermal deactivation of soluble enzyme is caused by disruption of weak intra

subsequent unfolding of the protein chain. Immobilization of trypsin on composite of magnetic 

polyaniline increased the thermal stability by stabilizing the weak ionic forces and 

hydrogen bonds, there by increasing the range of operating temperatures. Increase in thermal 

Trypsin was also due to multipoint attachment of the enzyme to PANI via 

yde  and prevention of autolysis. 

 

 

Thermal stability of the mPANIG-Trypsin (B). The obtained activities were referred to the highest activity 

The affinity of the enzyme for substrate is characterized by the constant of Michaelis

for soluble trypsin and mPANIG-Trypsin were determined using BAPNA. In comparison with 

of soluble trypsin (2.96 ± 0.23 mM) Km of mPANIG-Trypsin has decreased to the value of 2.13 

± 0.19 mM. In this amidolytic reaction catalyzed by immobilized trypsin, the value of saturation 

fold lower than that of the soluble enzyme, a clear sign of higher “apparent” 

affinity of BAPNA to the bound enzyme. This indicates an alteration in the affinity of the enzyme

covalent  immobilization on mPANIG. Amaral et al [28], Kumar and 

Gupta [29] and, Korecká et al. [30] reported similar results. The ratio Kcat/Km

the catalytic efficiency of an enzyme-substrate pair. In this study, the catalytic efficiencies (

of the soluble trypsin and mPANIG-Trypsin were found to be 645 and 580, respectively. The 

49 

sin which was 44%. An increase in thermal stability was observed when trypsin was 

immobilized on vermiculite [26], on  carboxymethylcellulose [27] and ferromagnetic Dacron [28]. 

These results suggest that the immobilized enzyme was more stable compared to the soluble 

Thermal deactivation of soluble enzyme is caused by disruption of weak intra-molecular forces and 

subsequent unfolding of the protein chain. Immobilization of trypsin on composite of magnetic 

rmal stability by stabilizing the weak ionic forces and 

hydrogen bonds, there by increasing the range of operating temperatures. Increase in thermal 

Trypsin was also due to multipoint attachment of the enzyme to PANI via 

Trypsin (B). The obtained activities were referred to the highest activity 

constant of Michaelis–Menten (Km). 

Trypsin were determined using BAPNA. In comparison with 

Trypsin has decreased to the value of 2.13 

on catalyzed by immobilized trypsin, the value of saturation 

fold lower than that of the soluble enzyme, a clear sign of higher “apparent” 

affinity of BAPNA to the bound enzyme. This indicates an alteration in the affinity of the enzyme 

on mPANIG. Amaral et al [28], Kumar and 

m defines a measure of 

substrate pair. In this study, the catalytic efficiencies (Kcat/Km) 

Trypsin were found to be 645 and 580, respectively. The 



 

catalytic efficiency of trypsin was de

the conclusion that the immobilization apparently did not introduce mass

limitations. According to Amaral et al. [28] such phenomenon could also be attributed to eventual

negatively charged matrix attraction for the positively charged substrate 

catalytic efficiency were similar to those obtained by Bayramo

 

3.3.3. Stability during storage 

Data of operational stability showed that 

Trypsin maintained 89% of its initial activity (Fig.

during this period. The immobilized trypsin on polyaniline supports retained 50% its original 

activity after 21days when stored at 4°C in phosphate buffer [32], 58% its original activity after 49 

days when stored at 4°C in glycine buffer containing CaCl

44 days (approximately) when stored in glycine buffer containing CaC

observed better results. Moreover, Chellapandian [26] reported that immobilized trypsin on 

vermiculite retained 84% its original activity after 60 days when stored in borate buffer. 

enzymatic derivative obtained this study was

activity after 55 days was 77% of initial value. This result indicates that the mPANIG

be stored in buffer only (no stabilizer, e.g. CaCl

of its initial activity.  

 

Figure 4. Shelf life of mPANIG

 

3.4. Model protein substrate digestion 

The main application of the mPANIG

for protein identification. The procedure included the digestion of BSA with mPANIG

catalytic efficiency of trypsin was decreased about 1.1-fold upon immobilization. These data lead to 

the conclusion that the immobilization apparently did not introduce mass-

limitations. According to Amaral et al. [28] such phenomenon could also be attributed to eventual

negatively charged matrix attraction for the positively charged substrate BAPNA. The results of the 

similar to those obtained by Bayramo?lu et al. [31]. 

Data of operational stability showed that after 5 cycles combining storage and reuse, mPANIG

Trypsin maintained 89% of its initial activity (Fig.4). An 11% decrease in activity was detected 

during this period. The immobilized trypsin on polyaniline supports retained 50% its original 

21days when stored at 4°C in phosphate buffer [32], 58% its original activity after 49 

days when stored at 4°C in glycine buffer containing CaCl2 [33] and 80% its original activity after 

44 days (approximately) when stored in glycine buffer containing CaCl2 [34]. In our study, we 

observed better results. Moreover, Chellapandian [26] reported that immobilized trypsin on 

vermiculite retained 84% its original activity after 60 days when stored in borate buffer. 

enzymatic derivative obtained this study was more stable during the period of 48 days, however its 

activity after 55 days was 77% of initial value. This result indicates that the mPANIG

be stored in buffer only (no stabilizer, e.g. CaCl2) for approximately 50 days, retaining about 90% 

 

Shelf life of mPANIG-Trypsin at 4°C stored in Tris-HCl buffer.

3.4. Model protein substrate digestion  

The main application of the mPANIG-Trypsin is residue-specific proteolysis to generate fragments 

identification. The procedure included the digestion of BSA with mPANIG

50 

fold upon immobilization. These data lead to 

-transfer and diffusion 

limitations. According to Amaral et al. [28] such phenomenon could also be attributed to eventual 

BAPNA. The results of the 

 

after 5 cycles combining storage and reuse, mPANIG-

An 11% decrease in activity was detected 

during this period. The immobilized trypsin on polyaniline supports retained 50% its original 

21days when stored at 4°C in phosphate buffer [32], 58% its original activity after 49 

[33] and 80% its original activity after 

[34]. In our study, we 

observed better results. Moreover, Chellapandian [26] reported that immobilized trypsin on 

vermiculite retained 84% its original activity after 60 days when stored in borate buffer. The 

more stable during the period of 48 days, however its 

activity after 55 days was 77% of initial value. This result indicates that the mPANIG-Trypsin may 

) for approximately 50 days, retaining about 90% 

HCl buffer. 

specific proteolysis to generate fragments 

identification. The procedure included the digestion of BSA with mPANIG-Trypsin in 



51 

 

15 min digestion. The resulting fragments were determined using MALDI-TOF MS and the 

analyses of these MS spectra were made using a Mascot database search as showed in the Table 5.  

 

 
Table 5. Identified peptide residues obtained from 15 min digestion using mPANIG-Trypsin 

 
Peptide sequence MW Missed  

cleavages 
Position 

BSA, 28% sequence coverage    
DTHKSEIAHR 1193.66 1 25–34 
SEIAHR  712.37 0 29–34 
FKDLGEEHFK 1249.67 1 35–44 
DLGEEHFK  974.49 0 37–44 
LVNELTEFAK 1163.68 0 66–75 
VASLR  545.25 0 101–105 
QEPER  658.29 0 118–122 
KFWGK  665.36 1 156–160 
FWGK  537.19 0 156–160 
GACLLPK  701.33 0 198–204 
GACLLPKIETMR 1347.58 1 198–209 
IETMR  664.28 0 205–209 
QRLR  572.23 1 219–222  
CASIQK  649.31 0 223–228 
FGER  508.15 0 229–232 
ALKAWSVAR 1001.63 1 233–241 
AWSVAR  689.37 0 236–241 
RHPEYAVSVLLR 1439.88 1 360–371 
HPEYAVSVLLR 1283.77 0 361–371 
HLVDEPQNLIK 1305.77 0 402–412 
QNCDQFEK 1011.41 0 413–420 
LGEYGFQNALIVR 1479.87 0 421–433 
YTRK  568.07 1 434–437  
KVPQVSTPTLVEVSR 1640.01 1 437–451 
VPQVSTPTLVEVSR 1511.91 0 438–451 
LCVLHEK 842.56 0 483–489 
RPCFSALTPDETYVPK 1823.99 0 508–523 
AFDEK  609.24 0 524–528 
QIKK  515.23 1 545–548 
EACFAVEGPK 1050.48 0 588–597 

 

The peptide mass fingerprinting (PMF) spectra of the in-solution tryptic digest was also measured 

as control (22 peptides matched, sequence coverage 30%).  As can be seen in the Table 5, a total of 

29 tryptic peptides from BSA were identified with the corresponding amino-acid sequence coverage 

of 28% for BSA using mPANIG-Trypsin. Comparing the MALDI-TOF MS results obtained from 

15 min digestion using mPANIG-Trypsin and 12 h in-solution digestion, the enzyme soluble 

exhibited higher sequence coverage (30%). The identification results of BSA are comparable to 

those obtained by using in-solution digestion that required a longer reaction time. The digestion 

time was significantly reduced from 12 h for in-solution digestion to 15 min for the digestion based 

on the immobilized enzyme. The results showed that mPANIG-Trypsin offers a proteolysis similar 

the in-solution digestion in relation to the sequence coverage, but the types of peptides obtained by 

the immobilized enzyme has a different profile from that of the soluble enzyme. According to Wang 



52 

 

et al. [35] the high surface area-to-volume ratio of trypsin-immobilized on magnetic particles can 

lead to the risks of the adsorption of proteins and peptides that might be the reason for the large 

missing parts in the coverage (e.g. 280–347 and 489–548 for BSA). Furthermore, the protein BSA 

contain several disulfide bridges and therefore more rigid and difficult to digest [36].  

A total of 28, 30 and 28 tryptic peptides from BSA were identified with the corresponding amino-

acid sequence coverage 46%, 44% and 43% for BSA after digestion with Trypsin-immobilized 

PA/Fe3O4/CNT composite [35], Trypsin-immobilized magnetic nanoparticles on chip [37] and 

Trypsin-immobilized on magnetic carbonaceous microspheres [38], respectively. In this study, the 

result found had a sequence coverage of 28%, much smaller than those observed by Wang et al. 

[35], Liu et al. [37] and Yao et al. [38]. A possible explanation for this low conversion (compared to 

the authors cited) may be due to the immobilization trypsin on microparticles and nanoparticles not, 

decreasing the surface area leading to a reduction in the enzyme-interaction. Another possible 

explanation may be due to a reduced contact, because the enzymatic derivative is not left under 

stirring proteolysis.   

Moreover, the digestion of specific proteins tends to be incomplete without additional pre-

treatments [39].  The reduced and alkylated BSA was generally used to obtain the digestive peptides 

with reproducibility [40], confirming the results of Sun et al. [41] that after pre-treatment of BSA 

exhibited sequence coverage above 90%.  

 

4. Conclusions 

The uses of the factorial design allowed obtaining an enzymatic derivative with residual activity of 

79% of the initial activity of soluble enzyme, showing the advantages offered by the use of 

optimized experimental conditions. In these conditions, the enzymatic derivative mPANIG-Trypsin 

exhibited: increased stability at high temperatures, and retention of 89% of its initial activity after 

storage at 4°C for 48 days. Furthermore, mPANIG-Trypsin showed higher affinity for the substrate 

BAPNA and a lower catalytic efficiency of 580. The excellent catalytic performance of mPANIG-

Trypsin is the major benefits of this enzymatic derivative. It can be used in proteins digestion to be 

simple method, rapid and low cost. 

 

Acknowledgements 

The authors wish to acknowledge financial support from the Brazilian agencies CNPq (Conselho 

Nacional de Desenvolvimento Científico e Tecnológico) and FACEPE (Fundação de Amparo a 

Ciência e Tecnologia de Pernambuco) and Júlia Campos (Centro de Tecnologias Estratégicas do 

Nordeste, Brazil) for the analyses of mass spectra.  

 



53 

 

References 

[1] W. Tischer, F. Wedekind, 1999. Immobilized Enzymes: Methods and Applications, in: Fessner, 

W.-D. (Ed.), Topics Current Chemistry (200). Springer Verlag Berlin Heidelberg, pp. 95-126. 

[2] U.T. Bornscheuer, Chem. Int. Edit. 42 (2003) 3336–3337. 

[3] F. Xi, J. Wu, Z. Jia, X. Lin, Process Biochem. 40 (2005) 2833–2840. 

[4] J. Ma, L. Zhang, Z. Liang, W. Zhang, W. Zhang, Y. Zhang, Anal. Chim. Acta 632 (2009) 1–8. 

[5] E. Bonneil, K.C. Waldron, Talanta 53 (2000) 687–699. 

[6] D. López-Ferrer, B. Cañas, J. Vázquez, C. Lodeiro, R. Rial-Otero, I. Moura, J.L. Capelo, Trends 

Anal. Chem. 25 (2006) 996–1005. 

[7] J.L. Capelo, R. Carreira, M. Diniz, L. Fernandes, M. Galesio, C. Lodeiro, H.M. Santos, G. Vale, 

Anal. Chim. Acta 650 (2009) 151–159. 

[8] B. Tural, N. Özkan, M. Voljan, J. Phys. Chem. Solids 70 (2009) 860–866. 

[9] K. Can, M. Ozmen, M. Ersoz, Colloid. Surface B 71 (2009) 154–159. 

[10] B.F. Pan, F. Gao, H.C. Gu, J. Colloid Interface Sci. 284 (2005), 1– 6.  

[11] D.F.M. Neri, V.M. Balcão, F.O.Q. Dourado, J.M.B. Oliveira, L.B. Carvalho Jr., 

J.A. Teixeira, React. Funct. Polym. 69 (2009) 246–251. 

[12] D.F.M. Neri, V.M. Balcão, F.O.Q. Dourado, J.M.B. Oliveira, L.B. Carvalho Jr., J.A. Teixeira, 

J. Mol. Catal. B-Enzym. 70 (2011) 74–80. 

[13] Y. Cao, P. Smith, A.J. Heeger, Synthetic Met. 48 (1992) 91–97. 

[14] A.G. MacDiarmid, J.C. Chiang, A.F. Richter, A.J. Epstein, Synthetic Met. 18 (1987) 285–290. 

[15] S.W. Ng, K.G. Neoh, J.T. Sampanthar, E.T. Kang, K.L. Tan, J. Phys. Chem. B 105 (2001) 

5618–5625. 

[16] W.R. Salaneck, I. Lundstrom, W.S. Huang, A.G. MacDiarmid, Synthetic Met. 13 (1986) 291–

297. 

[17] N. Nagaraja, J. Pattar, N. Shashank, J. Manjanna, Y., Kamada, K. Rajanna, H.M. Mahesh, 

Synthetic Met. 159 (2009) 718–722.  

[18] H.-Y.Ju, C.-H. Kuo, J.-R. Too, Y.-C. Liu, C.-J. Shieh, Biocatal. Agricultural Biotechnol. 1 

(2012) 20–24. 

[19] D. Bingol, N. Tekin, M. Alkan, Appl. Clay Sci. 50 (2010) 315– 321. 

[20] O.H. Lowry, N.J. Rosebrough, A.L. Farr, R.J. Randall, J. Biol. Chem. 193 (1951) 265–275. 

[21] M. Karas, F. Hillenkamp, Anal. Chem. 60 (1988) 2299–2301. 

[22] V. Ponnusami, F. Genoud, C. Menardo, M. Nechtschein, J. Hazard. Mater. 142 (2007) 397–

403.   

[23] J.C. Maciel, P.L. Andrad, D.F.M. Neri, L.B. Carvalho Jr., C.A. Cardoso, G.M.T. Calazans, J. 

Albino Aguiar, M.P.C. Silva, J. Magn. Magn. Mater. 324 (2012) 1312–1316.  



54 

 

[24] J. Bryjak, B.N. Kolarz, Process Biochem. 33 (1998) 409–417. 

[25] F.M.F. Monteiro, G.M.M. Silva, J.B.R. Silva, C.S. Porto, L.B. Carvalho Jr., J.L. Lima-Filho, 

A.M.A. Carneiro-Leão, M.G. Carneiro-da-Cunha, A.L.F. Porto, Process Biochem. 42 (2007) 884–

888. 

[26] M. Chellapandian, Process Biochem. 33 (1998) 169–173. 

[27] R. Villalonga, M.L. Villalonga, L. Gómez, J. Mol. Catal. B-Enzym. 10 (2000) 483–490. 

[28] I.P.G. Amaral, M.G. Carneiro-da-Cunha, L.B. Carvalho Jr., R.S. Bezerra, Process Biochem. 41 

(2006) 1213–1216. 

[29] A. Kumar, M.N. Gupta, J. Mol. Catal. B-Enzym. 5 (1998) 289–294. 

[30] L. Korecká, J. Ježová, Z. Bílková, M. Benes, D. Horák, O. Hradcová, M. Slováková, J.-L. 

Viovy, J. Magn. Magn. Mater. 293 (2005) 349–357.  

[31] G. Bayramo?lu, M. Yilmaz, A.Ü. ?enel, M.Y. Arica, Biochem. Eng. J. 40 (2008) 262–274. 

[32] SS. Caramori, K.F. Fernandes, Mater. Sci. Eng. C 28 (2008) 1159–1163. 

[33] L.L.A. Purcena, S.S. Caramori, S. Mitidieri, K.F. Fernandes, Mater. Sci. Eng. C 29 (2009) 

1077–1081. 

[34] SS. Caramori, F.N. de Faria, M.P. Viana, K.F. Fernandes, L.B. Carvalho Jr., Mater. Sci. Eng. 

C 31 (2011) 252–257.  

[35] S. Wang, H. Bao, P. Yang, G. Chen, Anal. Chim. Acta 612 (2008) 182–189. 

[36] E.C.A. Stigter, G.J. de Jong, W.P. van Bennekom, Anal. Chim. Acta 619 (2008) 231–238. 

[37] J. Liu, S. Lin, D. Qi, C. Deng, P. Yang, X. Zhang,  J. Chromatogr. A 1176 (2007) 169–177. 

[38] G. Yao, D. Qi, C. Deng, X. Zhang, J. Chromatogr. A 1215 (2008) 82–91. 

[39] E. Calleri, C. Temporini, E. Perani, C. Stella, S. Rudaz, D. Lubda, G. Mellerio, J.-L. Veuthey, 

G. Caccialanza, G. Massolini, J. Chromatogr. A 1045 (2004) 99–109. 

[40] S. Ota, S. Miyazaki, H. Matsuoka, K. Morisato, Y. Shintani, K. Nakanishi, J. Biochem. 

Biophys. Methods 70 (2007) 57–62. 

[41] L. Sun, Y. Li, P. Yang, G. Zhu, N.J. Dovichi, J. Chromatogr. A 1220 (2012) 68–74. 

 

 

 



55 

 

Capítulo 3 

 

5. Artigo submetido ao periódico Composites Science and Technology 

 

Título: Synthesis, characterization and magnetic property of composite of magnetic nanoparticles-
polyaniline for enzyme immobilization 
 
Autores: Jackeline C. Maciel, Willian T. Shigeyosi, Maristela Olzon-Dionysio, Cláudio A. 
Cardoso, David F.M. Neri, Maria da Paz C. Silva, Luiz B. Carvalho Jr. 

 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



56 

 

Synthesis, characterization and magnetic property of composite of magnetic nanoparticles-

polyaniline for enzyme immobilization 

 

Jackeline C. Maciela, Willian T. Shigeyosib, Maristela Olzon-Dionysiob, Cláudio A. Cardosob, 

David F.M. Neric, Maria da Paz C. Silvaa, Luiz B. Carvalho Jr.a 

 

aDepartamento de Bioquímica and Laboratório de Imunopatologia Keizo Asami, Universidade 

Federal de Pernambuco, 50670–901 Recife, PE, Brazil 
bDepartamento de Física, Universidade Federal de São Carlos, 13565–905 São Carlos, SP, Brazil 
cUniversidade Federal do Vale do São Francisco, 56304–205 Petrolina, PE, Brazil 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

*Corresponding author: 

Luiz Bezerra de Carvalho Júnior 

Laboratório de Imunopatologia Keizo Asami (LIKA) 

Universidade Federal de Pernambuco 

Cidade Universitária, Recife – PE CEP 50670–901, Brazil 

Telephone number: + 55-81-21268485/ Fax: +55-81-21268485 

E-mail address: lbcj@hotlink.com.br  



57 

 

Abstract 

In this paper, we report the preparation of magnetic nanoparticles via the chemical coprecipitation 

method. These magnetic nanoparticles were coated with polyaniline (PANI) in optimized conditions 

and characterized by different techniques. The electronic micrograph analysis showed nanoparticles 

with about 15 nm of average diameter and apparently regular morphology. A combination of FTIR, 

X-ray diffraction and Mössbauer spectroscopy techniques was used to understand the chemical 

composition of the nanoparticles, being identified as phases magnetite and maghemite. Both 

nanoparticles exhibited magnetic behavior and strong magnetization at room temperature. The 

coated magnetic nanoparticles (mPANI) presented ability to bind to biological molecules such as 

trypsin, forming the magnetic enzymatic derivative mPANIG-Trypsin. The protein amount and 

specific activity of the immobilized trypsin were 12.84 ± 4.95 µ g of protein/mg of mPANI (49.27% 

of immobilized protein) and 24.06 ± 0.67 U/mg of protein, respectively. After twenty reuses, the 

activity of mPANIG-Trypsin was 81% of initial activity. These results suggest that the use of this 

enzymatic derivative in different biomedical applications due to its excellent operational stability, 

high activity, simple method and at low cost. 

 

Keywords: magnetic nanoparticles, PANI, trypsin, biomedical applications. 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



58 

 

1. Introduction 

Functionalization of magnetic iron oxides nanoparticles by organic molecules gives rise to intensive 

research for biomedical applications such as magnetic drug targeting, hyperthermia and enzyme 

immobilization [1]. This attention is due to their unique catalytic, magnetic and electrical properties 

[2]. Within this scope, magnetite (Fe3O4) has become an important kind of magnetic material in 

different applications. The main aspects that have given a boost to the study of magnetite 

nanoparticles are mainly their chemical functionality of the active surface, biocompatibility and low 

cost [3], and its good magnetic property and a very high saturation magnetization [4].  

The need for combining the magnetic properties with the conductive properties leads to processing 

new materials such as conductive polymers with magnetic behavior, or magnetic particles 

containing a conductive polymer [5].  

Polyaniline (PANI) receives a special attention among other conducting polymers due to the simple 

synthetic methodology, good environmental stability, optical activity, controllable doping [6], an 

easy tunability of their electronic properties and high levels of electromagnetic shielding 

performances at microwave frequencies with a low mass by unit of surface [4]. The electromagnetic 

properties of polyaniline can be modified by the addition of inorganic fillers, such as the inclusion 

of magnetic particles may improve the magnetic and dielectric properties of host materials [7]. The 

production of monodisperse nanopowders and the control of their composition and size are 

therefore key points to address for applications of these materials [8]. 

Our main objective was to produce magnetic nanoparticles coated with polyaniline (PANI) to be 

used as a support for immobilization of trypsin. The catalytic performance of this enzymatic 

derivative was evaluated by its activity (reuses). For this, magnetic nanoparticles were prepared via 

coprecipitating ferrous and ferric ions in aqueous solution and then coated with PANI. These 

magnetic nanoparticles were characterized by electronic micrographic observations, FTIR, X-ray 

diffraction analysis, Mössbauer spectroscopy and magnetization measurements.  

 

2. Materials and methods 

2.1. Materials 

Trypsin (E.C.3.4.21.4) from porcine pancreas, bovine serum albumin (BSA), N-benzoyl-D-L-

arginine-p-nitroanilide (BAPNA), aniline (ACS reagent), potassium permanganate (ACS reagent), 

Folin-Ciocalteu’s phenol reagent and, 25 % glutaraldehyde were purchased from Sigma-Aldrich 

(USA). Dimethylsulfoxide (DMSO) and sodium hydroxide were from Vetec Chemical (Brazil). 

Ferric chloride hexahydrate and ferrous chloride tetrahydrate were from Merck (Germany). All 

other reagents were of analytical grade. 

 



59 

 

2.2. Magnetic particles preparation 

Solutions of 1.1 M FeCl3 .6H2O (5 mL) and of 0.6 M FeCl2 .4H2O (5 mL) were added to 50 mL of 

distilled water, under magnetic agitation, then 5.0 M NaOH was added dropwise up to pH 10 when 

black particles precipitate were produced. The mixture was heated at 50°C for 30 min with vigorous 

stirring. The magnetic nanoparticles were thoroughly washed with distilled water until pH was 

neutral. The material was dried up and kept at room temperature.  

 

2.3. Coating with PANI  

Oxidative polymerization of aniline was carried out in the presence of magnetic nanoparticles (0.5 

g) by treating them with 0.1 M KMnO4 (50 mL) solution at 25°C for 1 h and washed with distilled 

water. Then magnetic-KMnO4 nanoparticles were immersed into 50 mL of 0.5 M aniline solution 

(in 1.0 M HNO3). Polymerization was allowed to occur at 4°C for 1 h and after that the magnetic 

nanoparticles coated with polyaniline (mPANI) were successively washed with distilled water, 0.1 

M citric acid and rewashed with distilled water, and finally the material was dried up and kept at 

25°C. This process was performed using the optimum conditions obtained after the full factorial 

design (results not shown). 

        

2.4. Trypsin immobilization  

mPANI (0.01g) was incubated with 2.0% w/v glutaraldehyde (1.0 mL) at 25°C for 2 h under mild 

stirring, washed with distilled water and Tris-HCl buffer (0.1 M, pH 8.0) to remove the excess of 

glutaraldehyde. mPANI activated with glutaraldehyde (mPANIG) was kept in buffer at 4°C until 

use. mPANIG (0.01g) was incubated with trypsin for 16 h at 4°C under mild stirring. The 

enzymatic derivative (mPANIG-Trypsin) was collected by a magnetic field (Ciba corning; 0.6 T) 

and the supernatant and washings were used for protein determination.  

 

2.5. Activity assay  

Amidase activity of  trypsin was measured by using the artificial substrate BAPNA (4.0 mM 

BAPNA in DMSO). The mixture of reaction was incubated at 25°C for 15 min. The hydrolyzed p-

nitroanilide was monitored in spectrophotometer at 440 nm and the activity of enzyme was 

calculated. All assays were carried out in replicates and the results are expressed as mean ± SD. 

Proteolytic activity of trypsin (unit) was defined as µmol BAPNA hydrolyzed per minute using an 

absorption coefficient of 9.100 M-1 cm-1. The specific activity was calculated by dividing the 

enzymatic activity (U) by the amount of protein (mg). For the residual specific activity, was 

considered that the specific activity of free enzyme as 100%.  

 



60 

 

2.6. Protein determination 

The amount of immobilized protein was estimated by the difference between the offered protein and 

that found in the supernatant and washing solutions measured according to the method Lowry et al. 

[9] using bovine serum albumin (BSA) as a standard. 

 

2.7. Magnetic nanoparticles characterization  

The morphology and particle size of the nanoparticles were characterized using a FEI QUANTA 

200F scanning electron microscope (SEM) and a Jeol 1200EXII 80 transmission electron 

microscope (TEM). 

The polydispersity index (PDI) was obtained in a Delsa Nano C particle analyzer (Beckman 

Coulter, Krefeld, North Rhine-Wetphalia, Germany). Particles were suspended in 1.0 M HCl and 

placed in ultrasonic for 10 min to break aggregates. For each measurent, three analyzes were 

considered. 

The Fourier transform infrared (FTIR) spectra were obtained on an IFS–66 FTIR spectrometer 

(Bruker, Billerica, MA, USA) in the range of 4000-400 cm-1 using KBr pellets. Typically, 100 scans 

were recorded with a 4 cm-1 resolution.  

The BET surface area (Brunauer-Emmett-Teller) and pore volume was measured by nitrogen 

adsorption isotherm using an ASAP 2420 (Micromeritics, Atlanta, GA, USA).  

The structural properties of the magnetic particles were characterized by X-ray powder diffraction, 

which was carried out in a ray-X diffractometer Shimadzu model XDR 7000, using Cu K? radiation 

(? = 0.154 nm) at a scanning speed of 0.1° s-1 in the range of 2? = 10–90° with a step 0.02°.  

Mössbauer data collection was carried out at room temperature 298K using a 57Co (Rh-matrix) 

source of initially 10 mCi strength. The cobalt source is oscillated longitudinally so that its velocity 

varies between –10.5 and 10.5 mm s–1. Mössbauer spectrometer (model MB500) was calibrated 

using a thin ?-Fe foil. We performed a Mössbauer set using three distributions. In the first and the 

second were used a magnetic hyperfine field distribution (0 T to 55 T and 1 T-by-step). The third 

was using a quadrupole electric distribution (0 mm s–1 to 1.2 mm s–1 and 0.1 mm s–1 -by-step). Data 

analysis was performed using the computer program WinNormos for IGOR Pro 6.2® 

commercialized by WaveMetrics©, assuming that all the peaks are Gaussian in shape. 

Magnetization measurements were obtained at 298 K and 323 K in ± 50 KOe (50 T) applied field 

using a SQUID magnetometer (Quantum Design Model MPMS-5S).  

 

2.8. Reuse of the enzymatic derivate 

Two series of reuse was performed. The first reuse was carried out by assaying the same mPANIG-

Trypsin preparation with BAPNA ten times intercalating each successive use with buffer washing 



61 

 

(three times). This preparation was kept at 4°C during eight days and a second reuse was carried out 

as above. All of the experiments were conducted in triplicate. 

 

3. Results and discussion 

3.1. Synthesis of magnetic nanoparticles and PANI coating  

Magnetic particles were prepared in accordance with Carneiro Leão et al. [10] except by 

modifications in the incubation time (30 min), temperature (50°C), final pH of the mixture (10) and 

co-precipitation agent (NaOH) in order to obtain nanoparticles. According to Sun et al. [11], the 

synthesis of magnetite with sizes around 10 nm can be achieved using a reaction temperature of 

50°C, a solution pH of 10–11 and a high stirring rate (above 800 rpm). According to these authors, 

temperatures above 50°C lead to production of larger particles when the temperature increase, i.e., 

the growth of magnetite nucleus is easier to happen when the temperature is higher than 50°C. 

Regarding the pH, the reason that may explain why the size of magnetite nanoparticles is reduced 

with increasing pH of the solution when the pH is lower than 11 is based on the mechanism of 

formation of magnetite [11]. According to previous studies, Fe2+ adsorbs at the ferric hydroxide 

surface, the increase of the pH gives rise to dehydration of hydroxides and leads to the formation of 

magnetite facilitated by electron hopping between Fe2+ and Fe3+ [8]. NaOH was chosen as the 

precipitating agent instead of NH3· H2O used by Carneiro Leão et al. [10] because according to 

Hong et al. [12], the diameter of magnetite nanoparticles by co-precipitation with NaOH is smaller 

and with minor agglomeration then using NH3· H2O in water. The magnetic particles produced in 

this work (around 15 nm) have dimensions much smaller than those obtained by Neri et al. [13] 

(10–100 µ m) who followed the protocol of Carneiro Leão et al. [10]. 

The magnetic nanoparticles produced were coated with PANI (mPANI) by the oxidation of aniline 

with potassium permanganate. It is well known that, under certain synthesis conditions, PANI 

forms a sub-micrometer film on the surface of the objects immersed into a polymerization mixture. 

These films are formed on various types of substrates: conducting, insulating, hydrophobic, and 

hydrophilic. Thus, the polymer strongly adheres to the surface and covers even nanoparticles and 

nanostructure relief of the objects. The parameters of the film (its thickness, uniformity, and 

morphology) depend both on the chemical nature of the coated surface and on the synthesis 

conditions [14]. While hydrophobic materials are covered by a more or less uniform PANI film, the 

film relief on hydrophilic microparticles has often a discontinuous patchy character [15]. In addition 

to the film structure, the synthesis process results in a PANI precipitate which has no adhesion and 

is easily washed away from the surface. The ratio between the amounts of precipitate and film 

depends on the synthesis conditions [16]. Modifications of the experimental protocol [13] were 

made to obtain coated nanoparticles with good binding capacity for biomolecules. The optimal 



 

conditions were obtained from an experimental design (results not s

coating. The conditions were: 0.1 M KMnO

polymerization time of 1 h and polymerization temperature of 4°C. The concentrations of the 

oxidizing agent and aniline were identical to the pr

reduced from overnight to 1 h, the polymerization time from 2 h to 1 h and, the polymerization 

temperature from 25°C to 4°C. As a result, it was possible to form a core

which magnetic nanoparticles are the core and polyaniline the

 

3.2. Transmission and scanning electron micrographs

The morphology, shape and size distribution of magnetic nanoparticles and mPANI were examined 

by electron micrographs observation. Typical 

magnetic nanoparticles is shown in 

 

Figure 1. Electron microscopic images. TEM image of (A) magnetic nanoparticles and SEM images of (B) magnetic 
nanoparticles, (C) mPANI (lower resolution), (D) mPANI (higher resolution).

 

conditions were obtained from an experimental design (results not shown) used for the PANI 

coating. The conditions were: 0.1 M KMnO4, 0.5 M aniline, contact time of KMnO

polymerization time of 1 h and polymerization temperature of 4°C. The concentrations of the 

oxidizing agent and aniline were identical to the protocol; however, the contact time of KMnO

reduced from overnight to 1 h, the polymerization time from 2 h to 1 h and, the polymerization 

temperature from 25°C to 4°C. As a result, it was possible to form a core-shell structural mixture, in 

tic nanoparticles are the core and polyaniline the shell. 

Transmission and scanning electron micrographs  

The morphology, shape and size distribution of magnetic nanoparticles and mPANI were examined 

by electron micrographs observation. Typical transmission electron microscope (

magnetic nanoparticles is shown in Fig. 1A.  

Electron microscopic images. TEM image of (A) magnetic nanoparticles and SEM images of (B) magnetic 
(lower resolution), (D) mPANI (higher resolution). 

 

62 

hown) used for the PANI 

, 0.5 M aniline, contact time of KMnO4 of 1 h, 

polymerization time of 1 h and polymerization temperature of 4°C. The concentrations of the 

otocol; however, the contact time of KMnO4 was 

reduced from overnight to 1 h, the polymerization time from 2 h to 1 h and, the polymerization 

shell structural mixture, in 

The morphology, shape and size distribution of magnetic nanoparticles and mPANI were examined 

electron microscope (TEM) image of 

 

Electron microscopic images. TEM image of (A) magnetic nanoparticles and SEM images of (B) magnetic 



63 

 

Some magnetic nanoparticles are partially superimposed onto the agglomerate core, i.e., the 

boundary limit of each nanoparticle is partially diffuse; thus a precise average particle size cannot 

be determined. However, according to Cótica et al. [17] a narrowed particle sizes distribution can be 

seen. It should be noted that generally, magnetite nanoparticles with no surface treatments tend to 

agglomerate with the neighboring ones, which could be due to the substantial built-up specific 

surface area of the nanosized particles [18]. The presence of theses agglomerates may be due also to 

the magnetic nanoparticles aggregated together to reduce their surface energy [19] and/or due to the 

magnetic dipole-dipole interactions and the van der Waals forces between the nanoparticles [20,21]. 

In our work, the magnetic nanoparticles exhibited agglomerates with apparently regular 

morphology, nearly spherical/ellipsoidal shape, dimensions around 15 nm, and narrow particle size 

distribution (Fig. 1A). The morphology of the magnetic nanoparticles and mPANI was also 

investigated using a scanning electron microscope (SEM). The micrographs were obtained on 

metalized films deposited on carbon strip and results shown in Fig. 1B–D. SEM images revealed 

that mPANI present similar shape to the magnetic nanoparticles, a homogeneous structure and look 

like small flakes, i.e., the unstructured analog of PANI were obtained [22]. The surface of mPANI 

becomes rougher, which is due to the polymerization that occurred on the surface of magnetite 

nanoparticles and the strong interfacial interaction between the polymer matrix and magnetic 

nanoparticles as observed by Gu et al. [2]. 

The polydispersity index (PDI) of magnetic nanoparticles and mPANI was 0.47 and 0.29, 

respectively. According to Pich et al. [23], the increase in polydispersity can be explained by a 

simultaneous formation of large composite microparticles and smaller particles with iron oxide core 

and polymeric shell which precipitate on the surface of larger particles during polymerization 

process leading also to a noticeable morphology variation.  

 

3.3. FTIR spectra 

The emeraldine salt is the partly oxidized form of polyaniline where six benzene rings and two 

quinoid rings are present in an eight-ring repeating unit. The conductivity of the emeraldine form of 

polyaniline can be changed by about 10 orders of magnitude by doping [24]. The FTIR spectra of 

magnetic nanoparticles and mPANI are shown in Figure 2. It was found that mPANI had 

characteristic peaks at around 1494 cm-1 (C=C stretching of benzenoid ring), 1398 cm-1 (Q=N–B  

stretching deformation, Q refers to the quinoid ring and B to the benzenoid ring), 1305 and 1260 

cm-1 (C–N stretching benzenoid ring) and 805 cm-1 (out-of-plane deformation of C–H in the 1,4-

disubstitued benzene ring), which was similar with polyaniline [13,25,26]. The low intensity of the 

bands of the FTIR spectra (Fig. 2A) is believed to be due to the fact that, because of the presence of 

magnetic nanoparticles in the reaction system, aniline gets adsorbed on the oxide particles. 



 

Polymerization proceeds initially on the surface of these oxide particles in the presence of KMnO

in the reaction system. The adsorption of polymer to the magn

constrained chain growth around the particles. Such adsorption and constrained motion of the 

chains will restrict the modes of vibration in polyaniline, which in turn lead to the reduction in 

intensity in the FTIR spectra [24,

by two strong absorption bands at around 635 and 590 cm

band at 570 cm-1, which corresponds to the Fe

absorption bands of Fe–O bond were observed around 631 and 588 cm

and 630 and 580 cm-1 for mPANI. A principal effect of finite size of nanoparticles is the breaking of 

large number of bonds for surface atoms, resulting in the

surface [28]. The FTIR spectra in the range 750

are shown in the Fig. 2B. These spectra are compared with the spectrum of maghemite (not shown) 

confirming the oxidation and its increase after 

bands around the 570 cm–1 characteristic of magnetite 

small shoulders in the 600–750 cm

intensity after coating of the magnetic particles. The appearance of the characteristic maghemite 

peaks shows that the relative quantify of maghemite 

Figure 2. FTIR spectra of magnetic nanoparticles and mPANI.

Polymerization proceeds initially on the surface of these oxide particles in the presence of KMnO

in the reaction system. The adsorption of polymer to the magnetic nanoparticles results in 

constrained chain growth around the particles. Such adsorption and constrained motion of the 

chains will restrict the modes of vibration in polyaniline, which in turn lead to the reduction in 

intensity in the FTIR spectra [24,27]. The presence of Fe–O bond in magnetite particles can be seen 

by two strong absorption bands at around 635 and 590 cm-1. These bands result from split of the 

, which corresponds to the Fe–O bond of bulk magnetite [28

O bond were observed around 631 and 588 cm-1 for magneti

for mPANI. A principal effect of finite size of nanoparticles is the breaking of 

large number of bonds for surface atoms, resulting in the rearrangement of electrons on the particle 

The FTIR spectra in the range 750–450 cm–1 for magnetic nanoparticles and mPANI 

. These spectra are compared with the spectrum of maghemite (not shown) 

on and its increase after coating (Figure 2B). The spectra exhibit absorption 

characteristic of magnetite [8]. Although, the bandwidth increases, and 

750 cm–1 range as well as a band at 450 cm–

intensity after coating of the magnetic particles. The appearance of the characteristic maghemite 

peaks shows that the relative quantify of maghemite increases the coating. 

 

FTIR spectra of magnetic nanoparticles and mPANI. 

64 

Polymerization proceeds initially on the surface of these oxide particles in the presence of KMnO4 

etic nanoparticles results in 

constrained chain growth around the particles. Such adsorption and constrained motion of the 

chains will restrict the modes of vibration in polyaniline, which in turn lead to the reduction in 

O bond in magnetite particles can be seen 

. These bands result from split of the ?1 

O bond of bulk magnetite [28–31]. In our work, 

for magnetic nanoparticles 

for mPANI. A principal effect of finite size of nanoparticles is the breaking of 

rearrangement of electrons on the particle 

for magnetic nanoparticles and mPANI 

. These spectra are compared with the spectrum of maghemite (not shown) 

The spectra exhibit absorption 

Although, the bandwidth increases, and 
–1 appear with greater 

intensity after coating of the magnetic particles. The appearance of the characteristic maghemite 



 

3.4. Characterization of the surface areas of magnetic nanoparticles and mPANI

Nitrogen sorption isotherms for magnetic nanoparticles and mPANI can be seen in Fig. 3. The 

nitrogen adsorption–desorption isotherms of both magnetic materials produced belong to the type 

IV [32] with H4 hysteresis loops, according to IUPAC

represent the adsorption of N2 gas on the surfaces of the magnetic nanoparticles and mPANI, while 

the upper curve represents the progressive withdrawal; desorption, of the adsorbed N

observed by El-kharrag et al. 

materials (pores of widths between 2 nm and 50 nm) and their hysteresis loops are associated with 

the filling and emptying of the mesopores by capillary condensation [35]. 

For magnetic nanoparticles, the mesopores should be interparticle pores among magnetic 

nanoparticles. After coating such magnetic nanoparticles with polyaniline, there was a slight 

increase of 154.60 m2 g–1 to 162.93 m

average pore diameter (Barrett–Joyner

with uncoated magnetic nanoparticles. For magnetic nanoparticles, pore volume was of 0.36 cm

and average pore diameter of 9.46 nm, and for mPANI, pore volume was

average pore diameter of 8.72 nm, respectively. No pronounced difference in the pore size was 

observed between samples. Both samples show a broader pore distribution (results not shown) in 

which pores with different sizes coexist [35].

 

Figure 3. Nitrogen adsorption/desorption isotherms of magnetic nanoparticles and mPANI.

 

 

3.4. Characterization of the surface areas of magnetic nanoparticles and mPANI

Nitrogen sorption isotherms for magnetic nanoparticles and mPANI can be seen in Fig. 3. The 

desorption isotherms of both magnetic materials produced belong to the type 

IV [32] with H4 hysteresis loops, according to IUPAC–classification [33]. In the 

gas on the surfaces of the magnetic nanoparticles and mPANI, while 

the upper curve represents the progressive withdrawal; desorption, of the adsorbed N

kharrag et al. [34]. The magnetic nanoparticles and mPANI are mesoporous 

materials (pores of widths between 2 nm and 50 nm) and their hysteresis loops are associated with 

the filling and emptying of the mesopores by capillary condensation [35].  

the mesopores should be interparticle pores among magnetic 

nanoparticles. After coating such magnetic nanoparticles with polyaniline, there was a slight 

to 162.93 m2 g–1 in BET surface area. On the other hand, pore volume and 

Joyner–Halena, BJH method) were slightly reduced when compared 

with uncoated magnetic nanoparticles. For magnetic nanoparticles, pore volume was of 0.36 cm

average pore diameter of 9.46 nm, and for mPANI, pore volume was

average pore diameter of 8.72 nm, respectively. No pronounced difference in the pore size was 

samples. Both samples show a broader pore distribution (results not shown) in 

which pores with different sizes coexist [35]. 

Nitrogen adsorption/desorption isotherms of magnetic nanoparticles and mPANI.
 

65 

3.4. Characterization of the surface areas of magnetic nanoparticles and mPANI 

Nitrogen sorption isotherms for magnetic nanoparticles and mPANI can be seen in Fig. 3. The 

desorption isotherms of both magnetic materials produced belong to the type 

[33]. In the Fig. 3, the curves 

gas on the surfaces of the magnetic nanoparticles and mPANI, while 

the upper curve represents the progressive withdrawal; desorption, of the adsorbed N2 gas as 

]. The magnetic nanoparticles and mPANI are mesoporous 

materials (pores of widths between 2 nm and 50 nm) and their hysteresis loops are associated with 

the mesopores should be interparticle pores among magnetic 

nanoparticles. After coating such magnetic nanoparticles with polyaniline, there was a slight 

in BET surface area. On the other hand, pore volume and 

Halena, BJH method) were slightly reduced when compared 

with uncoated magnetic nanoparticles. For magnetic nanoparticles, pore volume was of 0.36 cm3 g–1 

average pore diameter of 9.46 nm, and for mPANI, pore volume was of 0.35 cm3 g–1 and 

average pore diameter of 8.72 nm, respectively. No pronounced difference in the pore size was 

samples. Both samples show a broader pore distribution (results not shown) in 

 

Nitrogen adsorption/desorption isotherms of magnetic nanoparticles and mPANI. 



 

3.5. XRD analysis 

Colors of iron oxide may be very dependent on grain size and chemical composition and this feature 

is a first auxiliary attribute in their 

mPANI are black and magnetic, suggesting that magnetite may be the dominant phase, although 

maghemite may not be completely excluded.

XRD patterns for magnetite and maghemite. As observed by 

peak due to other crystalline phase, which could occur as impurity, was observed, indicating that 

final products were pure enough, from this point of view, consisting

the two spinel magnetic iron oxides, meaning magnetite and maghemite. The differences in the 

crystalline behavior of magnetic nanoparticles and mPANI are analyzed by XRD 

Fig. 4 shows XRD patterns for magnetic

35.67°, 43.37°, 53.80°, 57.35°, 62.97°, 71.43° and 74.48° [2,6,37,38] are attributed to the crystal 

planes of magnetite at (111), (220), (311), (400), (422), (511), (440), (620) and (533) 

index of magnetite nanoparticles is in accordance with the International Center for Diffraction Data 

(reference code: ICDD 01–071

unmodified magnetite in the mPANI as can be seen in 

broadened lines that can be due to the magnetization relaxation from superparamagnetism and 

matrix constrictions for nanosized particles [40].

Figure 4. XRD patterns of magnetic nanoparticles and mPANI.

 

According to Yu et al. [37], the absence

corresponding to maghemite, suggests the magnetite as phase 

observed the absence of this peak. However, we cannot rule out the presence of maghemite i

Colors of iron oxide may be very dependent on grain size and chemical composition and this feature 

is a first auxiliary attribute in their identification [36]. In our work, magnetic nanoparticles and 

mPANI are black and magnetic, suggesting that magnetite may be the dominant phase, although 

maghemite may not be completely excluded. There are typically small differences between typical 

terns for magnetite and maghemite. As observed by Andrade et al. [

peak due to other crystalline phase, which could occur as impurity, was observed, indicating that 

final products were pure enough, from this point of view, consisting essentially of binary mixture of 

the two spinel magnetic iron oxides, meaning magnetite and maghemite. The differences in the 

crystalline behavior of magnetic nanoparticles and mPANI are analyzed by XRD 

shows XRD patterns for magnetic nanoparticles and mPANI. The 2? peaks at 18.44°, 30.30°, 

35.67°, 43.37°, 53.80°, 57.35°, 62.97°, 71.43° and 74.48° [2,6,37,38] are attributed to the crystal 

planes of magnetite at (111), (220), (311), (400), (422), (511), (440), (620) and (533) 

index of magnetite nanoparticles is in accordance with the International Center for Diffraction Data 

071–636). In this study, XRD results confirmed the presence of 

unmodified magnetite in the mPANI as can be seen in Fig. 4. Furthermore, the results showed 

broadened lines that can be due to the magnetization relaxation from superparamagnetism and 

matrix constrictions for nanosized particles [40]. 

XRD patterns of magnetic nanoparticles and mPANI. 

[37], the absence of the characteristic reflection of (221) plane, 

corresponding to maghemite, suggests the magnetite as phase predominant. In our w

of this peak. However, we cannot rule out the presence of maghemite i

66 

Colors of iron oxide may be very dependent on grain size and chemical composition and this feature 

identification [36]. In our work, magnetic nanoparticles and 

mPANI are black and magnetic, suggesting that magnetite may be the dominant phase, although 

There are typically small differences between typical 

Andrade et al. [36] no clear reflection 

peak due to other crystalline phase, which could occur as impurity, was observed, indicating that 

essentially of binary mixture of 

the two spinel magnetic iron oxides, meaning magnetite and maghemite. The differences in the 

crystalline behavior of magnetic nanoparticles and mPANI are analyzed by XRD measurements. 

peaks at 18.44°, 30.30°, 

35.67°, 43.37°, 53.80°, 57.35°, 62.97°, 71.43° and 74.48° [2,6,37,38] are attributed to the crystal 

planes of magnetite at (111), (220), (311), (400), (422), (511), (440), (620) and (533) [39]. The 

index of magnetite nanoparticles is in accordance with the International Center for Diffraction Data 

In this study, XRD results confirmed the presence of 

Furthermore, the results showed 

broadened lines that can be due to the magnetization relaxation from superparamagnetism and 

 

of the characteristic reflection of (221) plane, 

dominant. In our work, we also 

of this peak. However, we cannot rule out the presence of maghemite in the 



 

samples produced, since the FTIR results, for example, suggest 

al. [41] and Gorski and Scherer 

magnetite and magnetite–maghemite mixture was claimed

recent studies  report the differentiation between magnetite and maghemite by XRD analysis of high 

angle peaks as (511) or (440) and its

 

3.6. Mössbauer spectroscopy (MS) 

Because magnetite and maghemite have very similar XRD patterns, we performed further 

characterization by Mössbauer spectroscopy to distinguish the phases of iron oxide nanoparticles. 

The spectra were fitted using a two sextet model (sextet 1 and 2) 

adjusted Mössbauer spectra at 298 K for magnetic nanoparticles and mPANI, where the 

contribution of two magnetic subspectra corresponds to Fe

[Fe3+/Fe2+] in octahedral coordination in the spinel st

 

Figure 5. Mössbauer spectra of (A) magnetic nanoparticles and (B) mPANI.

 

The Table 1 shows the hyperfine parameters calculated from 

sextets present an important broadening, the hyperfine magnetic fields for magnetic nanoparticles 

are sextet 1 equal to 48.2 T and 

magnetic fields for mPANI are sexte

Table 1).  These values are similar to the bulk material 

are slightly inferior to the ones corresponding to the bulk material [45], this deviation in

ratio (1:2) of the iron in tetrahedral and octahedral position obtained from the subspectra area

in accordance with to the small particle size [44]. When the size is lower than 20 nm, the magnetic 

hyperfine structure is not resolved, cons

originating from the occurrence of superparamagnetic relaxation phenomena [8,47].  Previous work 

samples produced, since the FTIR results, for example, suggest otherwise (Fig. 4).

and Gorski and Scherer [42] reported that the differentiation between non

maghemite mixture was claimed to be almost impossible. However, more 

recent studies  report the differentiation between magnetite and maghemite by XRD analysis of high 

peaks as (511) or (440) and its resolution through the deconvolution [43].

. Mössbauer spectroscopy (MS)  

Because magnetite and maghemite have very similar XRD patterns, we performed further 

characterization by Mössbauer spectroscopy to distinguish the phases of iron oxide nanoparticles. 

The spectra were fitted using a two sextet model (sextet 1 and 2) for magnetite

adjusted Mössbauer spectra at 298 K for magnetic nanoparticles and mPANI, where the 

contribution of two magnetic subspectra corresponds to Fe3+ in the tetrahedral position and 

] in octahedral coordination in the spinel structure [38,44].  

Mössbauer spectra of (A) magnetic nanoparticles and (B) mPANI.

shows the hyperfine parameters calculated from Fig. 5. The resonant lines of both 

sextets present an important broadening, the hyperfine magnetic fields for magnetic nanoparticles 

to 48.2 T and sextet 2 equal to 44.9 T (Fig. 5A and Table 1). The hyperfine 

magnetic fields for mPANI are sextet 1 equal to 48.3 T and sextet 2 equal to 45.4 

These values are similar to the bulk material (sextet 1: 49.0 T and sextet 2: 46.0

are slightly inferior to the ones corresponding to the bulk material [45], this deviation in

ratio (1:2) of the iron in tetrahedral and octahedral position obtained from the subspectra area

in accordance with to the small particle size [44]. When the size is lower than 20 nm, the magnetic 

hyperfine structure is not resolved, consisting of broadened, overlapped, and asymmetrical lines 

originating from the occurrence of superparamagnetic relaxation phenomena [8,47].  Previous work 

67 

otherwise (Fig. 4). Vandenberghe et 

[42] reported that the differentiation between non-stoichiometric 

to be almost impossible. However, more 

recent studies  report the differentiation between magnetite and maghemite by XRD analysis of high 

resolution through the deconvolution [43]. 

Because magnetite and maghemite have very similar XRD patterns, we performed further 

characterization by Mössbauer spectroscopy to distinguish the phases of iron oxide nanoparticles. 

netite. Fig. 5 shows the 

adjusted Mössbauer spectra at 298 K for magnetic nanoparticles and mPANI, where the 

in the tetrahedral position and 

 

Mössbauer spectra of (A) magnetic nanoparticles and (B) mPANI. 

The resonant lines of both 

sextets present an important broadening, the hyperfine magnetic fields for magnetic nanoparticles 

(Fig. 5A and Table 1). The hyperfine 

sextet 2 equal to 45.4 T (Fig. 5B and 

and sextet 2: 46.0 T), but 

are slightly inferior to the ones corresponding to the bulk material [45], this deviation in the ideal 

ratio (1:2) of the iron in tetrahedral and octahedral position obtained from the subspectra area can be 

in accordance with to the small particle size [44]. When the size is lower than 20 nm, the magnetic 

isting of broadened, overlapped, and asymmetrical lines 

originating from the occurrence of superparamagnetic relaxation phenomena [8,47].  Previous work 



68 

 

reported on magnetite nanoparticles of 39 ± 5 nm in size have shown that the nanoparticles consist 

of a magnetite core surrounded by an oxidized layer close to maghemite [48].  

 

Table 1. Analyzed results of Mössbauer spectra for magnetic nanoparticles and mPANI. Bhf: hyperfine field; ?: 
quadrupole splitting; ?: isomer shift relative to the isomer shift of ?-iron at room temperature 
 

Sample Component Bhf (T) ? (mm s-1) ? (mm s-1) Area (%) 
Magnetic nanoparticles Doublet  0.00 0.21 ± 0.03 1 
 Sextet 1 48.2 ± 0.56 0.08 ± 0.03 0.17 ± 0.02 67 
 Sextet 2 44.9 ± 1.83 -0.21 ± 0.04 0.36 ± 0.04 32 
      
mPANI Doublet  0.00 0.21 ± 0.04 2 
 Sextet 1 48.3 ± 0.49 -0.13 ± 0.03 0.31 ± 0.04 49 
 Sextet 2 45.4 ± 0.56 0.11 ± 0.03 0.14 ± 0.02 48 

 

 

In addition to the signals relating to magnetite, the Fig. 5 also shows a doublet having an isomer 

shift equal to 0.21 mm s-1 for both samples and an area equal to 1% and 2% for magnetic 

nanoparticles and mPANI, respectively. In Fig. 5A, it is possible to observe the presence of a 

doublet at the center of the spectrum. Moreover, in Fig. 5B, the doublet is not well defined, possibly 

due to the presence of the coating. This doublet emanates from ferric iron in a non-spherical local 

surrounding, maybe coming from the rim of the iron oxide core, i.e., the magnetic relaxation effect 

which is attributed to the presence of superparamagnetic as well as the ferromagnetic nanoparticles 

[44]. Thus the Mössbauer spectrum could not be fitted with two discrete tetrahedral and octahedral 

sites along with a doublet because of the superposition of relaxing sextet and doublet patterns. To 

block the superparamagnetic relaxation effect, the Mössbauer spectrum should be recorded at low 

temperature [49]. According to Mössbauer spectra and the hyperfine parameters, it is evident that 

the process for obtaining the mPANI does not interfere significantly with the nature of the oxide 

[38]. However, a small percentage of maghemite must be present in the samples due to the 

oxidation process as can be corroborated by Fig. 2B. 

 

3.7. Magnetization measurements 

The magnetic properties of the magnetic nanoparticles and mPANI were investigated in the applied 

magnetic field sweeping from –60 to 60 kOe at 298 K and 323 K as shown in Fig. 6. It is well-

known that the size [50], structure and shape may affect the magnetic properties of the products 

[51]. Under applied magnetic field, magnetic nanoparticles and mPANI showed the positive 

magnetizations and there is no hysteresis (Fig. 6). It indicates the superparamagnetic behavior [30]. 

The difference between the magnetic behavior of small and medium sized particles can also be 

observed in their hysteresis loops [8]. 



 

Fig. 6 shows the field dependent magnetization curves of magnetic

saturation magnetization (Ms) for the magnetic

which is lower than that of bulk magnetite (

59.05 emu g–1 (Fig. 6). The reduction in the saturation magnetization values signifies the decrease in 

the particles size [53] and can be attributed to surface effects such as ma

containing spins that not collinear with the magnetic field as observed by 

These discrepancies in the saturation values of magnetization may be explained by variations in the 

methods employed to synthesize m

surfaces and chemical compositions 

 

Figure 6. Magnetization curves of magnetic nanoparticles and mPANI at 298 K and 323 K.

 

3.8. Reuse of the magnetic enzymatic derivative

The trypsin was immobilized on mPANIG yielding a preparation containing protein amount of 

12.84 ± 0.49 µ g of protein/mg of 

trypsin was reused ten times and presented a mean 

activity (22.44 ± 1.25 U/mg of protein), corresponding to 32.46 

enzyme. After ten reuses, immobilized trypsi

ten other reuses were performed.  This immob

mean specific activity of 81.26 ± 1.51% of the initial activity 

derivative activity during these twenty assa

Previously, immobilized trypsin on 

activity equal to 92.1 ± 7.3% of the initial activity [56

particles after ten reuses, a specific activity equal to 84.43 ± 5

shows the field dependent magnetization curves of magnetic nanoparticles and mPANI. 

for the magnetic nanoparticles has value equal to 60.51 emu g

n that of bulk magnetite (Ms = 92 emu g
–1) [52], and mPANI 

). The reduction in the saturation magnetization values signifies the decrease in 

and can be attributed to surface effects such as magnetically inactive layer 

containing spins that not collinear with the magnetic field as observed by Gu et al. (2009) 

These discrepancies in the saturation values of magnetization may be explained by variations in the 

methods employed to synthesize magnetite, which can generate different particle sizes, magnetite 

surfaces and chemical compositions [54]. 

Magnetization curves of magnetic nanoparticles and mPANI at 298 K and 323 K.
 

magnetic enzymatic derivative 

rypsin was immobilized on mPANIG yielding a preparation containing protein amount of 

mg of mPANI (49.27% of immobilized protein)

trypsin was reused ten times and presented a mean specific activity of 93.63 

of protein), corresponding to 32.46 ± 3.11% of the activity 

After ten reuses, immobilized trypsin on mPANI was stored at 4°C for

performed.  This immobilized enzyme presented the end of these reuses

± 1.51% of the initial activity (Fig. 7). The decrease in the trypsin 

derivative activity during these twenty assays was approximately 12% of the initial activity. 

Previously, immobilized trypsin on ferromagnetic Dacron presented after eight reuses a specific 

7.3% of the initial activity [56] and immobilized trypsin 

a specific activity equal to 84.43 ± 5.42% of the initial activity [57

69 

nanoparticles and mPANI. The 

nanoparticles has value equal to 60.51 emu g–1, 

and mPANI has value equal to 

). The reduction in the saturation magnetization values signifies the decrease in 

gnetically inactive layer 

Gu et al. (2009) [30]. 

These discrepancies in the saturation values of magnetization may be explained by variations in the 

agnetite, which can generate different particle sizes, magnetite 

 

Magnetization curves of magnetic nanoparticles and mPANI at 298 K and 323 K. 

rypsin was immobilized on mPANIG yielding a preparation containing protein amount of 

(49.27% of immobilized protein). The immobilized 

 ± 4.78% of the initial 

± 3.11% of the activity of the free 

n on mPANI was stored at 4°C for one week and then 

ilized enzyme presented the end of these reuses, a 

The decrease in the trypsin 

ys was approximately 12% of the initial activity. 

presented after eight reuses a specific 

immobilized trypsin magnetic levan 

.42% of the initial activity [57]. 



 

Moreover, Neri et al. [13] showed that after ten reuses the 

particles coated with PANI retained approximately 85% of

enzymatic derivative in this work

stability. Our goal is to use it in different applications in the biomedical field, especially in 

proteomics research, in the stage of p

Figure 7. Specific activity of mPANIG
initial concentration of BAPNA and Tris

4. Conclusions 

In conclusion, magnetic nanoparticles were obtained from modifications of the experimental 

protocol used routinely by our research group. These nanoparticles showed dimensions smaller than 

those obtained by original the protocol, corroborating the advantages of the optimization process. 

The FTIR, XRD and Mössbauer spectroscopy analysis of the nanoparticles confirmed 

of magnetite, but suggested the presence of another phase. Therefore, 

consist of a mixture of magnetite and maghemite, where maghemite is a result of oxidation of the 

magnetite. Furthermore, after PANI coating, nanoparticles exhibited good magnetization, an 

increase in the surface area and showed to be an excellent suppor

major benefits of the magnetic enzymatic derivative (

high activity, simple method and 

 

Acknowledgements 

The authors wish to acknowledge financial suppo

Nacional de Desenvolvimento Científico e Tecnológico)

Ciência e Tecnologia de Pernambuco)

(Laboratório de Ultraestrutura Celular Herta Meyer, UFRJ, Brazil) for the transmission electron 

Moreover, Neri et al. [13] showed that after ten reuses the ?-galactosidase immobilized on magnetic 

particles coated with PANI retained approximately 85% of the initial activity. Thus

in this work exhibited excellent activity retention and high 

stability. Our goal is to use it in different applications in the biomedical field, especially in 

proteomics research, in the stage of protein digestion.  

 

Specific activity of mPANIG-Trypsin. The immobilized trypsin on mPANIG was incubated with a 4 mM 
initial concentration of BAPNA and Tris-HCl buffer. After each cycle, the derivative were washed before new step.

 

In conclusion, magnetic nanoparticles were obtained from modifications of the experimental 

research group. These nanoparticles showed dimensions smaller than 

protocol, corroborating the advantages of the optimization process. 

The FTIR, XRD and Mössbauer spectroscopy analysis of the nanoparticles confirmed 

of magnetite, but suggested the presence of another phase. Therefore, the nanoparticles produc

consist of a mixture of magnetite and maghemite, where maghemite is a result of oxidation of the 

magnetite. Furthermore, after PANI coating, nanoparticles exhibited good magnetization, an 

increase in the surface area and showed to be an excellent support for trypsin immobilization. T

the magnetic enzymatic derivative (mPANIG-Trypsin) are its 

simple method and low cost of production. 

The authors wish to acknowledge financial support from the Brazilian agency CNPq (

Nacional de Desenvolvimento Científico e Tecnológico) and FACEPE (Fundação de Amparo a 

Ciência e Tecnologia de Pernambuco). The authors would like to thank Prof. Dr. Márcia Attias 

(Laboratório de Ultraestrutura Celular Herta Meyer, UFRJ, Brazil) for the transmission electron 

70 

galactosidase immobilized on magnetic 

l activity. Thus produced 

exhibited excellent activity retention and high operational 

stability. Our goal is to use it in different applications in the biomedical field, especially in 

 

Trypsin. The immobilized trypsin on mPANIG was incubated with a 4 mM 
HCl buffer. After each cycle, the derivative were washed before new step. 

In conclusion, magnetic nanoparticles were obtained from modifications of the experimental 

research group. These nanoparticles showed dimensions smaller than 

protocol, corroborating the advantages of the optimization process. 

The FTIR, XRD and Mössbauer spectroscopy analysis of the nanoparticles confirmed the presence 

nanoparticles produced 

consist of a mixture of magnetite and maghemite, where maghemite is a result of oxidation of the 

magnetite. Furthermore, after PANI coating, nanoparticles exhibited good magnetization, an 

t for trypsin immobilization. The 

are its operational stability, 

rt from the Brazilian agency CNPq (Conselho 

and FACEPE (Fundação de Amparo a 

Prof. Dr. Márcia Attias 

(Laboratório de Ultraestrutura Celular Herta Meyer, UFRJ, Brazil) for the transmission electron 



71 

 

microscopy analysis and Prof. Dr. Adilson J.A. de Oliveira (UFSCar, SP, Brazil) for the 

magnetization measurements.  

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



72 

 

References 

[1] Daou TJ, Grenèche JM, Pourroy G, Buathong B, Derory A, Ulhaq-Bouillet C, Donnio B, 

Guillon D, Begin-Colin S. Coupling agent effect on magnetic properties of functionalized 

magnetite-based nanoparticles. Chem Mater 2008; 20: 5869–5875. 

 

 [2] Gu H, Huang Y,  Zhang X,  Wang Q, Zhu J, Shao L, Haldolaarachchige N, Young DP, Wei S, 

Guo Z. Magnetoresistive polyaniline-magnetite nanocomposites with negative dielectrical 

properties. Polymer 2012; 53: 801–809. 

 

[3] Salado J, Insausti M,  Lezama L,  de Muro IG,  Goikolea E,  Rojo T. Preparation and 

characterization of monodisperse Fe3O4 nanoparticles: na electron magnetic resonance study. Chem 

Mater 2011; 23: 2879 – 2885. 

 

[4] Belaabed B,  Wojkiewicz JL,  Lamouri S,  Kamchi NE, Lasri T. Synthesis and characterization 

of hybrid conducting composites based on polyaniline/magnetite fillers with improved microwave 

absorption properties. J Alloy Compd 2012; 527: 137–144. 

 

[5] Khafagy RM. Synthesis, characterization, magnetic and electrical properties of the novel 

conductive and magnetic Polyaniline/MgFe2O4 nanocomposite having the core–shell structure. J 

Alloy Compd 2011; 509: 9849–9857. 

 

[6] Reddy KR, Lee K-P,  Gopalan AI, Kang H-D. Organosilane modified magnetite 

nanoparticles/poly(aniline-co-o/m-aminobenzenesulfonic acid) composites: Synthesis and 

characterization. React Funct Polym 2007; 67: 943–954. 

 

[7] Gandhi N, Singh K, Ohlan A, Singh DP, Dhawan SK. Thermal, dielectric and microwave 

absorption properties of polyaniline–CoFe2O4 nanocomposites. Compos Sci. Technol 2011; 71: 

1754–1760. 

 

[8] Salazar JS, Perez L, Abril O, Phuoc LT, Ihiawakrim D, Vazquez M, Greneche J-M,  Begin-

Colin S, Pourroy G. Magnetic iron oxide nanoparticles in 10–40 nm range: composition in terms of 

magnetite/maghemite ratio and effect on the magnetic properties. Chem Mater 2011; 23: 1379 – 

1386. 

 



73 

 

[9] Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol 

reagent. J Biol Chem 1951; 193: 265–275. 

 

[10] Carneiro Leão AMA, Oliveira EA, Carvalho Jr. LB. Immobilization for protein on 

ferromagnetic Dacron. Appl Biochem Biotech 1991; 32: 53–58. 

 

[11] Sun J, Zhou S,  Hou P, Yang Y, Weng J,  Li X,  Li M. Synthesis and characterization of 

biocompatible Fe3O4 nanoparticles. J Biomed Mater Res A 2007; 80A: 333–341. 

 

[12] Hong R,  Li J, Wang J, Li H. Comparison of schemes for preparing magnetic Fe3O4 

nanoparticles. China Part 2007; 5: 186–191. 

 

[13] Neri DFM, Balcão VM, Dourado FOQ, Oliveira JMB, Carvalho Jr. LB, Teixeira JA. 

Immobilized ?-galactosidase onto magnetic particles coated with polyaniline: support 

characterization and galactooligosaccharide production. J Mol Catal B-Enzym 2011; 70: 74–80. 

 

[14] Stejskal J, Sapurina I, Prokeš J, Zemek J. In-situ polymerization polyaniline films. Synthetic 

Met 1999; 105: 195–202. 

 

[15] Kohut-Svelko N, Reynaud S, Dedryevre R, Martinez H, Gonbeau D, Francois J. Study of a 

nanocomposite based on a conducting polymer: polyaniline. Langmuir 2005; 21: 1575–1583. 

 

[16] Stejskal J, Trchová M, Fedorova S, Sapurina I, Zemek J. Surface polymerization of aniline on 

silica gel. Langmuir 2003; 19: 3013–3018. 

 

[17] Cótica LF, Freitas VF, Dias GS, Santos IA, Vendrame SC, Khalil NM, Mainardes RM, Staruch 

M, Jain M. Simple and facile approach to synthesize magnetite nanoparticles and assessment of 

their effects on bloods cells. J Magn Magn Mater 2012; 324: 559–563. 

 

[18] Chen DH, He XR. Synthesis of nickel ferrite nanoparticles by sol-gel method. Mater Res Bull 

2001; 36: 1369–1377. 

 

[19] Hu C, Gao Z, Yang X. Fabrication and magnetic properties of Fe3O4 octahedra. Chem Phys 

Lett 2006; 429: 513–517.  

 



74 

 

[20] Lalatonne Y, Richardi J, Pileni MP. van der Waals versus dipolar forces controlling 

mesoscopic organizations of magnetic nanocrystals. Nat Mater 2004; 3: 121–125.  

 

[21] Valenzuela R, Fuentes MC, Parra C, Baeza J, Duran N, Sharma SK, Knobel M, Freer J. 

Influence of stirring velocity on the synthesis of magnetite nanoparticles (Fe3O4) by the co-

precipitation method. J Alloy Compd 2009; 488: 227–231. 

 

[22] Hopkins AR, Lipeles RA, Hwang S-J. Morphology characterization of polyaniline nano- and 

microstructures. Synthetic Met 2008; 158: 594–601. 

 

[23] Pich A, Bhattacharya S, Ghosh A, Adler HJP. Composite magnetic particles: 2. Encapsulation 

of iron oxide by surfactant-free emulsion polymerization. Polymer 2005; 46: 4596–4603. 

 

[24] Nagaraja N, Pattar J, Shashank N, Manjanna J, Kamada Y, Rajanna K, Mahesh HM. Electrical, 

structural and magnetic properties of polyaniline/pTSA-TiO2 nanocomposites. Synthetic Met 2009; 

159: 718–722. 

 

[25] Xiao Q, Tan X, Ji L, Xue J. Preparation and characterization of polyaniline/nano-Fe3O4 

composites via a novel Pickering emulsion route. Synthetic Met 2007;  157: 784–791. 

 

[26] Lin Y-W, Wu T-M. Synthesis and characterization of externally doped sulfonated 

polyaniline/multi-walled carbon nanotube composites. Compos Sci. Technol 2009; 69: 2559–2565. 

 

[27] Feng W, Bai XD, Lian YQ, Liang J, Wang XG, Yoshino K. Well-aligned polyaniline/carbon-

nanotube composite films grown by in-situ aniline polymerization. Carbon 2003; 41: 1551–1557. 

 

[28] Ma M, Zhang Y, Yu W, Shen H, Zhang H, Gu N. Preparation and characterization of 

magnetite nanoparticles coated by amino silane. Colloid Surface A 2003; 212: 219–226. 

 

[29] Xu XQ, Shen H, Xu JR, Li XJ. Aqueous-based magnetite magnetic fluids stabilized by surface 

small micelles of oleolysarcosine. Appl Surf Sci 2004; 221: 430–436. 

 

[30] Yamaura M, Camilo RL, Sampaio LC, Macêdo MA, Nakamura M, Toma HE. Preparation and 

characterization of (3-aminopropyl) triethoxysilane-coated magnetite nanoparticles. J Magn Magn 

Mater 2004; 279: 210–217. 



75 

 

[31] Klokkenburg M, Hilhorst J, Erné BH. Surface analysis of magnetite nanoparticles in 

cyclohexane solutions of oleic acid and oleylamine. Vib Spectrosc 2007; 43: 243–248. 

 

[32] Guo S, Li D, Zhang L, Li J, Wang E. Monodisperse mesoporous superparamagnetic single-

crystal magnetite nanoparticles for drug delivery. Biomaterials 2009; 30: 1881–1889. 

 

[33] Sing KSW, Everett DH, Haul RAW, Moscou L, Pierotti RA, Rouquérol J, Siemieniewska T. 

Reporting physisorption data for gas/solid systems with special reference to the determination of 

surface area and porosity. IUPAC 1985;  57: 603–619. 

 

[34] El-kharrag R, Amin A, Greish YE. Low temperature synthesis of monolithic mesoporous 

magnetite nanoparticles. Ceram Int 2012; 38: 627–634. 

 

[35] Yuan P, Fan M, Yang D, He H, Liu D, Yaun A, Zhu J, Chen T. Montmorillonite-supported 

magnetite nanoparticles for the removal of hexavalent chromium [Cr(IV)] from aqueuos solutions. J 

Hazard Mater 2009; 166: 821–829. 

  

[36] Andrade AL, Valente MA, Ferreira JMF, Fabris JD. Preparation of size-controlled 

nanoparticles of magnetite. J Magn Magn Mater 2012; 324: 1753–1757. 

 

[37] Yu W, Zhang T, Zhang J, Qiao X, Yang L, Liu Y. The synthesis of octahedral nanoparticles of 

magnetite. Mater Lett 2006; 60: 2998–3001. 

 

[38] Jaramillo-Tabares BE, Isaza FJ, Córdoba de Torresi SI. Stabilization of polyaniline by the 

incorporation of magnetite nanoparticles. Mater Chem Phys 2012; 132: 529–533. 

 

[39] Klug HP, Alexander LE. X-ray diffraction procedures for polycrystalline and amorphous 

materials 1974, 2 ed. New York: Willey-Interscience. 

 

[40] Quin XY. The exothermal and endothermal phenomena in nanocrystalline aluminum. 

Nanostruct Mater 1993; 2: 99–106. 

 

[41] Vandenberghe RE, Barrero CA, da Costa GM, Van San E, De Grave E. Mössbauer 

characterization of iron oxides and (oxy)hydroxides: the present state of the art. Hyperfine Interact 

2000; 126: 247–259. 



76 

 

[42] Gorski CA, Scherer MM. Influence of magnetite stoichiometry on FeII uptake and nitrobenzene 

reduction.  Environ Sci Techonol 2009; 43: 3675–3680. 

 

[43] Kim W, Suh C-Y, Cho S-W, Roh K-M, Kwon H, Song K, Shon I-J. A new method for the 

identification and quantification of magnetite–maghemite mixture using conventional X-ray 

diffraction technique. Talanta 2012; 94: 348–352. 

 

[44] Cabrera L, Gutierrez S, Menendez N, Morales MP, Herrasti P. Magnetic nanoparticles: 

electrochemical synthesis and characterization. Electrochim Acta 2008; 53: 3436–3441. 

 

[45] Dyar MD, Agresti DG, Schaefer MW, Grant CA, Sklute EC. Mössbauer spectroscopy of Earth 

and planetary materials. Annu Rev Earth Pl Sc 2006; 34: 83–125. 

 

[46] Kamali-M S, Ericsson T, Wäppling R. Characterization of iron oxide nanoparticles by 

Mössbauer spectroscopy. Thin Solid Films 2006; 515: 721–723. 

 

[47] Santana GP, Ramos AM, Fabris JD. Uma estratégia adaptada para síntese de magnetita. Quim 

Nova 2008; 31: 430–432. 

 

[48] Daou TJ, Pourroy G, Begin-Colin S, Greneche JM, Ulhaq-Bouillet C, Legare P, Bernhardt P, 

Leuvrey C, Rogez G. Hydrothermal synthesis of monodisperse magnetite nanoparticles. Chem 

Mater  2006; 18: 4399–4404. 

 

[49] Bandhu A, Mukherjee S, Acharya S, Modak S, Brahma SK, Das D, Chakrabarti PK. Dynamic 

magnetic behavior and Mössabauer effect measurements of magnetite nanoparticles prepared by a 

new technique in the co-precipitation method. Solid State Commun 2009; 149: 1790–1794. 

 

[50] Wen X, Yang J, He B, Gu Z. Preparation of monodisperse magnetite nanoparticles under mild 

conditions. Curr Appl Phys 2008; 8: 535–541. 

 

[51] Xu H, Shao M, Chen T, Zhuo S, Wen C, Peng M. Magnetism-assisted assembled porous Fe3O4 

nanoparticles and their electrochemistry for dopamine sensing. Micropor Mesopor Mat 2012; 153: 

35–40.  
 

[52] Cullity D. Introduction to Magnetic Materials 1972, Addison-Wesley, Reading, MA. 



77 

 

[53] Xu L, Du J, Li P, Qian Y. In situ synthesis, magnetic property, and formation mechanism of 

Fe3O4 particles encapsulated in ID bamboo-shaped carbon microtubes. J Phys Chem B 2006; 110: 

3871–3875. 

 

[54] Grigorova M, Blythe HJ, Blaskov V, Rusanov V, Petkov V, Masheva V,  Nihtianova D, 

Martinez LM, Muñoz JS, Mikhov M. Magnetic properties and Mössbauer spectra of nanosized 

CoFe2O4 powders. J Magn Magn Mater 1998; 183: 163–172. 

 

[55] Wei Y, Hsueh KF. Thermal analysis of chemically synthesized polyaniline and effects of 

thermal aging on conductivity. J Polym Sci A1 1989; 27: 4351–4363.  

 

[56] Amaral IPG, Carneiro-da-Cunha MG, Carvalho Jr. LB, Bezerra RS. Fish trypsin immobilized 

on ferromagnetic Dacron.  Process Biochem 2006; 41: 1213–1216. 

 

[57] Maciel JC,  Andrad PL, Neri DFM, Carvalho Jr. LB, Cardoso CA, Calazans GMT,  Aguiar JA,  

Silva MPC. Preparation and characterization of magnetic levan particles as matrix for trypsin 

immobilization.  J Magn Magn Mater 2012; 324: 1312–1316. 

 

 

 

 

 

 

 

 

 

 

 

 

 



78 

 

Capítulo 4 

 

6. Artigo publicado no periódico Journal of Magnetism and Magnetic Materials 

 

Título: Preparation and characterization of magnetic levan particles as matrix for trypsin 
immobilization 

Volume: 324  

Páginas: 1312–1316 

Ano: 2012  

Autores: J.C. Maciel, P.L. Andrade, D.F.M. Neri, L.B. Carvalho Jr., C.A. Cardoso, G.M.T. 
Calazans, J. Albino Aguiar, M.P.C. Silva 

 

 



79 

 

 



80 

 

 



81 

 

 



82 

 

 



83 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



84 

 

6. Conclusões 

 

• Foram produzidas partículas de levana magnética (seguindo o protocolo de rotina em nosso 

laboratório), por coprecipitação química de sais de ferro (II) e (III) em meio aquoso alcalino, 

na presença do polissacarídeo levana; 

• As partículas de levana magnética apresentaram como fase cristalina predominante a 

magnetita; exibiram bandas de absorção no infravermelho características de ligações 

químicas presentes no polissacarídeo; com formação de maiores agregados quando 

comparada ao material sem a levana; redução de dez vezes nas medidas de saturação da 

magnetização, provavelmente devido a presença do polímero durante o processo de 

coprecipitação. A tripsina imobilizada em levana magnética apresentou boa capacidade de 

reutilização, retendo 84% de sua atividade inicial após dez reutilizações.  

• Nanopartículas magnéticas foram obtidas a partir de modificações (temperatura, pH e agente 

de precipitação) do protocolo utilizado rotineiramente em nosso grupo de pesquisa; 

• As nanopartículas magnéticas são constituídas principalmente por magnetita, porém 

maghemita também foi detectada nas análises realizadas, indicando possível oxidação da 

magnetita à maghemita; 

• O processo de revestimento com polianilina não interferiu de forma significativa nas 

propriedades físicas, químicas e magnéticas do material magnético sintetizado; 

• O compósito mPANI foi utilizado para imobilização de tripsina de forma eficaz; 

• Foi observado que as condições de polimerização da anilina exercem influência na atividade 

da tripsina imobilizada, dessa forma o processo foi otimizado; 

• O derivado enzimático imobilizado mostrou melhores atividades em temperaturas mais 

elevadas quando comparado à enzima solúvel, indicando que a presença do revestimento 

confere estabilidade à enzima; 

• Foi verificado que o derivado enzimático apresenta excelente estabilidade operacional 

(reusos) e de estocagem; 

• A performance do derivado enzimático foi demonstrada pela digestão tríptica de albumina 

de soro bovino dentro de  15 min, apresentando uma sequência de conversão de 28%. A 

vantagem desta conversão em relação àquela com a enzima solúvel é o tempo de digestão 

que é bem menor; 

• O derivado enzimático produzido (mPANIG-Trypsina) apresenta boa capacidade de 

reutilização, baixo custo de obtenção, metodologia simples e grande número de possíveis 

aplicações. 



85 

 

7. ANEXOS 

7.1. Instruções para autores 

_____________________________________________________________________________ 

Preparation 
Use of wordprocessing software 
It is important that the file be saved in the native format of the wordprocessor used. The text should 
be in single-column format. Keep the layout of the text as simple as possible. Most formatting codes 
will be removed and replaced on processing the article. In particular, do not use the wordprocessor's 
options to justify text or to hyphenate words. However, do use bold face, italics, subscripts, 
superscripts etc. When preparing tables, if you are using a table grid, use only one grid for each 
individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align 
columns. The electronic text should be prepared in a way very similar to that of conventional 
manuscripts (see also the Guide to Publishing with Elsevier: 
http://www.elsevier.com/guidepublication). Note that source files of figures, tables and text 
graphics will be required whether or not you embed your figures in the text. See also the section on 
Electronic artwork.  
To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check' 
functions of your wordprocessor. 
Please use line numbering and double spacing for the manuscript at the time of submission. 
 
Article structure 
Subdivision - numbered sections 
Divide your article into clearly defined and numbered sections. Subsections should be numbered 1.1 
(then 1.1.1, 1.1.2,...), 1.2, etc. (the abstract is not included in section numbering). Use this 
numbering also for internal cross-referencing: do not just refer to 'the text'. Any subsection may be 
given a brief heading. Each heading should appear on its own separate line. 
Introduction 
State the objectives of the work and provide an adequate background, avoiding a detailed literature 
survey or a summary of the results. 
Materials and methods 
Experimental The experimental methods should be described after the introductory material. 
Detailed experimental descriptions should be restricted to one section of the paper. Sufficient detail 
should be given to allow any experienced worker to implement the procedures described. 
Procedural steps should not be numbered. 
Results 
Results should be clear and concise. 
Discussion 
This should explore the significance of the results of the work, not repeat them. A combined Results 
and Discussion section is often appropriate. Avoid extensive citations and discussion of published 
literature. 
Conclusions 
This should include key findings of the research, quantitative analytical performance figures (if 
appropriate) and their significance to real sample matrices. 
Appendices 
If there is more than one appendix, they should be identified as A, B, etc. Formulae and equations in 



86 

 

appendices should be given separate numbering: Eq. (A.1), Eq. (A.2), etc.; in a subsequent 
appendix, Eq. (B.1) and so on. Similarly for tables and figures: Table A.1; Fig. A.1, etc. 
 
Essential title page information 
• Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid 
abbreviations and formulae where possible. 
• Author names and affiliations. Where the family name may be ambiguous (e.g., a double name), 
please indicate this clearly. Present the authors' affiliation addresses (where the actual work was 
done) below the names. Indicate all affiliations with a lower-case superscript letter immediately 
after the author's name and in front of the appropriate address. Provide the full postal address of 
each affiliation, including the country name and, if available, the e-mail address of each author. 
• Corresponding author. Clearly indicate who will handle correspondence at all stages of 
refereeing and publication, also post-publication. Ensure that telephone and fax numbers (with 
country and area code) are provided in addition to the e-mail address and the complete postal 
address. Contact details must be kept up to date by the corresponding author. 
• Present/permanent address. If an author has moved since the work described in the article was 
done, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as a 
footnote to that author's name. The address at which the author actually did the work must be 
retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.  
Abstract 
A concise and factual abstract is required. The abstract should state briefly the purpose of the 
research, the principal results and major conclusions. An abstract is often presented separately from 
the article, so it must be able to stand alone. For this reason, References should be avoided, but if 
essential, then cite the author(s) and year(s). Also, non-standard or uncommon abbreviations should 
be avoided, but if essential they must be defined at their first mention in the abstract itself. 
Keywords 
Immediately after the abstract, provide a maximum of 6 keywords, using American spelling and 
avoiding general and plural terms and multiple concepts (avoid, for example, 'and', 'of'). Be sparing 
with abbreviations: only abbreviations firmly established in the field may be eligible. These 
keywords will be used for indexing purposes. 
Abbreviations 
Define abbreviations that are not standard in this field in a footnote to be placed on the first page of 
the article. Such abbreviations that are unavoidable in the abstract must be defined at their first 
mention there, as well as in the footnote. Ensure consistency of abbreviations throughout the article. 
Acknowledgements 
Collate acknowledgements in a separate section at the end of the article before the references and do 
not, therefore, include them on the title page, as a footnote to the title or otherwise. List here those 
individuals who provided help during the research (e.g., providing language help, writing assistance 
or proof reading the article, etc.). 
Nomenclature, abbreviations and symbols 
Please use L for litres. Always leave a space between units and use superscripts rather than /. For 
instance: use mg mL-1 and not mg/ml. Do not use ppm or ppb to denote solid/liquid concentrations.  
Do not use abbreviations in the title or keywords. Define abbreviations that are not standard in this 
field at their first occurrence in both the abstract and the main text. Ensure consistency of 
abbreviations throughout the remainder of the manuscript.  
In all other cases, the recommendations of the International Union of Pure and Applied Chemistry 
(IUPAC) should be followed, and attention should be given to the recommendations of the 
Analytical Chemistry Division in the journal Pure and Applied Chemistry (see also IUPAC 
Compendium of Analytical Nomenclature, Definitive Rules, 1987). 
Math formulae 
Present simple formulae in the line of normal text where possible and use the solidus (/) instead of a 
horizontal line for small fractional terms, e.g., X/Y. In principle, variables are to be presented in 



87 

 

italics. Powers of e are often more conveniently denoted by exp. Number consecutively any 
equations that have to be displayed separately from the text (if referred to explicitly in the text). 
Footnotes 
Footnotes should be used sparingly. Number them consecutively throughout the article, using 
superscript Arabic numbers. Many wordprocessors build footnotes into the text, and this feature 
may be used. Should this not be the case, indicate the position of footnotes in the text and present 
the footnotes themselves separately at the end of the article. Do not include footnotes in the 
Reference list.  
Table footnotes 
Indicate each footnote in a table with a superscript lowercase letter. 
ork 
Electronic artwork 
General points 
• Make sure you use uniform lettering and sizing of your original artwork.  
• Save text in illustrations as 'graphics' or enclose the font.  
• Only use the following fonts in your illustrations: Arial, Courier, Times, Symbol.  
• Number the illustrations according to their sequence in the text.  
• Use a logical naming convention for your artwork files.  
• Provide captions to illustrations separately.  
• Produce images near to the desired size of the printed version.  
• Submit each figure as a separate file.  
A detailed guide on electronic artwork is available on our website: 
http://www.elsevier.com/artworkinstructions 
You are urged to visit this site; some excerpts from the detailed information are given here. 
Formats 
Regardless of the application used, when your electronic artwork is finalised, please 'save as' or 
convert the images to one of the following formats (note the resolution requirements for line 
drawings, halftones, and line/halftone combinations given below):  
EPS: Vector drawings. Embed the font or save the text as 'graphics'.  
TIFF: Color or grayscale photographs (halftones): always use a minimum of 300 dpi.  
TIFF: Bitmapped line drawings: use a minimum of 1000 dpi.  
TIFF: Combinations bitmapped line/half-tone (color or grayscale): a minimum of 500 dpi is 
required.  
If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) 
then please supply 'as is'.  
 
Please do not: 
• Supply files that are optimised for screen use (e.g., GIF, BMP, PICT, WPG); the resolution is too 
low;  
• Supply files that are too low in resolution;  
• Submit graphics that are disproportionately large for the content. 
Color artwork 
Please make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office files) and 
with the correct resolution. If, together with your accepted article, you submit usable color figures 
then Elsevier will ensure, at no additional charge, that these figures will appear in color on the Web 
(e.g., ScienceDirect and other sites) regardless of whether or not these illustrations are reproduced 
in color in the printed version. For color reproduction in print, you will receive information 
regarding the costs from Elsevier after receipt of your accepted article. Please indicate your 
preference for color: in print or on the Web only. For 
further information on the preparation of electronic artwork, please see 
http://www.elsevier.com/artworkinstructions.  



88 

 

Please note: Because of technical complications which can arise by converting color figures to 'gray 
scale' (for the printed version should you not opt for color in print) please submit in addition usable 
black and white versions of all the color illustrations. 
 

Figure captions 
Ensure that each illustration has a caption. Supply captions separately, not attached to the figure. A 
caption should comprise a brief title (not on the figure itself) and a description of the illustration. 
Keep text in the illustrations themselves to a minimum but explain all symbols and abbreviations 
used. 
 
Tables 
Number tables consecutively in accordance with their appearance in the text. Place footnotes to 
tables below the table body and indicate them with superscript lowercase letters. Avoid vertical 
rules. Be sparing in the use of tables and ensure that the data presented in tables do not duplicate 
results described elsewhere in the article. 
 

Biographies and photographs 
Authors of reviews and tutorials will be required to upload a colour image and short biography of 
each individual author. Biographies should contain 2 to 3 sentences (max 100 words) indicating 
authors' present affiliation, number of publications, awards, current research interests and website if 
available. 
 
References 
Citation in text 
Please ensure that every reference cited in the text is also present in the reference list (and vice 
versa). Any references cited in the abstract must be given in full. Unpublished results and personal 
communications are not recommended in the reference list, but may be mentioned in the text. If 
these references are included in the reference list they should follow the standard reference style of 
the journal and should include a substitution of the publication date with either 'Unpublished results' 
or 'Personal communication'. Citation of a reference as 'in press' implies that the item has been 
accepted for publication. 
Web references 
As a minimum, the full URL should be given and the date when the reference was last accessed. 
Any further information, if known (DOI, author names, dates, reference to a source publication, 
etc.), should also be given. Web references can be listed separately (e.g., after the reference list) 
under a different heading if desired, or can be included in the reference list. 
References in a special issue 
Please ensure that the words 'this issue' are added to any references in the list (and any citations in 
the text) to other articles in the same Special Issue. 
Reference management software 
This journal has standard templates available in key reference management packages EndNote 
(http://www.endnote.com/support/enstyles.asp) and Reference Manager 
(http://refman.com/support/rmstyles.asp). Using plug-ins to wordprocessing packages, authors only 
need to select the appropriate journal template when preparing their article and the list of references 
and citations to 
these will be formatted according to the journal style which is described below. 
 
Reference style 
Text: Indicate references by number(s) in square brackets in line with the text. The actual 
authorscan be referred to, but the reference number(s) must always be given.  



89 

 

Example: '..... as demonstrated [3,6]. Barnaby and Jones [8] obtained a different result ....'  
List: Number the references (numbers in square brackets) in the list in the order in which they 
appear in the text.  
Examples: 
Reference to a journal publication:  
[1] J. van der Geer, J.A.J. Hanraads, R.A. Lupton, J. Sci. Commun. 163 (2010) 51–59.  
Reference to a book:  
[2] W. Strunk Jr., E.B. White, The Elements of Style, fourth ed., Longman, New York, 2000.  
Reference to a chapter in an edited book:  
[3] G.R. Mettam, L.B. Adams, in: B.S. Jones, R.Z. Smith (Eds.), Introduction to the Electronic Age, 
E-Publishing, Inc. New York, 2009, pp. 281–304. 
 
Journal abbreviations source 
Journal names should be abbreviated according to  
Index Medicus journal abbreviations: http://www.nlm.nih.gov/tsd/serials/lji.html;  
List of title word abbreviations: http://www.issn.org/2-22661-LTWA-online.php;  
CAS (Chemical Abstracts Service): http://www.cas.org/sent.html. 
 
Video data 
Elsevier accepts video material and animation sequences to support and enhance your scientific 
research. Authors who have video or animation files that they wish to submit with their article are 
strongly encouraged to include these within the body of the article. This can be done in the same 
way as a figure or table by referring to the video or animation content and noting in the body text 
where it should be placed. All submitted files should be properly labeled so that they directly relate 
to the video file's content. In order to ensure that your video or animation material is directly usable, 
please provide the files in one of our recommended file formats with a preferred maximum size of 
50 MB. Video and animation files supplied will be published online in the electronic version of 
your article in Elsevier Web products, including ScienceDirect: http://www.sciencedirect.com. 
Please supply 'stills' with your files: you can choose any frame from the video or animation or make 
a separate image. These will be used instead of standard icons and will personalize the link to your 
video data. For more detailed instructions please visit our video instruction pages at 
http://www.elsevier.com/artworkinstructions. Note: since video and animation cannot be embedded 
in the print version of the journal, please provide text for both the electronic and the print version 
for the portions of the article that refer to this content. 
 
Supplementary data 
Elsevier accepts electronic supplementary material to support and enhance your scientific research. 
Supplementary files offer the author additional possibilities to publish supporting applications, 
high-resolution images, background datasets, sound clips and more. Supplementary files supplied 
will be published online alongside the electronic version of your article in Elsevier Web products, 
including ScienceDirect: http://www.sciencedirect.com. In order to ensure that your submitted 
material is directly usable, please provide the data in one of our recommended file formats. Authors 
should submit the material in electronic format together with the article and supply a concise and 
descriptive caption for each file. For more detailed instructions please visit our artwork instruction 
pages at http://www.elsevier.com/artworkinstructions. 
 
Data at PANGAEA 
Electronic archiving of supplementary data enables readers to replicate, verify and build upon the 
conclusions published in your paper. We recommend that data should be deposited in the data 
library PANGAEA (http://www.pangaea.de). Data are quality controlled and archived by an editor 
in standard machine-readable formats and are available via Open Access. After processing, the 
author receives an identifier (DOI) linking to the supplements for checking. As your data sets will 



90 

 

be citable you might want to refer to them in your article. In any case, data supplements and the 
article will be automatically linked as in the following example: doi:10.1016/0016-7037(95)00105-
9. Please use PANGAEA's web interface to submit your data (http://www.pangaea.de/submit/). 
Submission checklist 
The following list will be useful during the final checking of an article prior to sending it to the 
journal for review. Please consult this Guide for Authors for further details of any item.  
 
Ensure that the following items are present: 
One author has been designated as the corresponding author with contact details:  
• E-mail address  
• Full postal address  
• Telephone and fax numbers  
All necessary files have been uploaded, and contain:  
• Keywords  
• All figure captions  
• All tables (including title, description, footnotes)  
Further considerations  
• Manuscript has been 'spell-checked' and 'grammar-checked'  
• References are in the correct format for this journal  
• All references mentioned in the Reference list are cited in the text, and vice versa  
• Permission has been obtained for use of copyrighted material from other sources (including the 
Web)  
• Color figures are clearly marked as being intended for color reproduction on the Web (free of 
charge) and in print, or to be reproduced in color on the Web (free of charge) and in black-and-
white in print  
• If only color on the Web is required, black-and-white versions of the figures are also supplied for 
printing purposes  
For any further information please visit our customer support site at http://support.elsevier.com. 
• Ensure that line numbering and double spacing are added to the manuscript. 
 
Additional information 
Computer programs Algorithms should be described clearly and concisely by means of a suitable 
algorithmic notation, although a standard high-level programming language may also be used. 
Complete program listings are not normally admissible. Flow charts should be avoided in favour of 
a textual or tabulated description of the program or data flow. Statements on the portability of the 
software described to other computer systems, as well as on its availability to interested readers, 
should be given. 
 
After acceptance 
Use of the Digital Object Identifier 
The Digital Object Identifier (DOI) may be used to cite and link to electronic documents. The DOI 
consists of a unique alpha-numeric character string which is assigned to a document by the 
publisher upon the initial electronic publication. The assigned DOI never changes. Therefore, it is 
an ideal medium for citing a document, particularly 'Articles in press' because they have not yet 
received their full bibliographic information. Example of a correctly given DOI (in URL format; 
here an article in the journal Physics Letters B): http://dx.doi.org/10.1016/j.physletb.2010.09.059 
When you use a DOI to create links to documents on the web, the DOIs are guaranteed never to 
change. 
 
Proofs 
One set of page proofs (as PDF files) will be sent by e-mail to the corresponding author (if we do 
not have an e-mail address then paper proofs will be sent by post) or, a link will be provided in the 



91 

 

e-mail so that authors can download the files themselves. Elsevier now provides authors with PDF 
proofs which can be annotated; for this you will need to download Adobe Reader version 7 (or 
higher) available free from http://get.adobe.com/reader. Instructions on how to annotate PDF files 
will accompany the proofs (also given online). The exact system requirements are given at the 
Adobe site: http://www.adobe.com/products/reader/tech-specs.html. If you do not wish to use the 
PDF annotations function, you may list the corrections (including replies to the Query Form) and 
return them to Elsevier in an e-mail. Please list your corrections quoting line number. If, for any 
reason, this is not possible, then mark the corrections and any other comments (including replies to 
the Query Form) on a printout of your proof and return by fax, or scan the pages and e-mail, or by 
post. Please use this proof only for checking the typesetting, editing, completeness and correctness 
of the text, tables and figures. Significant changes to the article as accepted for publication will only 
be considered at this stage with permission from the Editor. We will do everything possible to get 
your article published quickly and accurately – please let us have all your corrections within 48 
hours. It is important to ensure that all corrections are sent back to us in one communication: please 
check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. 
Proofreading is solely your responsibility. Note that Elsevier may proceed with the publication of 
your article if no response is received. 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



92 

 

 

_______________________________________________________________________________ 

Preparation 
Use of wordprocessing software 
It is important that the file be saved in the native format of the wordprocessor used. The text should 
be in single-column format. Keep the layout of the text as simple as possible. Most formatting codes 
will be removed and replaced on processing the article. In particular, do not use the wordprocessor's 
options to justify text or to hyphenate words. However, do use bold face, italics, subscripts, 
superscripts etc. When preparing tables, if you are using a table grid, use only one grid for each 
individual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align 
columns. The electronic text should be prepared in a way very similar to that of conventional 
manuscripts (see also the Guide to Publishing with Elsevier: 
http://www.elsevier.com/guidepublication). Note that source files of figures, tables and text 
graphics will be required whether or not you embed your figures in the text. See also the section on 
Electronic artwork.  
To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check' 
functions of your wordprocessor. 
 
Article structure 
Follow this order when typing manuscripts: Title, Authors, Affiliations, Abstract, Keywords, Main 
text, Acknowledgements, Appendix, References, Figure Captions and then Tables.  
Authors should consult a recent issue of the journal for style if possible. The Editors reserve the 
right to adjust style to certain standards of uniformity.  
The use of property names should be avoided as far as possible, but may be acceptable where, in the 
Editors opinion, the proprietary name is a universally known description of the material in question, 
eg Kevlar-49. 
Text Layout 
Use double spacing and wide (3 cm) margins. (Avoid full justification, i.e., do not use a constant 
right-hand margin.) Ensure that each new paragraph is clearly indicated. Present tables and figure 
legends on separate pages at the end of the manuscript. If possible, consult a recent issue of the 
journal to become familiar with layout and conventions. Number all pages consecutively, use 12 pt 
font size and standard fonts. 
Subdivision - numbered sections 
Divide your article into clearly defined and numbered sections. Subsections should be numbered 1.1 
(then 1.1.1, 1.1.2, ...), 1.2, etc. (the abstract is not included in section numbering). Use this 
numbering also for internal cross-referencing: do not just refer to 'the text'. Any subsection may be 
given a brief heading. Each heading should appear on its own separate line. 
Introduction 
State the objectives of the work and provide an adequate background, avoiding a detailed literature 
survey or a summary of the results. 
Material and methods 
Provide sufficient detail to allow the work to be reproduced. Methods already published should be 
indicated by a reference: only relevant modifications should be described. 
Results 
Results should be clear and concise. 
Discussion 
This should explore the significance of the results of the work, not repeat them. A combined Results 
and Discussion section is often appropriate. Avoid extensive citations and discussion of published 



93 

 

literature. 
Conclusions 
The main conclusions of the study may be presented in a short Conclusions section, which may 
stand alone or 
form a subsection of a Discussion or Results and Discussion section. 
Appendices 
If there is more than one appendix, they should be identified as A, B, etc. Formulae and equations in 
appendices should be given separate numbering: Eq. (A.1), Eq. (A.2), etc.; in a subsequent 
appendix, Eq. (B.1) and so on. Similarly for tables and figures: Table A.1; Fig. A.1, etc. 
Essential title page information 
• Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid 
abbreviations and formulae where possible. 
• Author names and affiliations. Where the family name may be ambiguous (e.g., a double name), 
please indicate this clearly. Present the authors' affiliation addresses (where the actual work was 
done) below the names. Indicate all affiliations with a lower-case superscript letter immediately 
after the author's name and in front of the appropriate address. Provide the full postal address of 
each affiliation, including the country name and, if available, the e-mail address of each author. 
• Corresponding author. Clearly indicate who will handle correspondence at all stages of 
refereeing and publication, also post-publication. Ensure that telephone and fax numbers (with 
country and area code) are provided in addition to the e-mail address and the complete postal 
address. Contact details must be kept up to date by the corresponding author. 
• Present/permanent address. If an author has moved since the work described in the article was 
done, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as a 
footnote to that author's name. The address at which the author actually did the work must be 
retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes. 
 
Abstract 
A concise and factual abstract is required. The abstract should state briefly the purpose of the 
research, the principal results and major conclusions. An abstract is often presented separately from 
the article, so it must be able to stand alone. For this reason, References should be avoided, but if 
essential, then cite the author(s) and year(s). Also, non-standard or uncommon abbreviations should 
be avoided, but if essential they must be defined at their first mention in the abstract itself. 
 
Keywords 
Authors should select a maximum of five keywords from the list at the end of these instructions. 
Each Keyword should be accompanied by the capital letter denoting the category from which the 
keyword has been selected. If authors wish they may nominate one keyword which is not included 
in the list below. The list of up to five keywords should appear on the title page of each paper 
submitted for consideration, following the abstract. 
 
Abbreviations 
Define abbreviations that are not standard in this field in a footnote to be placed on the first page of 
the article. Such abbreviations that are unavoidable in the abstract must be defined at their first 
mention there, as well as in the footnote. Ensure consistency of abbreviations throughout the article. 
Abbreviations for units should follow the suggestions of the British Standards publication BS 1991. 
The full stop should not be included in abbreviations, eg m (not m.), ppm (not p.p.m.): '%' and '/' 
should be used in preference to 'per cent' and 'per'. Where abbreviations are likely to cause 
ambiguity or not be readily understood by an international readership, units should be given in full. 
 
Acknowledgements 
Collate acknowledgements in a separate section at the end of the article before the references and do 
not, therefore, include them on the title page, as a footnote to the title or otherwise. List here those 



94 

 

individuals who provided help during the research (e.g., providing language help, writing assistance 
or proof reading the article, etc.). 
 
Units 
Follow internationally accepted rules and conventions: use the international system of units (SI). If 
other units are mentioned, please give their equivalent in SI. 
 
Nomenclature and units 
Follow internationally accepted rules and conventions: use the international system of units (SI). If 
other quantities are mentioned, give their equivalent in SI. You are urged to consult IUPAC: 
Nomenclature of Organic Chemistry: http://www.iupac.org/ for further information. 
 
Math formulae 
Present simple formulae in the line of normal text where possible and use the solidus (/) instead of a 
horizontal line for small fractional terms, e.g., X/Y. In principle, variables are to be presented in 
italics. Powers of e are often more conveniently denoted by exp. Number consecutively any 
equations that have to be displayed separately from the text (if referred to explicitly in the text). 
 
Footnotes 
Footnotes should be used sparingly. Number them consecutively throughout the article, using 
superscript Arabic numbers. Many wordprocessors build footnotes into the text, and this feature 
may be used. Should this not be the case, indicate the position of footnotes in the text and present 
the footnotes themselves separately at the end of the article. Do not include footnotes in the 
Reference list.  
Table footnotes 
Indicate each footnote in a table with a superscript lowercase letter. 
 
Artwork 
Electronic artwork 
General points 
• Make sure you use uniform lettering and sizing of your original artwork.  
• Save text in illustrations as 'graphics' or enclose the font.  
• Only use the following fonts in your illustrations: Arial, Courier, Times, Symbol.  
• Number the illustrations according to their sequence in the text.  
• Use a logical naming convention for your artwork files.  
• Provide captions to illustrations separately.  
• Produce images near to the desired size of the printed version.  
• Submit each figure as a separate file.  
A detailed guide on electronic artwork is available on our website:  
http://www.elsevier.com/artworkinstructions 
 
You are urged to visit this site; some excerpts from the detailed information are given here. 
Formats 
Regardless of the application used, when your electronic artwork is finalised, please 'save as' or 
convert the images to one of the following formats (note the resolution requirements for line 
drawings, halftones, and line/halftone combinations given below):  
EPS: Vector drawings. Embed the font or save the text as 'graphics'.  
TIFF: Color or grayscale photographs (halftones): always use a minimum of 300 dpi.  
TIFF: Bitmapped line drawings: use a minimum of 1000 dpi.  
TIFF: Combinations bitmapped line/half-tone (color or grayscale): a minimum of 500 dpi is 
required.  



95 

 

If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) 
then please 
supply 'as is'.  
Please do not: 
• Supply files that are optimised for screen use (e.g., GIF, BMP, PICT, WPG); the resolution is too 
low;  
• Supply files that are too low in resolution;  
• Submit graphics that are disproportionately large for the content. 
Color artwork 
Please make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office files) and 
with the correct resolution. If, together with your accepted article, you submit usable color figures 
then Elsevier will ensure, at no additional charge, that these figures will appear in color on the Web 
(e.g., ScienceDirect and other sites) regardless of whether or not these illustrations are reproduced 
in color in the printed version. For color reproduction in print, you will receive information 
regarding the costs from Elsevier after receipt of your accepted article. Please indicate your 
preference for color: in print or on the Web only. For further information on the preparation of 
electronic artwork, please see 
http://www.elsevier.com/artworkinstructions.  
Please note: Because of technical complications which can arise by converting color figures to 'gray 
scale' (for the printed version should you not opt for color in print) please submit in addition usable 
black and white versions of all the color illustrations. 
 
Figure captions 
Ensure that each illustration has a caption. Supply captions separately, not attached to the figure. A 
caption should comprise a brief title (not on the figure itself) and a description of the illustration. 
Keep text in the illustrations themselves to a minimum but explain all symbols and abbreviations 
used. 
 
Text graphics 
Text graphics may be embedded in the text at the appropriate position. If you are working with 
LaTeX and have such features embedded in the text, these can be left. Further, high-resolution 
graphics files must be provided separately whether or not the graphics are embedded. See further 
under Electronic artwork. 
 
Tables 
Number tables consecutively in accordance with their appearance in the text. Place footnotes to 
tables below the table body and indicate them with superscript lowercase letters. Avoid vertical 
rules. Be sparing in the use of tables and ensure that the data presented in tables do not duplicate 
results described elsewhere in the article. 
 
References 
Citation in text 
Please ensure that every reference cited in the text is also present in the reference list (and vice 
versa). Any references cited in the abstract must be given in full. Unpublished results and personal 
communications are not recommended in the reference list, but may be mentioned in the text. If 
these references are included in the reference list they should follow the standard reference style of 
the journal and should include a substitution of the publication date with either 'Unpublished results' 
or 'Personal communication'. Citation of a reference as 'in press' implies that the item has been 
accepted for publication. 
Web references 
As a minimum, the full URL should be given and the date when the reference was last accessed. 
Any further information, if known (DOI, author names, dates, reference to a source publication, 



96 

 

etc.), should also be given. Web references can be listed separately (e.g., after the reference list) 
under a different heading if desired, or can be included in the reference list. 
 
References in a special issue 
Please ensure that the words 'this issue' are added to any references in the list (and any citations in 
the text) to other articles in the same Special Issue. 
 
Reference management software 
This journal has standard templates available in key reference management packages EndNote 
(http://www.endnote.com/support/enstyles.asp) and Reference Manager 
(http://refman.com/support/rmstyles.asp). Using plug-ins to wordprocessing packages, authors only 
need to select the appropriate journal template when preparing their article and the list of references 
and citations to these will be formatted according to the journal style which is described below. 
 
Reference style 
All publications cited in the text should be presented in a list of references following the text of the 
manuscript. In the text refer to references by a number in square brackets on the line (e.g. Since Wu 
[1]), and the full reference should be given in a numerical list at the end of the paper. 
 
Submission checklist 
The following list will be useful during the final checking of an article prior to sending it to the 
journal for review. Please consult this Guide for Authors for further details of any item.  
Ensure that the following items are present: 
One author has been designated as the corresponding author with contact details:  
• E-mail address  
• Full postal address  
• Telephone and fax numbers  
All necessary files have been uploaded, and contain:  
• Keywords  
• All figure captions  
• All tables (including title, description, footnotes)  
Further considerations  
• Manuscript has been 'spell-checked' and 'grammar-checked'  
• References are in the correct format for this journal  
• All references mentioned in the Reference list are cited in the text, and vice versa  
• Permission has been obtained for use of copyrighted material from other sources (including the 
Web)  
• Color figures are clearly marked as being intended for color reproduction on the Web (free of 
charge) and in print, or to be reproduced in color on the Web (free of charge) and in black-and-
white in print  
• If only color on the Web is required, black-and-white versions of the figures are also supplied for 
printing purposes  
For any further information please visit our customer support site at http://support.elsevier.com. 
 
After acceptance 
Use of the Digital Object Identifier 
The Digital Object Identifier (DOI) may be used to cite and link to electronic documents. The DOI 
consists of a unique alpha-numeric character string which is assigned to a document by the 
publisher upon the initial electronic publication. The assigned DOI never changes. Therefore, it is 
an ideal medium for citing a document, particularly 'Articles in press' because they have not yet 
received their full bibliographic information. Example of a correctly given DOI (in URL format; 
here an article in the journal Physics Letters B): 



97 

 

http://dx.doi.org/10.1016/j.physletb.2010.09.059 
When you use a DOI to create links to documents on the web, the DOIs are guaranteed never to 
change. 
 
Proofs 
One set of page proofs (as PDF files) will be sent by e-mail to the corresponding author (if we do 
not have an e-mail address then paper proofs will be sent by post) or, a link will be provided in the 
e-mail so that authors can download the files themselves. Elsevier now provides authors with PDF 
proofs which can be annotated; for this you will need to download Adobe Reader version 7 (or 
higher) available free from http://get.adobe.com/reader. Instructions on how to annotate PDF files 
will accompany the proofs (also given online). The exact system requirements are given at the 
Adobe site:  http://www.adobe.com/products/reader/tech-specs.html.  
If you do not wish to use the PDF annotations function, you may list the corrections (including 
replies to the Query Form) and return them to Elsevier in an e-mail. Please list your corrections 
quoting line number. If, for any reason, this is not possible, then mark the corrections and any other 
comments (including replies to the Query Form) on a printout of your proof and return by fax, or 
scan the pages and e-mail, or by post. Please use this proof only for checking the typesetting, 
editing, completeness and correctness of the text, tables and figures. Significant changes to the 
article as accepted for publication will only be considered at this stage with permission from the 
Editor. We will do everything possible to get your article published quickly and accurately – please 
let us have all your corrections within 48 hours. It is important to ensure that all corrections are sent 
back to us in one communication: please check carefully before replying, as inclusion of any 
subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility. Note that 
Elsevier may proceed with the publication of your article if no response is received. 
 
Offprints 
The corresponding author, at no cost, will be provided with a PDF file of the article via e-mail. For 
an extra charge, paper offprints can be ordered via the offprint order form which is sent once the 
article is accepted for publication. The PDF file is a watermarked version of the published article 
and includes a cover sheet with the journal cover image and a disclaimer outlining the terms and 
conditions of use. 
 

 

 

 

 

 

 

 

 

 

 

 

 

 



98 

 

 

_______________________________________________________________________________ 

Guide for Authors  
 
Submission of papers  
Authors are encouraged to submit their papers using the Journal of Magnetism and Magnetic 
Materials online submission tool. Alternatively authors can submit by sending their manuscripts 
(one original + two copies), to one of the Editors. Papers for the section Information Storage: Basic 
and Applied should be submitted to R.W. Chantrell. Letters to the Editor should not exceed six 
pages when printed and will be given priority in both the refereeing and production processes. The 
faster production schedule may preclude sending proofs of letters to authors. Original material: 
Submission of a manuscript implies it is not being simultaneously considered for publication 
elsewhere and that the authors have obtained the necessary authority for publication. 
 
Manuscript preparation  
All manuscripts should be written in good English. The paper copies of the text should be prepared 
with double line spacing and wide margins, on numbered sheets. See notes opposite on the 
electronic version of manuscripts. Structure. Please adhere to the following order of presentation: 
Article title, Author(s), Affiliation(s), Abstract, PACS codes and keywords, Main text, 
Acknowledgements, Appendices, References, Figure captions, Tables.Corresponding author. The 
name, complete postal address, telephone and fax numbers and the e-mail address of the 
corresponding author should be given on the first page of the manuscript. PACS codes/keywords. 
Please supply one or more relevant PACS-1996 classification codes and about 5 keywords of your 
own choice for indexing purposes. References. References to other work should be consecutively 
numbered in the text using square brackets and listed by number in the Reference list. Please refer 
to recent issues for examples. 
 
Illustrations  
Illustrations should also be submitted in triplicate: one master set and two sets of copies. Theline 
drawings in the master set should be original laser printer or plotter output or drawn in black india 
ink, with careful lettering ,large enough (3-5 mm) to remain legible after reduction for printing.The 
photographs should be originals, with somewhat more contrast than is required in the printed 
version. They should be unmounted unless part of a composite figure. Any scale markers should be 
inserted on the photograph itself, not drawn below it. Colour plates. Figures may be published in 
colour, if this is judged essential by the Editor. The Publisher and the author will each bear part of 
the extra costs involved. Further information is available from the Publisher. 
 
After acceptance  
Notification. You will be notified by the Editor of the journal of the acceptance of your article and 
invited to supply an electronic version of the accepted text, if this is not already available. 
Copyright transfer. In the course of the production process you will be asked to transfer the 
copyright of the article to the Publisher. This transfer will ensure the widest possible dissemination 
of information. 
 
Electronic manuscripts  
The Publisher heartily welcomes the receipt of an electronic version of your accepted manuscript. If 
there is not already a copy of this (on diskette) with the Journal Editor at the time the manuscript is 
being refereed, you will be asked to send a file with the text of the accepted manuscript directly to 



99 

 

the Publisher by e-mail or on diskette to the address given below. (When e-mailing a non-ASCII 
word-processor file, you should encode it, e.g. with Uuencode or BinHex, so as to retain all 
formatting codes.) The name and version of the word-processing program and the type of operating 
system should always be indicated. Please note that no deviations from the version accepted by the 
Editor of the journal are permissible without the prior and explicit approval by the Editor. Such 
changes should be clearly indicated on an accompanying printout of the file. 
 
Author benefits  
No page charges. Publishing in the Journal of Magnetism and Magnetic Materials is free. Free 
offprints. The corresponding author will receive 25 offprints free of charge. An offprint order form 
will be supplied by the Publisher for ordering any additional paid offprints. Discount. Contributors 
to Elsevier journals are entitled to a 30% discount on all Elsevier books. 
 
 
 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



100 

 

7.2.  Comprovação da submissão dos artigos 
 
7.2.1. Artigo submetido ao periódico Analytica Chimica Acta 
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 



101 

 

7.2.2. Artigo submetido ao periódico Composites Science and Technology 
 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 



102 

 

7.3. Artigos publicados em periódicos 
 
ANGELI, R.; DA PAZ, N.V.N.; MACIEL, J.C.; ARAÚJO, F.F.B.; PAIVA, P.M.G.; CALAZANS, 
G.M.T.; VALENTE, A.P.; ALMEIDA, F.C.L.; COELHO, L.C.B.B.; CARVALHO, L.B.; SILVA, 
M.P.C.; CORREIA, M.T.S. Ferromagnetic Levan Composite: An Affinity Matrix to Purify Lectin. 
Journal of Biomedicine and Biotechnology, 2009, 1-7, 2009. 
 
MACIEL, J.C.; ANDRADE, P.L.; NERI, D.F.M.; CARVALHO Jr, L.B.; CARDOSO, C. A.; 
CALAZANS, G.M.T.; AGUIAR, J. ALBINO; SILVA, M.P.C. Preparation and characterization of 
magnetic levan particles as matrix for trypsin immobilization. Journal of Magnetism and Magnetic 
Materials, 324, 1312-1316, 2012. 
 
7.4. Artigos a serem submetidos 
 
Investigation of the molecular weight influence of levans from Zymomonas mobilis in the 
production of magnetic levan particles  
Jackeline C. Maciel, Mariana P. Cabrera, Cláudio A. Cardoso, David F.M. Neri, Maria da Paz C. 
Silva, Luiz B. Carvalho Jr. 
Periódico: Carbohydrate Polymers FI: 3.628 

 
Properties of immobilized trypsin on magnetic levan particles 
Jackeline C. Maciel, Ian P.G. Amaral, Givanildo B. Oliveira, Glícia M.T. Calazans, Luíz B. 
Carvalho Jr., Maria da Paz C. Silva 
Periódico: Applied Catalysis A: General FI: 3.903 
 

 
7.5. Trabalhos apresentados em congressos 
 
MACIEL, J.C.; ANDRADE, P.L.; CALAZANS, G.M.T.; CARDOSO, C.A.; AGUIAR, J.A.; 
SILVA, M.P.C. Synthesis and characterization of levan-coated magnetite particles. In: 
International Conference on Science and Technology of synthetic metals, 2008, Porto de 
Galinhas.  
 
ANDRADE, P.L.; MACIEL, J.C.; SILVA, V.A.J.; CALAZANS, G.M.T.; SILVA, M.P.C.; 
AGUIAR, J.A. Synthesis and structural studies of polysaccharides coated magnetite particles. In: II 
Simpósio Nacional em Diagnóstico e Terapêutica Experimental, V Jornada Científica do LIKA e 
II Fórum Brasileiro de Genética em Neuropsiquiatria, 2009, Recife. 
 
ANDRADE, P.L.; SILVA, V.A.J.; MACIEL, J.C.; CALAZANS, G.M.T.; SILVA, M.P.C.; 
AGUIAR, J.A. Síntese e caracterização da magnetita revestida por levana e fucana como suporte 
para imobilização de enzimas. In: 32a Reunião Anual da Sociedade Brasileira de Química, 2009, 
Fortaleza.  
 
SILVA, V.A.J.; ANDRADE, P.L.; MACIEL, J.C.; SOARES, M.T.C.V.; SILVA, M.P.C.; 
AGUIAR, J.A. Síntese e caracterização de partículas de magnetita recobertas pelo polissacarídeo 
fucana. In: 32a Reunião Anual da Sociedade Brasileira de Química, 2009, Fortaleza.  
 
MACIEL, J. C.; SILVA, V.A.J.; ANDRADE, P.L.; AGUIAR, J.A.; NERI, D.F.M.; SILVA, 
M.P.C.; CARVALHO Jr, L.B. Magnetic iron particles coated with polyaniline (PANI). In: IX 
Brazilian MRS Meeting, 2010, Ouro Preto.  



103 

 

MACIEL, J. C.; ANDRADE, P.L.; CARVALHO JR, L.B.; CALAZANS, G.M.T.; AGUIAR, J.A.; 
SILVA, M.P.C. Preparation and characterization of levan magnetite particles. In: XXXIX Annual 
Meeting of the Brazilian Society of Biochemistry and Molecular Biology (SBBq), 2010, Foz do 
Iguaçu.  
 
ANDRADE, P.L.; SILVA, V.A.J.; MACIEL, J.C.; SILVA, M.P.C.; AGUIAR, J.A. Study of fucan-
coated cobalt ferrite nanoparticles for immobilization of enzyme. In: III Simpósio Internacional 
em Diagnóstico e Terapêutica e VI Jornada Científica do LIKA, 2011, Recife.  
 
MOURA, E.M.; MACIEL, J.C.; ANDRADE, P.L.; SILVA, V.A.J.; CARVALHO JR, L.B.; 
SILVA, M.P.C. Magnetic particles coated with PANI and Fucan for enzyme immobilization. In: III 
Simpósio Internacional em Diagnóstico e Terapêutica e VI Jornada Científica do LIKA, 2011, 
Recife.  
 
MACIEL, J. C.; MOURA, E.M.; ANDRADE, P.L.; NERI, D.F.M.; AGUIAR, J.A.; SILVA, 
M.P.C.; CARVALHO JR, L.B. Preparation of magnetic microparticles magnetite coated with 
polyaniline. In: III Simpósio Internacional em Diagnóstico e Terapêutica e VI Jornada Científica 
do LIKA, 2011, Recife. 
 
MACIEL, J.C.; MOURA, E.M.; ANDRADE, P.L.; SILVA, V.A.J.; AGUIAR, J.A.; SILVA, 
M.P.C.; CARVALHO Jr, L.B. Characterization of magnetic particles coated with polyaniline for 
enzyme immobilization. In: X Encontro da Sociedade Brasileira de Pesquisa em Materiais - 
SBPMat, 2011, Gramado.  
 
MOURA, E.M.; MACIEL, J. C.; ANDRADE, P.L.; SILVA, V.A.J.; CARVALHO Jr, L.B.; SILVA, 
M.P.C. Magnetic particles coated with polymers for enzyme immobilization. In: X Encontro da 
Sociedade Brasileira de Pesquisa em Materiais - SBPMat, 2011, Gramado.  
 
SILVA, V.A.J.; ANDRADE, P.L.; MACIEL, J.C.; SILVA, M.P.C.; AGUIAR, J.A. 
Characterization and application of magnetite-fucan nanoparticles. In: X Encontro da Sociedade 
Brasileira de Pesquisa em Materiais - SBPMat, 2011, Gramado.  
 
 
7.6. Participação em bancas examinadoras 
 
Helena Paula Oliveira do Nascimento. Imobilização de proteases coaguladoras do leite em 
quitosana magnetizada. 2008. Trabalho de Conclusão de Curso (Graduação em Biologia) –  
Universidade Federal de Pernambuco. (Suplente). 
 
Larissa Parra de Araújo. Monitorização terapêutica de fármacos. 2009. Trabalho de Conclusão de 
Curso (Graduação em Farmácia) – Universidade Federal de Pernambuco. (Titular).  
 
Anna Carolina Araujo Ferreira da Silva. Protocolo quimioterápico baseado em fluorouracil e 
leucovorin para tratamento de câncer colorretal: uma revisão de suas variações. 2010. Trabalho de 
Conclusão de Curso (Graduação em Farmácia) – Universidade Federal de Pernambuco. (Titular). 
 
Sílvia Guedes Braga. Terra de diatomáceas magnética revestida com polianilina para imobilização 
de invertase. 2011. Trabalho de Conclusão de Curso (Graduação em Biomedicina) – Universidade 
Federal de Pernambuco. (Titular). 
 
 
 



104 

 

7.7. Orientações e colaborações 
 
Elaine Martins de Moura. Viabilização de partículas magnéticas revestidas com polímeros para a 
imobilização de enzimas. 2012. Dissertação (Mestrado em Bioquímica e Fisiologia) – 
Universidade Federal de Pernambuco. (Colaboradora).  
 
Albert Rocha de Oliveira. A importância do diagnóstico precoce e do tratamento adequado para 
gestantes com sífilis. 2012. Trabalho de Conclusão de Curso (Graduação em Farmácia) - 
Universidade Federal de Pernambuco. (Orientadora). 


</field>
	</doc>
</add>